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3Abstract
The  enzyme  transketolase  (Enzyme  Commission  number:  2.2.1.1)  has 
significant potential as a biocatalyst in the production of pharmaceuticals and 
fine  chemicals.  The enzyme  catalyses  the  irreversible  transfer  of a  C2  (1,2- 
dihydroxyethyl) moiety from p-hydroxypyruvate (P-HPA) to a wide range of 
acceptor  substrates  in  a  stereospecific  reaction.  However,  commercial 
application of transketolase is currently  restricted by  the limited availability 
and expense of p-HPA.  This project describes efforts to generate and identify 
variants  of  E.  coli  transketolase  that  are  capable  of  accepting  pyruvate:  a 
related, but much cheaper compound.  The variants were prepared by a novel 
directed evolution technique, "focused"  error-prone PCR (fepPCR), and then 
screened  for  the  desired  activity:  pyruvate  (donor)  and  glycolaldehyde 
(acceptor) to (S)-3,4-dihydroxybutan-2-one (and carbon dioxide).
The  high-throughput  screen  consisted  of  the  following  steps:
(1) transformation of a plasmid library into E. coli XL10-Gold competent cells;
(2) culture of individual colonies in 384-well plates; (3) lysis of the cultures; (4) 
incubation of the lysates with cofactors and the target substrates; and finally 
(5)  high-throughput  HPLC  analysis  measuring  donor  substrate  (pyruvate) 
depletion.  The first four steps were optimised to ensure the highest possible 
concentration  of  holotransketolase  in  each  screening  reaction.  The  HPLC 
method  utilised  a  50mm  guard  column  as  the  separation  matrix  and  was 
capable of processing one sample every 1.2 minutes.
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Several libraries of transketolase variants were generated using a novel 
mutagenesis technique:  "focused"  error-prone PCR  (fepPCR).  FepPCR uses 
knowledge  of  an  enzyme  as  a  map  for  targeting  mutation  to  the  most 
beneficial regions of the gene - in this case, three stretches of residues in the 
active  site  of  E.  coli transketolase  (Ser24-His26,  Gly99-Prol01,  and  Asp469- 
His473).  Primers were designed to flank these small target sites (9-15bp) and 
they were PCR-amplified from the tkt gene under conditions that drastically 
lowered  the  fidelity  of  Taq  DNA  polymerase  (0.14  misincorporations  per 
nucleotide).  The three mutated fepPCR products (50-54bp) were then cloned 
into the  tkt vector pQR711  singly  and  in combination to create four distinct 
libraries.  The  PCR-based  cloning  techniques  QuikChange  Site-Directed 
Mutagenesis  (Stratagene  Ltd.)  and  QuikChange  Multi  Site-Directed 
Mutagenesis (Stratagene Ltd.) were both found to be effective for this step.
The  four  libraries  were  screened  for  the  target  activity  and  the 
following levels of coverage were achieved: ~100% of all possible single point 
mutations in the three targets sites and ~22%  of all possible combinations of 
double  point  mutations  in  the  target  sites.  Careful  analysis  of  the  HPLC 
chromatograms failed to identify any variants with the desired activity.  It is 
proposed that larger libraries may yield positive results.
5Abbreviations
Om standard error of the mean
An absorbance at nnm
Amp+ denotes the inclusion of lSOmg.l1  ampicillin
ampR ampicillin resistance gene
AU absorbance unit
bp base-pair
BSA bovine serum albumin
CLERY combinatorial libraries enhanced by recombination in yeast
DNA deoxyribonucleic acid
DNAP DNA polymerase
dsDNA double-stranded DNA
DXP 1 -deoxy-D-xy lulose-5-phosphate
EC Enzyme Commission
EDTA ethylenediaminetetraacetic acid
epPCR error-prone PCR
FDA Federal Drugs Agency
fepPCR focused error-prone PCR
P-HPA p-hydroxypyruvate
HPLC high performance liquid chromatography
IGPS indole-3-glycerol-phosphate synthase
ISPR in situ product removal
ITCHY incremental truncation from the creation of hybrid enzymes
kat katal: 1 mole of product formed per second
kat.rrr3 katals per cubic metre
fccat catalytic constant (or turnover number)
Kd dissociation constant
KDPG 2-keto-3-deoxy-6-phosphoguconate
Km Michaelis constant
LB Luria Bertani
MEGAWHOP megaprimer PCR of whole plasmid
mpv mutations per variant
Mr relative molecular mass
MSDM "multi" site-directed mutagenesis
MTEH 5-(2-methylthioethyl)-hydantoin
NADH nicotinamide adenine dinucleotide, reduced form
OD„ optical density at nnm
ODU optical density unit
PCR polymerase chain reaction
PDA protein data automation
PDB RCSB Protein Data Bank
pQR711AH a library of pQR711 plasmids with mutations in target A
pQR711BP as above with mutations in target B
PQR711CP as above with mutations in target C
6Abbreviations
pQR711ABO* as above with mutations in targets A, B, and C
pQR711tktH a library of pQR711 plasmids with mutations in the tkt gene
PRAI phosphoribosylanthranilate isomerase
RACHITT random chimeragenesis on transient templates
rpm revolutions per minute
RPR random-priming recombination
scFv antibody single-chain Fv fragment
SCOPE structure-based combinatorial protein engineering
SDM site-directed mutagenesis
SDS-PAGE sodium dodecyl sulphate polyacrylamide gel electrophoresis
SHIPREC sequence homology-independent protein recombination
StEP staggered extension process
TAE Tris acetate EDTA
TBE Tris borate EDTA
TEMED N^N^N'-tetramethylethylendiamine
TFA trifluoroacetic acid
ThDP thiamine diphosphate
tkt Escherichia coli transketolase gene
Tm melting temperature
Tris tris(hydroxymethyl)aminomethane
UCL University College London
UV ultraviolet
17m ax maximal velocity
Note  that  an E.  coli  XLIO-Gold  pQR711ABCH  colony  with  the  label
pQR711ABO-M5H24 would have been generated by QuikChange™ MSDM 
("M") and stored in well H24 of pQR711ABO* master plate 5.  Similarly, an £. 
coli XLIO-Gold pQR711C^ colony with the label pQR711Q1 -SlJ16 would have 
been  generated  by  QuikChange™  SDM  ("S")  and  stored  in  well  J16  of 
pQR71TO master plate 1.
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1.1  Transketolase
Transketolase  (EC  2.2.1.1)  was  first  purified  from  the  yeast  Saccharomyces 
cerevisiae  (de  la  Haba  et  al,  1955),  and  subsequently  isolated  from  other 
sources  including:  rat  liver  (Horecker et al,  1956),  spinach  (Horecker et al, 
1956), pig liver (Simpson, 1960), the bacterium Lactobacillus pentosus  (Racker, 
1961),  the  fungus  Torula  sp.  (Racker,  1961),  rabbit  liver  (Racker,  1961),  the 
yeast  Saccharomyces  carlsbergensis  (Racker,  1961),  the  bacterium  Alcaligenes 
faecalis  (Domagk  and  Horecker,  1965),  the  yeast  Candida  utilis  (Kiely  et al, 
1969), human erythrocytes (Heinrich and Wiss, 1971), mouse brain (Blass et al, 
1982),  wheat  (Murphy  and  Walker,  1982),  human  leukocytes  (Mocali  and 
Paoletti, 1989), and the bacterium Escherichia coli (Sprenger, 1991).
The  ubiquitous  transketolase  is  a  thiamine  diphosphate  (ThDP) 
dependent  enzyme  that  catalyses  the  transfer  of  a  C2  moiety  (a  1,2- 
dihydroxyethyl  group) between a ketose sugar and  an aldose sugar (Figure 
1.1).  In vitro, transketolase is somewhat promiscuous and will accept a wide 
range of substrates. In vivo, the enzyme is found in the non-oxidative branch 
of the pentose phosphate pathway where it, together with transaldolase (EC 
2.2.1.2),  creates  a  link  to  glycolysis.  It  catalyses  two  reactions:  (a)  the 
conversion  of  D-xylulose-5-phosphate  and  D-ribose-5-phosphate  to  D- 
sedulose-7-phosphate  and  D-glyceraldehyde-3-phosphate;  and  (b)  the 
conversion  of  D-xylulose-5-phosphate  and  D-erythose-4-phosphate  to  D- 
fructose-6-phosphate  and  D-glyceraldehyde-3-phosphate.  In  plants  and
17Chapter 1 - Introduction
CHpH  CH2OH
c=o  c=o
H\   o .  /H
HO—C—H  +  ^   +  HO—C—H
I   I   I   I
H—C—OH  H—C—OH  H—C—OH  H—C—OH
I I   I I
X  Y  X  Y
Figure 1.1.  Scheme of the transketolase reaction shown in Fischer projection. 
A  1,2-dihydroxyethyl  group  is  transferred  between  a  ketose  (red  carbon 
skeleton)  and  an  aldose  (blue  carbon  skeleton).  X  and  Y  are  variable  (R 
groups).
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Figure  1.2.  Amino  acid  sequences  of  S.  cerevisiae  ("Sc")  and  £.  coli  ("Ec") 
transketolases aligned using ClustalW.  The 302 identical residues are shaded 
red  and  the  98  similar  residues  (determined  by  the  BLOSUM62  matrix: 
Henikoff and Henikoff, 1992) are shaded blue.  (Adapted from Schenk et al, 
1997.)
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photosynthetic bacteria, transketolase is also found in the Calvin cycle where 
ribulose-l,5-phosphate is regenerated from phosphoglycerate.
The  amino  acid  sequences  of  transketolases  from  different  species 
show  a  high  degree  of  sequence  homology;  for  example,  Schenk  and  co­
workers (1997)  aligned 22 sequences, 519-710 residues in length, and found 
that 50 residues were totally invariant.  Figure 1.2 shows an alignment of the S. 
cerevisiae  and  £.  coli  transketolases  that  illustrates  the  high  degree  of 
homology.  The  majority  of  transketolases  that  have  been  studied  are 
homodimeric with subunit molecular weights ranging from 67 to 75 kDa.
The enzyme from S. cerevisiae was the first to yield to a crystallographic
o
structural  analysis.  The  crystal  structure,  initially  determined  at  2.5  A
o
resolution  (Lindqvist  et  al,  1992)  and  subsequently  extended  to  2.0  A 
resolution  (Nikkola et al,  1994),  revealed  the first  insights  into the catalytic 
mechanism of  transketolase.  E.  coli  transketolase  has  also  been  crystallised
o
(Littlechild  et al,  1995)  and  the  crystal  structure  has  been  solved  at  1.9  A 
resolution (RCSB Protein Data Bank structure file 1QGD) (Figure 1.3).
Homologous  expression  systems  for  transketolase  have  been 
established in S. cerevisiae (Sundstrom et al, 1993) and E. coli (Draths and Frost, 
1990;  French  and  Ward,  1995).  Bacterial  heterologous  expression  systems 
have been created for human (Singleton et al, 1996) and maize (Gerhardt et al, 
2003) transketolases.
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Figure  1.3.  Ribbon  diagram  of  the  E.  coli  transketolase  homodimer.  One 
monomer is coloured yellow and the other is coloured green.  (Created from 
the PDB structure file 1QGD.)
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1.1.1  Structure
The  following  discussion  is  based  on  articles  published  by  Schneider  and 
Lindqvist  (Schneider  and  Lindqvist,  1998  and  references  therein)  and 
concerns the structure of transketolase from S. cerevisiae.  The PDB structure 
file  of E.  coli transketolase  (1QGD)  permitted  the counterparts  of important 
residues to be identified.
Each  subunit  of  transketolase  comprises  three  domains  (Figure  1.4). 
The amino-terminal, or PP-domain, consists of a five-stranded parallel p-sheet 
with a-helices on both sides.  This domain is 320 amino acids in S. cerevisiae, 
which corresponds to a 315 amino acid stretch in E. coli.  The second domain, 
the  Pyr-domain,  is  a  six-stranded  parallel  p-sheet,  sandwiched  between  a- 
helices.  Residues 323-538 constitute this domain in S. cerevisiae and residues 
318-529  in  E.  coli.  Both  domains  are  involved  in  binding  ThDP  and  their 
topology has been denoted the "ThDP binding fold" (Muller et al., 1993).  The 
carboxy-terminal domain contains a mixed p-sheet with four parallel and one 
antiparallel  strand.  Residues  539-680  comprise  this  domain  in  S.  cerevisiae 
and residues 530-663 in E. coli.  The C-domain does not contribute any amino 
acids to the active site and its function remains unclear.
The transketolase dimer is formed through tight interactions between 
the  PP-  and  Pyr-domains  (Figure  1.4).  The  C-domain  makes  few  contacts 
with the other subunit.
Experiments with transketolase from S. cerevisiae (Heinrich et al., 1972) 
and E. coli (Sprenger et al., 1995) have demonstrated the necessity of divalent
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PP-domain
Figure 1.4.  Ribbon diagram of a single subunit of £. coli transketolase.  Two 
ThDP molecules, which bind to the PP- and Pyr-domains, are shown as CPK 
space-filling models.  The divalent metal ion required for catalytic activity, in 
this case Ca2+,  is highlighted  in cyan.  (Created from the PDB structure file 
1QGD.)
Figure  1.5.  Structure of thiamine and  ThDP.  The  methylaminopyrimidine 
ring (coloured red) is linked via a methylene bridge to the methylthiazolium 
ring (coloured blue).  R is a hydrogen atom in thiamine and  a diphosphate 
moiety (P2063-) in ThDP.
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metal ions for the formation of the active holoenzyme.  A cation binds to each 
subunit through the main chain oxygen of Ilel89 and  by  the  side chains  of 
Aspl57 and Asnl87 (Ilel89, Aspl55, and Asnl85 in E. coli).  The reconstitution 
rates of holoenzyme from apoenzyme vary  depending on the  nature  of the 
cation, but final catalytic activity is not affected.  For S. cerevisae transketolase 
the rates descend in the order Ca2+ > Mn2+ > Co2+ > Mg2+  > Ni2+ (Heinrich et 
ah, 1972) and for the E. coli enzyme they descend in the order Mn2+   >  (Mg2+  
and Ca2+) > (Co2+ and Zn2+) > Ni2+ (Sprenger et al., 1995).
ThDP binds to transketolase through several  interactions (Figures 1.4 
and  1.5).  Its  diphosphate  group  is  bound  at  the  switchpoint  between 
neighbouring strands 1 and 3 at the amino-terminus of a small a-helix in the 
PP-domain of one subunit.  The diphosphate group interacts with the protein 
in two ways.  Firstly, there are direct interactions through hydrogen bonds to 
His69, His263, and Glyl58  (His66,  His261,  and  Glyl56 in  E. coli).  Secondly, 
there  are  indirect  interactions  through  the  bound  divalent  metal  ion.  The 
thiazolium  ring  of  ThDP  sits  in  the  cleft  between  the  PP-domain  of  one 
subunit  and  the  Pyr-domain  of  the  second  subunit  and  interacts 
hydrophobically with residues from both subunits.  The conserved aspartate 
residue Asp382 (Asp381  in E. coli) is probably involved in compensating the 
positive charge of the thiazolium ring.  The pyrimidine ring of ThDP binds in 
a hydrophobic pocket, formed by residues from the Pyr-domain of the second 
subunit.  The  pocket  is  made  up  of  a  number  of  aromatic  side  chains 
belonging to Phe442, Phe445, and Tyr448  (Phe434, Phe437, and Tyr440 in E.
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coli).  A hydrogen bond between the NT atom of the pyrimidine ring and the 
side  chain  of  a  conserved  glutamate  residue  (Glu418  in  S.  cerevisiae  and 
Glu411  in  E.  coli)  is  significant  since  it  is  observed  in  all  ThDP-dependent 
enzymes.
An interesting feature of the  enzyme is a large solvent-filled channel 
which  spans  the  region  between  the  two  ThDP  molecules.  This  channel 
contains several conserved glutamate residues:  Glul62,  Glul67,  and  Glu418 
(Glul60,  Glul65,  and  Glu411  in  E.  coli).  A  hydrogen  bonding  network 
through these residues connects the NT  atom of the pyrimidine ring of one 
ThDP to the corresponding atom of the ThDP molecule in the other subunit. 
The purpose of this conserved network is not clear, but it could be to shuffle 
protons  between  the  two  active  sites.  However,  no  cooperative  behaviour 
between the active sites during catalysis has yet been observed.
1.1.2  Catalysis
1.1.2.1  Substrate binding and recognition
A crystallographic  study of a complex  of S. cerevisiae transketolase with the 
acceptor substrate D-erythrose-4-phosphate identified several residues in the 
substrate channel  that may be  involved  in substrate binding  (Nilsson et al, 
1997).  Table 1.1 lists these residues and their proposed roles.
The  structure  of the active  site  suggests  that  the  invariant active site 
residues His69 and Hisl03 (His66 and HislOO in E. coli) bind the Cl-hydroxyl 
group of the donor substrate and stabilise the reaction intermediate (Wikner
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Residue number Residue Function
S. cerevisiae E. coli identity
30 26 His Catalysis and stereospecificity
69 66 His Substrate recognition and binding
103 100 His Substrate recognition and binding
263 261 His Catalysis and stereospecificity
359 358 Arg Phosphate binding
386 385 Ser Phosphate binding
418 411 Glu Catalysis
469 461 His Phosphate binding
477 469 Asp Stereospecificity
481 473 His Transition state stabilisation
528 520 -------- Phosphate binding
Table 1 .1 .  Residues  that are  proposed  to be  involved  in substrate binding 
and/or catalysis in transketolase.
\
NH'
His30
Asp477
HO
O
0
O Ser386. -OH-
His469 NH.
NH
Arg359
Arg528
Figure  1.6.  Active  site  of  S.  cerevisiae  transketolase  with  D-erythrose  4- 
phosphate (coloured red).  (Adapted from Hecquet et al., 2001.)
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et  al,  1995;  Wikner  et  al,  1997).  p-hydroxypyruvate  (p-HPA)  is  a  donor 
substrate  for  transketolase  and  it  has  been  widely  used  as  the  donor  in 
biotransformations  (refer  to  Section  1.1.3).  However,  pyruvate  is  not  a 
substrate for transketolase and  the recognition of the Cl-hydroxyl  group of 
the  donor  by  the  side  chains  of  these  two  histidine  residues  may  be  the 
molecular basis for this discrimination in substrate binding.
Residues Arg359, Arg528, and His469 (Arg358, Arg520, and His469 in
E.  coli) are close to the phosphate group of the substrate.  Replacement of any 
of  these  residues  with  alanine  yields  mutant  enzymes  with  considerable 
residual  activities  but  large  increases  in  the  Km  values  for  phosphorylated 
substrates (Nilsson et al, 1997).  These findings suggest that these residues are 
involved in binding the phosphate group of the substrate.  They also provide 
a  molecular  explanation  as  to  why  non-phosphorylated  sugars  are  bad 
substrates for transketolase (Sprenger et al, 1995).
Asp477 (Asp469 in E. coli) is another conserved residue in the substrate 
channel.  Analysis of the crystal structure has shown that this residue forms a 
hydrogen bond with the C2-hydroxyl group of the acceptor substrate (Nilsson 
et al, 1997).  The transketolase reaction is stereoselective and donor substrates 
with D-threo configuration and  acceptor substrates with C2-D configuration 
are preferred (Kobori et al, 1992).  The hydrogen bond between the side chain 
of Asp477 and  the C2-hydroxyl  group  of the acceptor substrate is  therefore 
very  likely  to  be  a  determinant  of  the  enantioselectivity  of  the  enzyme 
(Nilsson et al, 1998).
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1.12.2  Catalytic mechanism
The  first  half  of  the  reaction  is  the  cleavage  of  the  donor  substrate  and 
formation of the first product, an aldose, and a covalent intermediate, the 2-a- 
carbanion of 1,2-dihydroxyethyl ThDP.  In the second half of the reaction, a 
nucleophilic attack by the 2-a-carbanion on the acceptor substrate occurs and 
the second product, a ketose with its carbon skeleton extended by two carbon 
atoms,  is  formed.  This  reaction  mechanism,  proposed  by  Schneider  and 
Lindqvist (1993), is illustrated in Figure 1.7.
Glu418 (Glu411 in £. coli) is sufficiently close to form a hydrogen bond 
with the NT  atom of the pyrimidine ring of ThDP.  It is proposed that this 
hydrogen bond promotes the generation of a resonance form of ThDP with a 
positively-charged imino-group at the 4,-position of the pyrimidine ring.  The 
side chain of His481  (His473  in  E. coli)  is close  to this charged  imino group 
and could conceivably abstract a proton.  This would increase the pKa of the 
group  sufficiently  that  it  would,  in  turn,  remove  a  proton  from  C2  of  the 
thiazolium  ring.  Once  formed,  the  C2-carbanion  of  the  cofactor  is  able  to 
attack  the  carbonyl  carbon  of  the  donor  substrate.  For  covalent  bond 
formation  between  these  two  atoms  to  occur,  stabilisation  of  the  negative 
charge developing at the carbonyl oxygen is required.  His481  (His473 in E. 
coli) and the charged 4/-imino group of ThDP are the most likely candidates 
for this role.  Subsequently, the abstraction of a proton from the C3-hydroxyl 
group  of  the  substrate,  possibly  mediated  by  the  concerted  action  of His30 
and  His263  (His26  and  His261  in  E.  coli),  leads  to  cleavage  of  the  addition
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Figure  1.7.  Reaction  mechanism  of  transketolase.  The  donor  substrate  (a 
ketose)  and  the  acceptor  substrate  (an  aldose)  are  coloured  red  and  blue 
respectively.  Bi  is  most  likely  to  be  the  4'-imino  group  of  the  ThDP 
pyrimidine ring.  This group is also a candidate for B2; His481  (His473 in E. 
coli) is another possibility.  His30 and His263 (His26 and His261 in E. coli) are 
the two candidates for B3.  (Adapted from Schneider and Lindqvist, 1998.)
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compound.  This manipulation yields the first product, an aldose sugar, and 
the 2-a-carbanion of the reaction intermediate 1,2-dihydroxyethyl-ThDP.
In  the  second  half  of  the  reaction,  the  2-a-carbanion  of  1,2- 
dihydroxyethyl-ThDP  reacts  with  an  aldose  acceptor  substrate.  The  1,2- 
dihydroxyethyl  moiety  is  transferred  to  the  acceptor  to  form  a  new  ketose 
sugar and simultaneously regenerate ThDP.  This second part of catalysis is 
essentially a reversal of the first part and  it is therefore likely  that the same 
amino acid residues will be involved in the proton transfer.
This  model  for catalytic  mechanism  was  proposed  by  Schneider and 
Lindqvist  (1993)  following  detailed  analysis  of  the  three-dimensional 
structure  of S. cerevisiae transketolase.  A  subsequent kinetic  study  of E. coli 
transketolase by Gyamerah and Willetts (1997) supported this model.
1.1.3  Transketolase as a biocatalyst
1.1.3.1  Substrates
In vivo, transketolase catalyses the reversible transfer of a 1,2-dihydroxy  ethyl 
group  from  D-xylulose-5-phosphate  to  D-ribose-5-phosphate  to  yield  D- 
sedulose-7-phosphate  and  D-glyceraldehyde-3-phosphate  (Figure  1.8a).  In 
addition,  it  catalyses  the  reversible  transfer  of  a  1,2-dihydroxyethyl  group 
from D-xylulose-5-phosphate to D-erythose-4-phosphate to yield D-fructose-6- 
phosphate and D-glyceraldehyde-3-phosphate (Figure 1.8b).  In experimental 
and  preparative  condensations  p-HPA  frequently  replaces  D-xylulose-5- 
phopshate  as  the  donor  substrate.  The  use  of  p-HPA  renders  the  reaction
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Figure  1.8.  In vivo and  in vitro reactions  of transketolase shown in Fischer 
projection.  Reactions (a) and (b) occur in vivo and are reversible.  p-HPA is 
used  as  the  donor  substrate  in  biotransformations  to  make  the  reaction 
irreversible.  If the R group is a hydrogen atom, then the reaction is p-HPA 
and glycolaldehyde to L-erythrulose (and carbon dioxide).
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effectively irreversible by virtue of the concomitant release of carbon dioxide 
as one of the two products (Figure 1.8c).
The carbon-carbon bond-formation that transketolase catalyses is both 
stereoselective, in that the enzyme has a preference for a-hydroxyaldehydes 
with (R)-configuration at C2, and stereospecific, in that the new chiral centre 
formed in the product has the (S)-configuration.  Consequently, transketolase- 
mediated  condensation of an a-substituted  aldehyde  with  p-HPA  produces 
enantiomerically pure chiral triols with D-threo stereochemistry (Kobori et al., 
1992).  The best acceptor substrates for transketolase are a-hydroxyaldehydes 
with  (R)-configuration,  although  a-oxo-  and  a-unsubstituted  aldehydes  are 
also  accepted.  Table  1.2  lists  the  kinetic  constants  for  various  E.  coli 
transketolase substrates.
1.1.3.2  Transketolase-based biotransformations versus chemical processes 
The  fact  that  transketolase  will  act  on  such  a  wide  range  of  substrates 
advocates  its  use  in  the  synthesis  of  fine  chemicals  and  pharmaceuticals. 
Biotransformations  such  as  those  listed  in  Table  1.3  have  several  key 
advantages over traditional chemistry-based routes to the same compounds. 
These advantages are summarised in Table 1.4.
From  an  industrial  point  of  view,  low  environmental  impact  and 
simple process steps are both favourable characteristics of biotransformations. 
However,  the  greatest  driving  force  for  the  increased  use  of 
biotransformations  in  industry,  particularly  in  the  pharmaceutical  sector,  is
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Substrate Km
(M)
vm ax
(U.mg-1)
Acceptor components
P-Hydroxyaldehyde phosphates
D,L-Glyceraldehyde-3-phosphate 2.1 X  10-3 100
D-Erythrose-4-phosphate 90.0 x l(F6 £110
D-Ribose-5-phosphate 1.4 x 10-3 50.4
P-Hydroxyaldehydes
Glycolaldehyde 14.0 x 10-3 60
D,L-Glyceraldehyde 10.0 x 10-3 25
D-Erythrose 150.0 x 10-3 75
D-Ribose 1.4 25
Aldehydes
Formaldehyde 31.0 x 10-3 12.5
Acetaldehyde 1.2 20
Donor components
P-HPA 18.0 x 10-3 60
Xylulose-5-phosphate 160.0 x 10-* £110
Fructose-6-phosphate 1.1  x 10-3 62
Sedoheptulose-7-phosphate 4.0 x 10-3 6
Table 1.2.  Kinetic constants for E. coli  transketolase.  The Km values for  D- 
ribose,  D-ribose-5-phosphate,  and  sedoheptulose-7-phosphate  are  apparent 
constants, because only a small part of each compound exists in an open form, 
which can serve as a transketolase substrate.  (Reproduced from Sprenger et 
al, 1995.)
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Su jstrate
Product Reference
Donor Acceptor
P-HPA Glycolaldehyde L-Erythrulose Bolte et al, 1987
[2/3-13C2]hydroxy-
pyruvate
D-Glyceraldehyde D-[l,2-13C2]xylulose Demuynck et 
al, 1990
p-HPA Racemic 3-hydroxy-4- 2-Deoxy-L-threo-5- Effenberger and
oxobutyronitrile hexulosonitrile Null, 1992
P-HPA D-Ribose D-Sedoheptulose Dalmas and 
Demuynck, 
1993
P-HPA 4-Deoxy-L-threose 6-Deoxy-L-sorbose Hecquet et al, 
1996
L-Erythrulose 2-Deoxy-D-erythrose- 4-Deoxy-D-fructose-6- Guerard et al,
4-phosphate phosphate 1999
Xylulose-5- D-[5-14C, 5-3H] [7-14C, 7-3H]sedo Lee et al, 1999
phosphate ribose-5-phosphate heptulose-7-phosphate
P-HPA D-Glyceraldehyde-3- D-Xylulose-5- Zimmermann et
phosphate phosphate al, 1999
p-HPA 3-O-benzyl-
glyceraldehyde
5-O-benzyl-D-xylulose Humphrey et 
al, 2000
Table 1.3.  A selection of fine chemicals and drug precursors that have been 
synthesised using transketolase.
Advantages
Mild operating conditions
Can be highly chemo-, regio-, and stereoselective
Potential to perform complex reactions with no equivalent in traditional chemistry
Potential for low environmental impact
Aqueous reaction medium reduces need for organic solvents
Potential for fewer reaction by-products
Potential avoidance of protection and de-protection steps________________________
Disadvantages 
Biocatalyst may show poor operational stability 
Low volumetric productivities are common 
Biocatalyst production may be expensive 
Absolute substrate specificity may make the process inflexible 
Bulk removal of water may be a problem in downsteam processing
Table  1.4.  Summary  of  the  advantages  and  disadvantages  of 
biotransformations  when  compared  to  traditional  chemical  processes. 
(Adapted from Cheetham, 1994.)
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the  potential  to  produce  optically-pure  products.  The  Food  and  Drug 
Administration  (FDA)  and  equivalent  agencies  around  the  world  now 
demand  pharmacological  and  toxicity  data  for  each  enantiomer  of a  chiral 
drug  (FDA,  1992).  These  regulations  have  provided  pharmaceutical 
companies  with  a  strong  incentive  to  develop  single  enantiomer  drugs: 
providing  separate  data  for  two  enantiomers  massively  increases  costs. 
Companies  also  have  the  possibility  of  redeveloping  previously  licensed 
racemic drugs as single enantiomers to extend their patent protection (Stinson, 
2000).
Chemical  processes  such  as  aldol  condensation  have  the  potential  to 
produce similar chiral compounds to transketolase (Trost and Fleming, 1991; 
Seyden-Penne,  1995),  but  only  when  chiral  auxiliaries  are  used.  These 
auxiliaries  are  necessary  because  chemical  syntheses  are  themselves 
fundamentally  incapable  of  creating  new  stereocentres.  The  expense  and 
limited  variety  of  these  reagents  make  large-scale  chemical  processes  more 
costly and less flexible than equivalent biotransformations.
1.1.3.3  Overexpression of transketolase
Early  work  on  transketolase-based  biotransformations  used  transketolase 
protein extracted from two sources: S. cerevisiae and spinach.  The yields from 
these sources were relatively  poor, so high-yielding recombinant expression 
systems were developed.  Initially, Draths and Frost (1990) cloned the E. coli 
transketolase gene (tkt, 1991bp) on a 5kb fragment into the low copy number
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vector pBR325.  French and Ward (1995) subsequently improved expression 
levels  by  subcloning  the  tkt gene  from this construct  into  a  variety  of high 
copy-number expression vectors.  Host cells containing these new constructs 
expressed  sufficient  recombinant  E.  coli  transketolase  to  permit  large-scale 
biotransformations.  One of these strains,  E. coli JM107 pQR711  (Figure 1.9), 
was grown to 20g dry cell weight per litre, producing 4kg of enzyme from a 
1000 litre glycerol-fed fermentation (Hobbs et al, 1996).
1.1.3.4  Reaction conditions
The principal transketolase-based biotransformation studied by researchers at 
UCL is the synthesis of L-erythrulose from p-HPA and glycolaldehyde (Hobbs 
et al., 1993; Hobbs et al., 1996; Mitra and Woodley, 1996; Woodley et al, 1996; 
Chauhan et al.f  1997;  Mitra et al.,  1998;  Brocklebank et al.,  1999).  Standard 
reaction conditions are used whenever possible to permit the comparison of 
data  generated  by  different researchers  (Table  1.5).  The biocatalyst itself is 
usually derived from E. coli JM107 pQR711.
The  concentrations  of  cofactors  used  in  transketolase-based 
biotransformations  vary  from  laboratory  to  laboratory.  Generally  speaking 
though, these concentrations are always high enough to ensure an excess of 
both cofactors in the reaction.  The cofactors are incubated with the enzyme 
for a period of time prior to the addition of substrates to permit reconstitution 
of the holoenzyme.  This  period  of time,  "preincubation",  varies between 3 
and 30 minutes, depending on the laboratory.
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Figure  1.9.  Map  of the  E.  coli transketolase  overexpression  vector  pQR711 
(French and Ward, 1995).  The orientation of each gene is represented by the 
direction of its arrow.  ampR   is the ampicillin resistance gene and  tkt  is the 
transketolase gene.
Variable Optimum Literature UCL standard  ||
7.0-7.5
.   7   s .
Preincubation period 3-30min 15min
Temperature 20-40°C 25°C
Cofactor concentrations
Mg2+ 0.9-1 OmM 9m M
ThDP 0.2-2.5mM 2.5mM
Substrate concentrations
(J-HPA (donor) <0.6M lOOmM
Glycolaldehyde (acceptor) <0.5M lOOmM
Table 1.5.  Reaction conditions for £. coli transketolase-based bioconversion of 
p-HPA  and  glycolaldehyde  to  L-erythrulose  (and  carbon  dioxide). 
"Optimum"  ranges are for maximum  transketolase activity  (Sprenger et al., 
1995; Mitra et al., 1998).  "Literature" ranges are based on the conditions used 
by  various  laboratories  around  the world.  "UCL  standard"  values  are  the 
conditions typically used by researchers at UCL.
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Glycolaldehyde concentration should not exceed 0.5M because it has a 
destabilising effect on transketolase (Mitra et al., 1998).  The upper limit for f> - 
HPA (0.6M) is governed by its maximum solubility at room temperature and 
neutral pH (Mitra et al., 1998).
1.1.3.5 Maximising productivity in large-scale biotransformations 
Brocklebank and co-workers (1998) observed that immobilising transketolase 
on  the  commercially-available  supports  Eupergit  C  and  Amberlite  XAD-7 
increased  the  enzyme's  half-life  during  biotransformations  by  80-100-fold. 
Immobilisation  was  found  to  stabilise  the  enzyme  against  the  denaturing 
effects of the aldehyde acceptor substrate (glycolaldehyde).
In  an  effort  to  reduce  product  inhibition,  Chauhan  and  co-workers 
(1997)  explored  the  use  of  in  situ  product  removal  (ISPR).  Immobilised 
boronate resins were found to effectively sequester product as it formed in the 
reactor,  thus  preventing  the  build-up  of  inhibiting  concentrations.  The 
authors  note  that  this  method  could  be  used  to  recover  any  transketolase 
product,  providing  that  it  is  derived  from  an  a-hydroxylated  aldehyde 
acceptor substrate.
Woodley and co-workers (1996) suggested that substrate inhibition and 
product  inhibition  could  be  tackled  simultaneously  by  prudent  reactor 
selection.  A fed-batch stirred tank reactor is recommended for transketolase- 
based  biotransformations  as  it  permits  the  maintenance  of  low  aldehyde 
acceptor concentration (by feeding) and low product concentration (by ISPR).
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1.2 Directed evolution
The  excellent  advantages  that  biotransformations  have  over  traditional 
chemistry have already been discussed (refer to Section 1.1.3.2).  However, the 
application  of  wild-type  enzymes  as  synthetic  agents  is  limited  by  factors 
such  as  substrate  specificity,  instability,  and  low  activity  in  non-aqueous 
solvents (Cheetham, 1994).  Being a product of millions of years of evolution, 
enzymes  did  not evolve  to be  efficient in every  situation a  process chemist 
might like.
A way around this problem is " rational protein engineering"  by site- 
directed mutagenesis.  Specific amino acids are substituted for different ones 
at  defined  positions  in  the  peptide  chain  of  an  enzyme  with  the  aim  of 
improving  activity  or  selectivity.  Successful  implementations  of  this 
approach  have,  however,  been  few  and  far  between  (for  examples  see: 
Cedrone et al., 2000; Hult and Berglund, 2003).  Attempts have, perhaps, relied 
too  heavily  on  static  protein  structure  models  and  transition-state  theory 
(Dalby,  2003).  Ignoring  the  contributions  that  enzyme  dynamics  and 
quantum tunnelling make  to catalysis  may  make  the  design  process easier, 
but it will almost certainly fail to deliver many positive results (Sutcliffe and 
Scrutton, 2000; Sutcliffe and Scrutton, 2002).
Until  enzyme  mechanics  are  better  understood,  an  alternative 
approach  presents  itself  for  the  modification  of  biocatalysts.  "Directed 
evolution" contrasts with rational protein design in that it does not require a 
complete, or indeed any, understanding of how an enzyme works (Shao and
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Arnold,  1996).  It  is  an  algorithm  that  mimics  natural  evolution  with 
successive cycles of mutation and selection.  A set of mutant genes, a "library", 
is created by either random mutagenesis of the gene encoding the enzyme or 
recombination of gene fragments.  The mutant genes are then inserted into an 
appropriate  microorganism  and  the  mutant  enzymes,  "variants",  are 
expressed individually.  The optimal mutant is isolated and used as the basis 
for  another  cycle  of  mutagenesis  and  selection.  Further  cycles  create  an 
evolutionary pressure, leading to the formation and identification of superior 
biocatalysts at every generation.  A typical  directed evolution experiment is 
shown in Figure 1.10.
1.2.1  Methods of mutagenesis
There are two general approaches to creating libraries for directed evolution:
(a)  non-recombinative  mutagenesis  methods,  such  as  error-prone  PCR 
(epPCR) (Zhou et al, 1991); and (b) recombinative mutagenesis methods, such 
as  DNA-shuffling  (Stemmer,  1994).  In  non-recombinative  mutagenesis, 
diversity is generated by random point mutation.  The majority of variants are 
typically  less  fit  than  the  parental  gene.  The  top  variant  is  identified  by 
screening or selection and used as the basis for a new cycle of mutation and 
selection.  In  recombinative  mutagenesis,  full-length  chimerical  genes  are 
generated from a single gene or a family of genes and  the best variants are 
pooled and recombined.
39Chapter 1 - Introduction
(2)
t  1
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Figure 1.10.  Typical steps in the directed evolution of an enzyme.  (1) A gene 
is selected.  (2) Mutation: a library of mutant genes is created (mutations are 
shown as red dots).  (3) The gene library is inserted into an expression vector 
(coloured blue) to express them.  (4) Selection:  the colonies are screened for 
improvement in  a  particular enzyme  characteristic  and  the  optimal  variant 
(circled in green) is isolated to repeat the entire process.
plasmid
Reagent Volume Final conc.  |
ddH2 0 variable
10x PCR buffer pH 8.3 lOpl
Tris-HCl lOmM
MgCl2 1.5mM
KC1 50mM
dNTPs 2pl
dATP 0.2mM
dCTP 0.2mM
dGTP 0.2mM
dTTP 0.2mM
Primer 1 0.2-2pl 0.1-1.OpM
Primer 2 0.2-2pl 0.1-1.0pM
Template DNA variable
Taq DNAP 0.5pl 2.5U
Total lOOpl
Table 1.6.  The components of a typical PCR.  The stock solution of dNTPs is 
usually  a  mixture  of  lOmM  dATP,  lOmM  dCTP,  lOmM  dGTP,  and  lOmM 
dTTP.  Primers  are  usually  stored  at  50pM  concentration.  (Adapted  from 
Roche Diagnostics Ltd., 2000.)
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1.2.1.1  Non-recombinative methods
The  polymerase  chain  reaction  (PCR)  is  normally  carried  out  in  order  to 
generate many faithful copies of a specific segment of deoxyribonucleic acid 
(DNA) (Mullis et al., 1986).  The components of a standard PCR are shown in 
Table 1.6; subjecting this mixture to repeated cycles of temperature changes 
brings about amplification of the target DNA sequence  (Figure 1.11).  DNA 
polymerases  (DNAPs)  generally  proceed  accurately,  but  occasionally 
incorrect  nucleotides  are  incorporated.  For  DNAP  from  Thermus  aquaticus 
(Taq DNAP), the frequency of misincorporations  is 1.1  *  104 per nucleotide 
(Tindall and  Kunkel,  1988).  This very  small  error rate can be  increased for 
epPCR  by:  (a)  increasing  the  concentration  of  Mg2+;  (b)  adding  Mn2+;  (c) 
increasing the concentrations of dCTP and dTTP; or (d) increasing the amount 
of Taq DNAP (Cadwell et al., 1995).  Following epPCR the mutant genes are 
cloned into a suitable vector by restriction and ligation.
An alternative to epPCR for non-recombinative mutagenesis is the use 
of bacterial  mutator strains.  Wild-type  E.  coli  strains  exhibit a spontaneous 
mutation frequency of about 2.5 * 107 per nucleotide of DNA propagated on 
a  pBluescript-like  plasmid  after  30  generations  of  growth.  Strains  with 
compromised  DNA-repair  pathways  exhibit  much  higher  spontaneous 
mutation rates (Miller, 1992).  Stratagene Ltd. has created a commercial strain 
of  E.  coli  -  XLl-Red  -  that  contains  mutations  in  three  independent  DNA 
repair  pathways  (mutD,  mutS,  and  mutT)  (Greener et al,  1997).  This  strain 
exhibits  a  spontaneous  mutation  frequency  of  5  x  IQ-4  mutations
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(1) Denaturation (94°C, 1 min)
I
(2) Annealing (55°C/ 1 min)
(3) Extension (72°C/ 1 min)
Z f t»
X
3 n_
fT
Figure  1.11.  The  mechanism  of  PCR.  (1)  Denaturation  (94°C):  double­
stranded  DNA  melts  open  to  form  single-stranded  DNA.  (2)  Annealing 
(55°C):  a reduction in temperature allows stable bonds to form between the 
oligonulcleotide  primers  (coloured  red)  and  complementary  bases  of  the 
template  DNA  (coloured  blue).  (3)  Extension  (72°C):  DNAP  extends  the 
primers according to the sequence of the template DNA.  The entire cycle is 
then  repeated  by  denaturing  the  two  copies  of  the  target  sequence  and 
starting again.  In this way the number of copies of the target sequence grows 
exponentially.  (Mullis et al., 1986.)
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per nucleotide of DNA.  To generate a mutant library, a gene is cloned into a 
suitable  plasmid,  transformed  into  E.  coli  XLl-Red,  and  propagated. 
Unfortunately,  if  the  target  sequence  is  small  (<100  bp),  or  if  multiple 
mutations are required, the number of generations needed for propagation of 
the plasmid becomes impractically high.  In addition, due to the lack of DNA 
repair  pathways,  the strain is fairly  unstable  and  cannot be  propagated  for 
long periods.
The remaining technique that is commonly used for non-recombinative 
mutagenesis  is  random  oligonucleotide  mutagenesis  (Oliphant  et  al,  1986; 
Sneeden and Loeb, 2003).  Oligonucleotides that encode a specific region of a 
plasmid-bome  gene  are  synthesised  with  certain  bases  randomised  either 
fully  (A /C/G /T)  or  partially  (e.g.  C/G).  These  oligonucleotides  are 
amplified by minimal  cycles of PCR to generate  double-stranded fragments 
which are then cloned into plasmids by restriction and ligation.  The libraries 
generated by this approach can be very large: for example, randomising just 
four residues in a protein results in a library size of 1.6  x 105 unique protein 
sequences.1   Such a library would require a large amount of time to screen.
1.2.1.2  Recombinative methods
One of the oldest hypotheses for the advantage of sex and recombination is 
that it allows beneficial mutations, initially carried by different individuals, to 
be combined together into the same individual (Fisher, 1930).  In other words,
1  Every possible amino acid is accessed at each of the four positions so there are 204 = 1.6 x 105  
unique protein sequences.
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mutations  that  arise  on  a  poor  genetic  background  can  recombine  onto  a 
better  genetic  background.  Recombinative  mutagenesis  methods  were 
developed in an effort to recreate this phenomenon in vitro.
Stemmer published the first account of in vitro recombination in 1994 
(Stemmer,  1994).  In  DNA-shuffling  one  or  more  closely-related  genes  are 
digested with DNase I to yield double-stranded oligonucleotide fragments of 
10-50bp,  which  are  purified  and  used  in  a  PCR-like  reaction.  Full-length 
genes are reconstructed from the fragments  over the course of the reaction. 
Recombination occurs by template-switching:  fragments from one copy of a 
gene  prime  on another.  The  combination  of this  technique with epPCR  or 
bacterial  mutator  strains  to  introduce  point  mutations  allows  the 
simultaneous permutation of both single mutations and large blocks of DNA 
sequences.  Mutants with improved properties can be reshuffled against each 
other or against the wild-type gene which would correspond to the backcross 
technique  of  classical  genetics.  This  process  may  eliminate  neutral  or 
deleterious mutations from the gene pool.  It is also possible to perform DNA- 
shuffling  with  homologous  genes  from  different  species  (family-shuffling) 
which  results  in  sparse  sampling  of  a  large  sequence  space,  thereby 
significantly  accelerating  the  rate  of  functional  enzyme  improvement 
(Crameri et al, 1998).
StEP is a simple and efficient variation of DNA-shuffling that is based 
on a staggered, PCR-like reaction (Zhao et al.,  1998).  StEP employs thermal 
cycling  with  extremely  abbreviated  annealing/ DNAP-catalysed  extension
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cycles.  In  each  cycle  the  growing  fragments  anneal  to  different  templates 
based  on  sequence  complementarity  and  extend  further.  This  is  repeated 
until  full-length  chimerical  genes  are  reassembled.  RPR,  CLERY,  and 
RACHITT are other variations of the DNA-shuffling technique (Table 1.7).
To  permit  recombination  of  unrelated  or  distantly-related  proteins, 
non-homologous  recombination  methods  have  also  been  developed  (Table 
1.7).  SHIPREC  and  ITCHY  both  permit  the  creation  of  arrays  of  hybrid 
proteins  from  distantly-related  genes.  However,  neither  technique  permits 
more than one crossover to occur per hybrid.  This limitation was addressed 
by  developing  SCRATCHY,  a  combination  of  ITCHY  and  DNA-shuffling. 
SCOPE is a different technique to those already mentioned because it utilizes 
protein  structure  information to  guide  the  generation  of multiple-crossover 
hybrids from non-homologous genes.
1.2.2  Evolutionary strategies
The  number  of  possible  permutations  of  an  amino  acid  sequence  balloons 
with sequence length.  As there are 20 natural amino acids available at each 
position  in  a  sequence,  an  enzyme  of  300  amino  acids  has  a  total  of  20300 
possible  mutants.  This  "sequence  space"  is  mostly  empty  of function  and, 
from a practical point of view, infinite.  As complete inspection of this space is 
impossible,  it must be sampled  in a  manner  that suits a  particular  directed 
evolution  project.  Non-recombinative  and  homologous  recombination 
methods  are  ideally  suited  for  the  generation,  diversification,  and
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|  Technique Description and merits Reference
Non-recombinative
Error-prone PCR (epPCR)
Mutator strain: E. coli XLl-Red
Random oligonucleotide 
mutagenesis
A gene is amplified by PCR under conditions 
that encourage the random misincorporation 
of nucleotides
Mutations in three independent DNA repair 
pathways cause high levels of spontaneous 
mutation in an introduced plasmid 
Random mutations, encoded on a synthetic 
oligonucleotide, are incorporated into a 
specific region of a gene by ligation
Zhou et 
al., 1991
Greener et 
al, 1997
Sneeden 
and Loeb, 
2003
Homologous recombination 
DNA-shuffling
Staggered extension process (StEP)
Random-priming recombination 
(RPR)
Combinatorial libraries enhanced 
by recombination in yeast (CLERY)
Random chimeragenesis on 
transient templates (RACHITT)
One or more homologous genes are 
fragmented with DNase I.  Full-length hybrid 
genes are reconstructed from these fragments 
in a PCR-like reaction 
Simple and efficient variation of DNA- 
shuffling based entirely on PCR 
Variation of DNA-shuffling where every 
nucleotide has an equal probability of being 
mutated
In vitro family-shuffling followed by in vivo 
homologous recombination in yeast.  High 
complexity hybrids but low fitness 
Randomly-cleaved parental gene fragments 
are annealed to a transient full-length 
template.  100% chimerical gene products are 
generated
Stemmer,
1994
Zhao et 
al, 1998 
Shao et al, 
1998
Abecassis 
et al, 2000
Coco et 
al, 2001
Non-homologous recombination
Sequence homology-independent 
protein recombination (SHIPREC)
Incremental truncation for the 
creation of hybrid enzymes (ITCHY)
ITCHY with DNA-shuffling 
(SCRATCHY)
Structure-based combinatorial 
protein engineering (SCOPE)
Two non-homologous parent genes are fused 
end-to-end and randomly fragmented by 
DNase I.  Parent-sized fragments are isolated 
and circularised.  Single-crossover hybrids are 
thus generated
Nucleotide triphosphate analogues are used to 
create incremental truncation libraries.  Single­
crossover hybrids of unrelated or distantly 
related proteins are generated 
Same as ITCHY but capable of generating 
multiple-crossover hybrids 
In a series of PCRs, “hybrid oligonucleotides" 
act as surrogate introns to direct the assembly 
of coding segments from two non-homologous 
genes.  Multiple crossovers occur in each 
hybrid
Sieber et 
al, 2001
Lutz et al, 
2001a
Lutz et al, 
2001b 
O'Maille 
etal, 2002
Table 1.7.  Current techniques for generating libraries of mutants for directed 
evolution.
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optimization  of  local  protein  space  (Bogarad  and  Deem,  1999;  Miller  and 
Orgel,  1974).  In  other  words,  DNA  base  substitutions  are  best  for  "fine- 
tuning"  the  activity  or  specificity  of  an  enzyme.  Non-homologous 
recombination, on the other hand, permits the creation of productive tertiary 
folds by way of the novel juxtaposition of encoded structures  (Bogarad and 
Deem, 1999).  This approach is, therefore, suited to the evolution of entirely 
novel protein functionality.
Evolution is often referred to as a hill-climbing exercise in the "fitness 
landscape" of sequence space (Kauffman, 1993).  The individual fitness levels 
of  the  protein  sequences  in  sequence  space  make  up  this  landscape. 
"Tweaking"  an  enzyme's  activity  or  specificity  by  non-recombinative 
methods or homologous recombination is akin to climbing the local optimum. 
Beneficial  point  mutations  are  very  rare,  so  most  paths  lead  downwards 
(decreasing fitness).  Furthermore, the probability that one will find oneself at 
a higher fitness point decreases rapidly as the number of simultaneous point 
mutations  increases  (Arnold,  1998).  Consequently,  an  uphill  climb  in  this 
landscape is more likely to be successful if it can take place in small steps (a 
single  amino  acid  substitution  per  generation).  While  the  global  optimum 
may  never  be  achieved,  the  accumulated  improvements  yielded  by  this 
approach may nonetheless yield a highly successful result.
An alternative to this up-hill walk by single amino acid substitutions is 
to  subject  small  regions  of  the  gene  to  a  higher  level  of  random  mutation 
(Figure 1.12).  This approach may yield novel combinations of substitutions
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Sequence space
Figure  1.12.  Simplified  representation  of evolutionary  progressions by:  (a) 
repeated  single amino acid substitutions; and  (b)  intense mutation of small 
regions of the gene.  It is possible for method (b)  to yield highly successful 
mutants with substituted residues that work together.  Note that, in reality, 
sequence space has many more dimensions.
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that operate synergistically.2  Also, careful selection of a targeted region could 
lead  to  a  smaller  proportion  of  the  scrutinised  sequence  space  being 
functionally-derelict.  Voigt  and  co-workers  have  described  computational 
tools  for  identifying  amino  acids  in  a  given  protein  that  are  tolerant  to 
mutation (Voigt et al., 2001a; Voigt et al., 2001b).  This concept of pre-screening 
libraries in silico has been  taken  a  step  further by  Protein Data  Automation 
(PDA) technology which eliminates sequences that are incompatible with the 
protein fold (Hayes et al., 2002).  After selecting 19 residues near to the active 
site  of  p-lactamase,  Hayes  and  co-workers  used  PDA  to  trim  the  7  *  1023 
possible  sequences  down  to  just  172800.  The  remaining  variants  were 
constructed  and  experimentally  screened  in  a  single  round  to  produce 
entirely  novel  mutations and an  incredible  1280-fold  increase  in cefotaxime 
resistance.
1.2.3  Library size and coverage
To  demonstrate  the  calculations  involved  in  assessing  library  size  and 
coverage,  an  example  utilising  the  E.  coli  transketolase  gene  and  a  non- 
recombinative mutagenesis method will be used.
1.2.3.1  Library size
The entire tkt gene is subjected to non-recombinative mutation at a frequency 
of  exactly  two  base  changes  per  variant.  The  total  number  of  possible
2 These  combinations  may  not  be  identified  by  making  single  amino  acid  substitutions 
because the intermediates might not be favourable.
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nucleotide sequences in this library can be calculated using the formula:
21(1986-2)!
= 1.77 x 107
Where V = number of possible sequences, x = number of mutations, and N = 
length of the gene in base-pairs (excluding start and stop codons).  There are
mutated to any of the three other bases, giving the 3X  term (Patrick et al, 2003).
The  number  of unique  protein  sequences  encoded  by  this  library  is, 
however, less than the number of unique nucleotide sequences.  Because the 
gene is long  (1986bp),  the probability  that two  nucleotide mutations would 
occur in the same codon is extremely low:
Thus, the mutations will not cooperate in the vast majority of cases, but will 
affect  different  residues.  Codon  degeneracy  means  that  these  separated 
mutations can grant access to only 5.98 new residues at each site (on average). 
This figure was calculated for the tkt gene by building a table of the possible 
residue changes for each codon (Table 1.8) and averaging the totals.  As the 
number of residues accessible from each codon after a single base change was 
found  to  vary  with  the  codon  (5-7),  the  results  were  weighted  for  codon
3X N!
x\(N -*)! 
32  x 1986!
different ways of choosing x bases  to  mutate and  each of these  may be
= 6.72 xlO-4
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Original rresidue Identity of residue following a single point mutation at...
Codon CU tkt Identity First position Second position Third position NOPE
A c G T A C G T A c G T
AAA 4.82 K K Q E 0 K T R I K N K N 6
AAC 2.71 N N H D Y N T S I K N K N 7
AAG 0.45 K K Q E 0 K T R M K N K N 6
AAT 0.60 N N H D Y N T S I K N K N 7
ACA 0.15 T T P A S K T R I T T T T 6
ACC 3.46 T T P A S N T S I T T T T 5
ACG 0.30 T T P A S K T R M T T T T 6
ACT 1.05 T T P A S N T S 1 T T T T 5
AGA 0.00 R R R G ® K T R I R S R S 5
AGC 0.45 S S K G C N T S I K s R s 6
AGG 0.00 R R R G W K T R M R s R s 6
ACT 0.00 S S R G c N T S I R s R s 6
ATA 0.00 I I L V L K T R I I 1 M I 6
ATC 3.01 I I L V F N T S I I I M I 7
ATG 331 M M L V L K T R M I I r I 6
ATT 1.81 I 1 L V F N T S I I I M I 7
CAA 0.30 Q K Q E 0 Q P R L Q H Q H 6
CAC 2.56 H N H D Y H P R L u H Q H 7
CAG 3.16 Q K Q E 0 Q P R L Q II Q H 6
CAT 0.15 H N H D Y H P R L Q H Q H 7
CCA 0.00 P T P A S Q P R L P P p P 6
CCC 0.00 P T P A S H P R L P P P P 6
CCG 4.07 P T P A S P R L P P p P 6
CCT 0.30 P T P A S H P R L P P P P 6
CGA 0.15 R R R G 0 P R L R R R R 4
CGC 1.66 R S R G c H P R L R R R R 6
CGG 0.00 R R R G w P R L R R R R 5
CGT 2.41 R S R G c H P R L R R R R 6
CTA 0.00 L I L V L Q P R L L L L L 5
CTC 0.45 L I L V 1 H P R L L L L L 6
CTG 6.78 L M L V L Q P R L L L L L 5
CTT 0.15 L I L V F H P R L L L L L 6
GAA 5.87 E K 0 E 0 E A G V E D E D 6
GAC 4.07 D N H D Y D ■ n G V 1 D E D 7
GAG 1.36 E K Q E 0 E A G V E D E D 6
GAT 1.20 D N H D Y D A G V I D E D 7
GCA 2.71 A T P A S E A G V A A A A 6
GCC 2.11 A T P A S D A G V A A A A 6
GCG 4.22 A T P A S E A G V A A A A 6
GCT 437 A T P A S D A G V A A A A 6
GGA 0.00 G R R G < s > E A G V G G G G 4
GGC 2.86 G S R G c D A G V G G G G 6
GGG 0.30 G R R G w E A G V G G G G 5
GGT 5.57 G S R G c D A G V G G G G 6
GTA 0.90 V I L V L E A G V V V V V 5
GTC 0.90 V I L V F D A G V V V V V 6
GTG 131 V M L V L E A G V V V V V 5
GTT 2.41 V I L V F D A G V V V V V 6
TAA 0.15 0 K Q E 0 0 S ® L ® Y ® Y
TAC 2.71 Y N H D Y Y S C F ® Y ® Y 6
TAG 0.00 0 K Q E 0 Q S W L ® Y ® \
TAT 0.75 Y N FI D Y Y S c F ® Y ® Y 6
TCA 030 S T P A S ® S ® L s S s S 4
TCC 2.56 S T P A S Y S c F s S s S 6
TCG 0.15 S T P A S ® S w L s S s S 5
TCT 2.26 S T P A S Y S c F s S s S 6
TGA 0.00 0 R R G Q ® S ® L ® C w c
TGC 0.60 c S R G c Y S c F ® C w c 6
TGG 1.66 w R R G w ® S w L ® t w c 5
TGT 0.15 c S R G c Y S c F ® C vv c 6
TTA 0.00 L I L V L ® S ® L L F L F 4
TTC 3.31 F I 1. V F Y S c F 1 F 1 F 6
TTG 0.15 L M L V L ® s w L L F L I 5
TTT 0.60 F I L V F Y s c F I. F L F 6  1
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Table  1.8.  (Previous  page.)  The  possible  identities  of  any  given  codon 
following  a  single  point  mutation  at  either  the  first,  second,  or  third 
nucleotide position.  The start (ATG) and stop (TAA) codons of the gene are 
not included.  "CU tkt" is an abbreviation for "codon usage in the gene tkt". 
"NOPE"  is an abbreviation for "number of possible exchanges"  and is equal 
to  the total  number of new residues  that can be  accessed  by  a  single  point 
mutation in a particular codon.  Changes leading to new residues are shaded 
green.  Changes leading to or from stop (O) codons are shaded red.
100
bo
|H
0.5 x 107  1.0 x 107  1.5 x 107  2.0 x 107  2.5 x 107  3.0 x 107 0
Number of clones analysed
Figure 1.13.  The relationship between the number of transformants analysed 
and percentage library coverage in the example scenario.  Transformants are 
analysed at random from a library of 7.82 x  106 unique proteins.  Percentage 
library coverage increases with the number of transformants analysed in an 
exponential rise to maximum (100%).
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usage in the tkt gene before being averaged.  The number of unique proteins 
encoded by the library of 1.77 x 107 nucleotide sequences is:
(N  /$) W =  (5.98*) I  *   J
5.98* (f); 
x!(N-x)l
_ 5.982  X 662!
" 2!(662 -2)!
= 7.82 x 106
Where W = number of possible sequences, x =  number of mutations, and N/3 
= length of the protein in residues.  There are  different ways of choosing
x residues to mutate and each of these may be mutated to 5.98 other residues 
(on average), giving the 5.98* term.
1.2.3.2  Library coverage
Screening  or  selecting  7.82  x  106  transformants  would  not,  however,  cover 
100% of the library.  The actual proportion would be:
C = l - eM
f - 7.82x lQ fe "i
= 1 _ gl 7  82xl°6  J 
= 0.632 
= 63.2%
Where C = proportion of library examined, L = library size (number of unique 
proteins), and A -  number of clones analysed.  If 90% coverage of the library 
was  required,  then  2.53  x  107  transformants  would  need  to  be  analysed. 
Although  library  coverage  increases  with  the  number  of  transformants 
analysed,  it  never  actually  reaches  100%  (Figure  1.13).  This  is  because
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transformants  are  picked  at  random  from  the  population:  some  protein 
sequences are analysed more than once and some are not analysed at all.
1.2.4  Screening and selection
Following the creation of a mutant library,  the  mutant genes are expressed 
and a screening or selection step is used to isolate the best variant(s) for the 
next cycle.  "Screening"  is the process of identifying a desired member of a 
library  in  the  presence  of  all  other  members;  for  example,  each  variant  is 
assayed  for  improved  catalytic  activity  under  a  specific  set  of  conditions. 
With  automation,  approximately  104  mutant  proteins  can  be  studied  by 
screening (Reetz and Jaeger, 1999).  If "selection" is applied instead, then only 
the desired member of a library appears; for example, as a viable microbial 
clone.  Selection processes allow the experimenter to examine approximately 
108  individual  variants  -  suggesting  an  increased  chance  of  finding  the 
desired enzyme - but have severe drawbacks.  True selections in which only 
those clones carrying a desired improvement survive or grow faster are rare, 
usually  highly  specific  to  one  problem,  and  difficult  to  implement 
productively in directed evolution (Reetz and Jaeger, 1999).  When available 
and validated, however, they can deliver dramatic results:
Recombinant  antibody  fragments  are  unstable  in  the  reducing 
environment of the cytoplasm because the intradomain disulphide bonds are 
not  formed.  Martineau  and  co-workers  (1998)  have  described  a  directed 
evolution experiment with a selection procedure that linked correct folding of
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a recombinant antibody fragment to cell survival.  An antibody single-chain 
Fv  fragment  (scFv)  that  binds  and  activates  an  inactive  mutant  f> - 
galactosidase  was  isolated.  The  gene  encoding  this  scFv  fragment  was 
subjected  to  random  mutation  by  epPCR  and  the  resulting  library  was 
coexpressed with the mutant p-galactosidase gene in lac bacteria.  By plating 
on limiting lactose, antibody mutants with improved  folding were selected. 
After four successive rounds of mutation and selection, a variant was isolated 
that was expressed correctly in the bacterial cytoplasm with an excellent yield 
(B.lg.l1  in a fermentor).
A  screen  is  required  when  the  desired  activity  or  feature  cannot be 
easily  linked  to  cell  survival  or  growth.  Screens  are  more  versatile  than 
selections, but at a cost to throughput.  Reactions that take place in microwell 
plates - allowing for spectrophotometric detection of the products - are still 
the method of choice in the development of screens.
A  simple  spectrophotometric  approach  for  following  the course  of a 
reaction that depletes or generates protons is to include a pH indicator in the 
reaction.  May  and  co-workers  (2000)  used  this  tactic  in  a  screen  for 
enantioselectivity.  A  library  of  mutants  was  created  from  a  D-selective 
hydantoinase  gene  using  epPCR.  10000  variants  were  grown  up  and 
incubated  with  L-5-(2-methylthioethyl)-hydantoin  (L-MTEH)  and  D-MTEH 
separately.  The rate of each reaction was measured by following the change 
in A580 of the pH indicator cresol red as it responded to changes in pH.  This 
simple  screen  identified  several  mutants  with  novel  L-selectivity.  Further
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genetic manipulation of these variants improved performance and yielded an 
enzyme with possible application in the industrial synthesis of the amino acid 
L-methionine.
1.2.5  Successful applications of directed evolution
There are many excellent examples of biocatalysts being modified for specific 
applications.  Characteristics of wild-type enzymes that have been improved 
include:  activity,  enantioselectivity,  oxidative  stability,  solvent  stability, 
substrate specificity, and thermostability (Table 1.9).  These changes have all 
been  brought  about  by  favourable  combinations  of  mutagenesis  (refer  to 
Section 1.2.1) and selection/screening (refer to Section 1.2.4).
With  regard  to  carbon-carbon  bond-forming  enzymes,  several  have 
been  successfully  modified  by  directed  evolution  to  accept  unnatural 
substrates, including: the pyruvate-dependent aldolases N-acetylneuraminate 
lyase  (Wada  et  al.,  2003)  and  2-keto-3-deoxy-6-phosphogluconate  (KDPG) 
aldolase  (Griffiths  et  al.,  2004);  and  the  dihydroxyacetone  phosphate- 
dependent  aldolase  tagatose-bisphosphate  aldolase  (Williams  et  al,  2003). 
The in vivo selection strategy employed by Griffiths and co-workers involved 
a pyruvate kinase-deficient E. coli cell line.  The auxotroph could be rescued 
by supplementing the  growth  medium with  pyruvate or,  in the case of the 
selection,  retro-aldol  cleavage  of  an  unnatural  2-keto-4-hydroxybutyrate 
adduct by a suitable mutant of KDPG aldolase.  107 KDPG aldolase mutants 
were selected using this method and three active variants were identified.
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Improvement Mutagenesis
technique
Reference
Type Enzyme Extent of change
Activity Phospho- 63-fold increase in fcca t Saturation Griffiths and  1
triesterase mutagenesis Tawfik, 2003
Activity in an Subtilisin E 256-fold increase in kc*i/Km  in 60% epPCR Chen and
organic co-solvent aqueous dimethylformamide Arnold, 1993
Enantioselectivity Hydantoinase L-selective enzyme evolved from epPCR May et al.,
D-selective wild-type 2000
Site specificity Cre recombinase Evolved to selectively recombine Saturation Santoro and
a novel recombination site mutagenesis Schultz, 2002
Substrate P-Galactosidase 10-20-fold higher kc*t/Km  for DNA-shuf  fling Zhang et al.,
specificity fucose (not galactose) substrates 1997
Thermostability p-Nitrobenzyl Tm  increased 14°C without epPCR Giver et al.,
esterase activity at lower temperatures DNA-shuffling 1998
being compromised
Table 1.9.  Examples of enzyme characteristics that have been improved by 
directed evolution.
CEI3
c=o
co2 HO—C—H
H
pyruvate  glycolaldehyde  (S)-3,4-dihydroxybutan-2-one
Figure 1.14.  Scheme of the desired activity shown in Fischer projection.  A 1- 
hydroxyethyl group is transferred from pyruvate to glycolaldehyde, forming 
(S)-3,4-dihydroxybutan-2-one and carbon dioxide.
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1.3  The aims of this project
The ability of transketolase to transfer a C2 moiety from a donor substrate to a 
wide range of acceptor substrates in a stereospecific manner advocates its use 
in the synthesis of fine chemicals and pharmaceuticals.  (3-HPA is frequently 
employed as the donor substrate because the formation of carbon dioxide as 
co-product  renders  the  reaction  irreversible.  However,  p-HPA  is  an 
extremely  expensive  compound  (£113.60  per  gram)  so  adoption  of 
transketolase  as  an  industrial  biocatalyst  is  unlikely  unless  a  new  donor 
substrate  can be  found.  Pyruvate  would  be  a  suitable  replacement as  it is 
inexpensive  (£0.19  per  gram)  and  differs  from  p-HPA  chemically  by  the 
absence of a single hydroxyl group.  As pyruvate is not accepted as a donor 
substrate by any wild-type transketolase, the goal of this project is to modify 
E. coli transketolase so that it does.  This feat will be accomplished through the 
use  of  directed  evolution  and  a  high-throughput  screen  for  transketolase 
activity.  The aims of this project are, therefore:
Firstly,  to  generate  a  library  of  E.  coli  transketolase  variants  with 
mutations  limited  to  stretches  of  residues  likely  to  be  involved  in  p- 
HPA/pyruvate discrimination.  This "focused" approach has two advantages 
over "whole-gene" mutagenesis:  (a) library size is dramatically reduced; and
(b)  much higher mutational loads can be applied, permitting the identification 
of synergistic  combinations  of  mutations.  It  is  believed  that  this  approach 
may  yield  larger  step  enhancements  than  existing  approaches.  The 
development  of  a  novel,  focused  mutagenesis  technique  -  focused  epPCR-
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QuikChange - is discussed in Chapter 5.  The implementation of this method 
in creating a transketolase library is discussed in Chapters 5 and 6.  Chapter 4 
discusses  the  initial  design  of  the  library,  i.e.  the  selection  of  mutagenesis 
targets.
Secondly, to develop a high-throughput screen capable of identifying 
the desired activity (Figure 1.14) in a quantitative manner.  The sensitivity of 
this screen will be maximised by doing the following: (a) selecting the best E. 
coli strain for hosting the transketolase library;  (b)  developing a method for 
culturing  library  members  to  high  optical  densities  in  a  massively-parallel 
format;  (c)  developing  an  effective  procedure  for  releasing  transketolase 
protein from intact cells; and (d) optimising the cofactor concentrations in the 
reaction  step  so  that  the  amount  of  holotransketolase  is  maximised.  The 
synthesis of (S)-3,4-dihydroxybutan-2-one  in each screening reaction will be 
monitored  by  a  suitable  high-throughput  assay.  The  development  of  this 
screen is discussed in Chapter 3.
Thirdly,  to  screen  the  transketolase  library  for  the  desired  reaction 
(Figure 1.14).  A variant capable of catalysing the transfer of a 1-hydroxyethyl 
group  from  pyruvate  to  an  acceptor  substrate  in  a  stereospecific  manner 
would be extremely useful to the pharmaceutical and fine-chemical industries. 
The results of the screening operation are discussed in Chapter 6.
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The  protocols  described  in  this  chapter  are  standard  practices  and  not 
experimental.  Experimental techniques are described in Chapters 3-6.
2.1 Materials
Unless  otherwise  stated,  all  materials  were  purchased  from  Sigma-Aldrich 
Company  Ltd.  Water was  purified  to  15M£Lcm  resistivity  using  an  Elix  5 
water purification system (Millipore Corp.).
2.2 Preparation of buffers, media, and reagents
Unless otherwise stated, all buffers, media, and reagents were stored at room 
temperature.
2.2.1 Luria Bertani (LB) medium
LB  medium  was  prepared  by  dissolving  lOg.l*1   tryptone,  lOg.H  sodium 
chloride,  and  5g.F  yeast extract in pure water.  A  concentrated  solution of 
sodium hydroxide was used to adjust the pH to 7.  The medium was sterilised 
by autoclaving.
2.2.2 LB agar
LB agar was prepared by adding 20g.F select agar to LB medium.  The agar 
preparation was sterilised by autoclaving.
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2.2.3 NZY+ medium
NZY+   medium  was  prepared  by  dissolving  lOg.l1   NZ  amine,  5g.F  yeast 
extract, and 5g.F sodium chloride in pure water.  A concentrated solution of 
sodium hydroxide was used to adjust the pH to 7.5.  After autoclaving,  the 
following  filter-sterilised  solutions  were  added:  20mM  glucose,  12.5mM 
MgCh, and 12.5mM MgSQi.
2.2.4 SOC medium
SOC medium was prepared by dissolving 20g.F tryptone, 5g.F yeast extract, 
0.58g.l_ 1   sodium  chloride,  and  0.19g.l1   potassium  chloride  in  pure  water. 
After autoclaving, the following filter-sterilised solutions were added:  2mM 
glucose, ImM MgCh, and ImM MgSC>4.
2.2.5 Ampicillin
Ampicillin was dissolved in pure water to a concentration of 150g.l_1.  Stocks 
were sterilised by filtration and stored at -20°C.
Ampicillin  was  used  at  a  concentration  of  lSOmg.h1   (a  1000-fold 
dilution  of  the  stock)  to  select  bacteria  carrying  the  plasmid  pQR711. 
Preparations containing this concentration of ampicillin are labelled Amp+.
2.2.6 0.5M Tris buffer (pH 7.5)
0.5M  tris(hydroxymethyl)aminomethane  (Tris)  buffer  with  a  pH  of  7.5  was 
prepared by dissolving 63.5g.l-1   Tris hydrochloride and 11.8g.F  Tris base in 
pure water.
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2.2.7 Standard cofactor solution
Standard  cofactor  solution was  prepared by  dissolving  0.0915g magnesium 
chloride hexahydrate (Mr = 203.3) and 0.0576g ThDP (Mr = 460.8) in 4.5ml of 
pure water.  A concentrated solution of sodium hydroxide was used to adjust 
the pH to 7.5.  The cofactor solution was topped up to 5ml with pure water 
and stored at 4°C (for no more than 24 hours).
2.2.8 Standard substrate solution
Standard substrate solution was prepared by dissolving 0.1375g p-HPA (Mr = 
109.99), 0.0751g glycolaldehyde (Mr = 60.05), and 1.25ml of 0.5M Tris buffer 
(pH  7.5)  in  3.25ml  of  pure  water.  A  concentrated  solution  of  sodium 
hydroxide  was  used  to  adjust  the  pH  to  7.5.  The  substrate  solution  was 
topped  up  to 5ml  with pure water  and  stored  at 4°C  (for no more  than 24 
hours).
2.2.9 Cresol red substrate solution
Cresol  red  substrate  solution  was  prepared  by  dissolving  0.0688g  p-HPA, 
0.0376g  glycolaldehyde,  and  25mgT1   cresol  red  in 4.5ml  of  pure  water.  A 
concentrated solution of sodium hydroxide was used to adjust the pH to 7.5. 
The substrate solution was topped up to 5ml with pure water and stored at 
4°C (for no more than 24 hours).
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2.3  Standard procedures
2.3.1 Streaked plates
A culture was streaked out on a Petri dish of LB agar (Amp+  if appropriate) 
using a wire loop.  The plate was incubated overnight at 37°C and stored at 
4°C.
2.3.2 Overnight cultures
A single colony  was  picked  from a  plate  into  5ml  of LB  medium  (Amp+   if 
appropriate) in a 50ml Falcon tube.  The tube was incubated for 16 hours at 
37°C with 220rpm agitation.
2.3.3 Shake flask cultures
lml  of  an  overnight  culture  was  added  to  49ml  of  LB  medium  (Amp+   if 
appropriate) in a sterile 500ml shake flask.  The shake flask was incubated for 
16 hours at 37°C with 220rpm agitation.
2.3.4 Glycerol stocks
A 20% (v/v) glycerol stock was prepared by adding filter-sterilised 40% (v/v) 
glycerol to an overnight culture in a one to one volume ratio.  Aliquots were 
stored at -80°C.
2.3.5 Sonication
An open 1.5ml Eppendorf tube containing lml of culture was packed into a 
small beaker with ice.  The probe of an MSE Soniprep 150 (Sanyo Europe Ltd.)
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was placed in the culture and the following program of sonication was used: 
eight cycles of 15 seconds on-time and 15 seconds off-time.  The amplitude of
o
sonication was 8A.
2.3.6 Preparation of plasmid DNA
Plasmid DNA was prepared from an overnight culture using a QIAprep Spin 
Miniprep  (QIAGEN  Ltd.).  The  concentration  of  DNA  in  the  product  was 
determined  by  measuring  its  absorbance  at  260nm  (A260).  One  A26O   unit 
corresponds to 50pg.ini'1  dsDNA at neutral pH when a path length of 1cm is 
used (QIAGEN Ltd., 2001).  Plasmid DNA was stored at -20°C.
2.3.7 Transformation by heat-shock
Three  strains  of  competent  cells  were  routinely  transformed:  E.  coli  BL21- 
Gold(DE3), JM109, and XLIO-Gold (all supplied by Stratagene Ltd.).
The relevant competent cells were thawed on ice and an aliquot (Table
2.1)  was  transferred  to  a  chilled  1.5ml  Eppendorf  tube.  If  necessary,  p- 
mercaptoethanol was added (Table 2.1) and the cells were incubated on ice for 
10  minutes,  lpl  of  the  relevant  plasmid  DNA  was  added  to  the  cells  and 
mixed  gently.  The  transformation  reaction  was  incubated  on  ice  for  30 
minutes.  Heat-shock  was  performed  in  a  42°C  waterbath  for  a  specified 
length of time (Table 2.1).  The transformation reaction was then incubated on 
ice for a further 2 minutes.  0.5ml of preheated (42°C) growth medium (Table
2.1) was added to the tube which was then incubated at 37°C for 1 hour with
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E. coli strain Aliquot
m
(3-mercapto-
ethanol
Heat-shock
(seconds)
Growth
medium
BL21-Gold(DE3) 50 20 SOC
JM109 50 0.4pl, 1.42M 45 SOC
XL10-Gold 45 2pl 30 NZY+
Table  2.1.  Values  for  various  parameters  during  the  transformation  of 
competent  cells.  The  concentration  of  the  p-mercaptoethanol  solution 
provided with the competent XL10-Gold cells could not be discovered.
1.0  X  1Q6
0.0
0 5 10 15 20 25
Concentration (mM)
Figure  2.1.  HPLC  calibration  curves  for  L-erythrulose  and  P-HPA.  The 
relationships between concentration and detector response are approximately 
linear for L-erythrulose (•) and p-HPA (o) with R2 values of 0.9997 and 0.9999, 
respectively.  Above 25mM the relationships become more curved.
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220rpm agitation.
2.3.8 Measurement of absorbance and optical density
2.3.8.1 Cuvettes
Absorbance  and  optical  density  measurements  were  performed  in  a  UV2 
spectrophotometer  (Unicam  Ltd.).  An  ultra-micro  quartz  cuvette  (Sigma- 
Aldrich  Company  Ltd.)  was  used  when  measuring  absorbance  in  the 
ultraviolet  region  (200-400nm  wavelength).  Each  sample  was  sufficiently 
diluted to register an absorbency (or an optical density) of ^1AU (or ^lODU).
2.3.8.2 Microwell plates
Wells were scanned at 600nm wavelength in a FLUOstar Optima plate reader 
(BMG Labtechnologies GmbH.) to determine optical density.
2.3.9 Determination of p-HPA and L-erythrulose concentrations by HPLC
This  protocol  was  developed  by  Christine  Ingram  (Department  of 
Biochemical Engineering, UCL).
2.3.9.1  Sample preparation
The reaction sample was diluted 1:4 by the addition of 0.2% (v/v) TFA.  The 
addition of acid quenched the reaction by dropping the pH to well below the 
lower limit for transketolase activity (Mitra et al., 1998).  The concentration of 
L-erythrulose in this quenched sample was determined by HPLC.
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2.3.92 HPLC system
The  HPLC  system  consisted  of  an  Endurance  autosampler  (Spark  Holland 
BV), a GP50 gradient pump  (Dionex Corp.), an LC30 chromatography  oven 
(Dionex  Corp.),  a  PC10  pneumatic  controller  (Dionex  Corp.),  and  an  AD20 
absorbance detector (Dionex Corp.).  A chromatography workstation running 
PeakNet 5.1  (Dionex Corp.) was used  to control the HPLC components and 
collect data from the detector.
1.3.9.3 HPLC method
The mobile phase was 0.1% (v/v) trifluoroacetic acid (TFA) and the flow rate 
was 0.8ml.min_1.  Separation of the components was achieved using a 300mm 
Aminex  HPX-87H  ion-exclusion  column  (Bio-Rad  Laboratories).  The 
temperature of the column was  maintained  at 60°C by the chromatography 
oven.  The detector monitored the absorbance of the output stream from the 
column at 210nm wavelength (the range was 0.1AU).  The injection volume 
was lOpl for all samples.
2.3.9.4 Retention times and calibration curves
The retention times of p-HPA and L-erythrulose using this method are 8.32 
and  11.32  minutes,  respectively.  Glycolaldehyde  does  not  yield  a  peak  of 
significant size at any concentration lower than 200mM.3
Figure  2.1  illustrates  the  calibration  curves  for  p-HPA  and  L- 
erythrulose.  In  both cases  the  relationship  between  injection concentration
3 Glycolaldehyde has a low extinction coefficient at 210nm wavelength.
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and peak area is proportional up to 25mM.
2.3.10  Agarose gel electrophoresis
A  GNA-100  system  (Amersham  Biosciences  Ltd.)  was  used  for  agarose  gel 
electrophoresis  of  DNA.  The  amount  of  agarose  used  in  a  particular  gel 
depended upon the desired linear range of DNA fragment separation:  0.7% 
(w/v)  was  used for 0.8-10.0kbp fragments  (plasmid  DNA)  and  2.0%  (w/v) 
was used for 800-2000bp fragments (PCR products).
The appropriate amount of agarose was dissolved in 50ml of lx  TAE 
buffer  (40mM  Tris acetate  and  ImM  EDTA  in  pure  water)  by  heating  in  a 
microwave.  O.Smg.L1  ethidium bromide was added to the gel to permit the 
visualisation of DNA by UV light.  A comb was inserted at one end to form 
the sample wells.  After the gel had set it was submerged in lx TAE buffer in 
the gel tank and the comb was removed.
Samples  were  prepared  for  loading  by  adding  6x  loading  buffer 
(Sigma-Aldrich Company Ltd.).  The wells of sample lanes were loaded with 
3pl of sample.  The wells of marker lanes were loaded with 1.5pl of Novagen 
0.5-12.0kbp  Perfect  DNA  Markers  (EMD  Biosciences  Inc.)  or  Novagen  50- 
2000bp PCR Markers (EMD Biosciences Inc.).  Electrophoresis was performed 
at 60V for 1 hour.  The gel was visualised and photographed using a Gel Doc 
2000 system (Bio-Rad Laboratories).
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2.3.11 Polyacrylamide gel electrophoresis (DNA)
A Mini-Protean II system (Bio-Rad Laboratories) was used for polyacrylamide 
gel electrophoresis of DNA.  Precast 4-20%  gradient Tris borate EDTA (TBE) 
gels (Bio-Rad Laboratories) were used for all analyses.
A precast gel was clipped  into the  gel cassette  and submerged  in lx 
TBE buffer in the gel tank.  Samples were prepared for loading by adding 6x 
loading  buffer  (Sigma-Aldrich  Company  Ltd.).  The  wells  of  sample  lanes 
were loaded with 5pl of sample.  The wells of marker lanes were loaded with 
2.5pl  of  Novagen  50-2000bp  PCR  Markers  (EMD  Biosciences  Inc.). 
Electrophoresis was performed at 80V for 2 hours.  Following electrophoresis 
the DNA in the gel was stained by soaking in a solution of O.Smg.l1  ethidium 
bromide in lx  TBE.  The gel was visualised and  photographed using a Gel 
Doc 2000 system (Bio-Rad Laboratories).
2.3.12 SDS-PAGE
A  Mini-Protean  II  system  (Bio-Rad  Laboratories)  was  used  for  sodium 
dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) of proteins. 
12.5% (w/v) acrylamide gels were used for all SDS-PAGE analyses.
2.3.12.1  Stock solutions
The acrylamide solution was 29.2%  (w/v) acrylamide and 0.8%  (w/v) N,N'- 
methylene bisacrylamide in water (Bio-Rad Laboratories).  The separating gel 
buffer was 1.5M Tris buffer (pH 8.8).  The stacking gel buffer was 0.5M Tris
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buffer (pH 6.8).  The running buffer was 0.05M TrisHCl, 0.38M glycine, and 
0.1% (w/v) SDS in pure water, adjusted to pH 8.8.  The staining solution was 
0.05%  (w/v)  Coomassie  Brilliant Blue,  50%  (v/v)  methanol,  and  10%  (v/v) 
acetic acid in pure water.
2.3.22.2 Gel casting
The gel cassette was assembled according to the manufacturer's instructions. 
12.5% (w/v) separating and 6% (w/v) stacking gels were prepared according 
to Table 2.2.
The  separating  gel  was  poured  first,  overlaid  with  isopropanol  to 
ensure a flat surface, and allowed to set.  The solvent was carefully removed 
and the stacking gel was poured above the first gel.  A comb was positioned 
in  the  stacking  gel  to  form  the  sample  wells.  After  polymerisation  was 
complete,  the  comb  was  removed  and  the  gel  cassette  was  secured  in  the 
electrophoresis tank.
2.3.22.3 Sample preparation and running the gel
Samples were mixed with 2* Laemmli Sample Buffer (Bio-Rad Laboratories) 
and  heated  to  100°C  for  2  minutes  to  denature  the  protein.  The  wells  of 
sample lanes  were  loaded  with 20pl  of sample.  The  wells  of marker  lanes 
were  loaded  with  5pl  of  Precision  Plus  Protein  Standards  (Bio-Rad 
Laboratories).  Electrophoresis was performed at 100V for 3 hours.
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Component Separating gel 
(ml)
Stacking gel 
(ml)
Acylamide solution 4.2 2.0
Stacking gel buffer 0.0 2.5
Separating gel buffer 2.5 0.0
10% (w/v) SDS solution 1.0 1.0
Pure water 2.3 4.5
10%  (w/v) ammonium persulphate 
TEMED
0.1
0.01
0.1
0.01
Table  2.2.  Components  of 12.5%  (w/v)  separating  and  6%  (w/v)  stacking 
gels.  Ammonium  persulphate  and  TEMED  (N ^N'^'-tetram ethylethyl- 
endiamine)  were  added  to  each  gel  at  the  last  minute  to  initiate 
polymerisation.
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2.3.12.4  Staining with Coomassie Brilliant Blue
Protein bands were visualised by staining with Coomassie Brilliant Blue.
The gel was placed in a plastic container, covered with 50ml of staining 
solution, and microwaved on full power for 3 minutes.  The stain was poured 
away and the gel was destained by boiling for 10 minutes in 1  litre of pure 
water.  The  gel  was  photographed  using  a  Gel  Doc  2000  system  (Bio-Rad 
Laboratories).
2.3.13 DNA sequencing
Cycle sequencing (Sambrook et al., 1989) was performed by  the Sequencing 
Service  of the  Wolfson  Institute  for  Biomedical  Research  (UCL).  All  DNA 
samples  were  given  to  the  service  at  a  concentration  of  lOOfmoles  in  6pl. 
Primer  TKN  (5,-GATCCAGAGATTTCTGA-3,/  tkt  nucleotides  -140  to  -124) 
was  used  for  sequencing  targets  A  and  B  and  primer  TKC  (5'- 
TATCTCCCTGCACGGTGGCTTCC-3',  tkt  nucleotides  +1260  to  +1282)  was 
used for target C.
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3.1  Introduction
It was envisaged that the screening phase of this project would involve four 
steps:  (1)  transformation  of  the  pQR711  variants  into  a  suitable  host;  (2) 
microwell  culture  of  the  colonies;  (3)  lysis  of  the  cultures;  and  finally  (4) 
incubation with the target substrates (pyruvate and glycolaldehyde).  If any of 
the  mutant  transketolases  were  capable  of  synthesising  (S)-3,4- 
dihydroxybutan-2-one (and carbon dioxide) from these substrates (Figure 1.14) 
they would be identified by a suitable assay.
The  principal  methods  for  measuring  transketolase  activity  are  a 
continuous  multi-enzyme-linked  spectrophotometric  assay  (Villafranca  and 
Axelrod, 1971) and a discontinuous HPLC assay (Mitra and Woodley, 1996). 
The  multi-enzyme-linked  assay  uses  a-glycerophosphate  dehydrogenase, 
triosephosphate  isomerase,  phosphoribose  isomerase,  and  D-ribulose-5- 
phosphate-3-epimerase to link transketolase activity to NADH oxidation.  By 
monitoring  the  rate  of  NADH  depletion  at  340nm  wavelength  (A340),  the 
transketolase  activity  can be  elucidated.  The  spectrophotometric  nature  of 
this assay makes it a good choice for high-throughput screening: hundreds of 
transketolase variants could be screened simultaneously in a microwell plate. 
However,  the  assay  relies  on  a  specific  chain  of reactions  that:  (a)  will  not 
permit p-HPA or pyruvate to be used as the donor substrate; and (b) will not 
yield a true measure of transketolase activity if one of the downstream links 
becomes the rate-limiting step.
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HPLC  methods  evaluate  the  concentration  of  product  formed  in  a 
reaction at intervals, thus allowing enzyme activity to be elucidated.  As the 
product  is  examined  directly,  HPLC-based  determinations  of  transketolase 
activity do not suffer from the limitations of the multi-enzyme-linked assay. 
One  such  method,  developed  by  Christine  Ingram  (Department  of 
Biochemical  Engineering,  UCL),  allows  the  bioconversion  of  (3-HPA  and 
glycolaldehyde to L-erythrulose  (and carbon dioxide)  to be followed.4  This 
method  has  been  useful  in  making  precise  measurements  of  transketolase 
activity  (refer to Section 2.3.9), but it was  too sluggish for  high-throughput 
application (11 minutes per sample = 131 samples per day).
A  recent  publication  describes  an  entirely  new  approach  to 
determining transketolase  activity:  the use  of a fluorogenic  donor substrate 
(Sevestre et al.r 2003).  When this compound (1) is cleaved by transketolase it 
yields a highly unstable compound (2) that rapidly undergoes p-elimination 
to  form  umbelliferone  (Figure  3.1).  Umbelliferone  is  a  highly  fluorescent 
compound whose formation could be easily measured in a high-throughput 
manner.  This method would, therefore, be extremely useful for the directed 
evolution of new acceptor substrate-specificities in transketolase.  However, 
as  the  goal  of  this  project  is  to  modify  donor  substrate  specificity,  this 
technique cannot be used.
As  the  existing  methods  for  determining  transketolase  activity  were 
not suitable for the screening phase of this project, a new one was required.
4 This method was in turn developed from that of Mitra and Woodley (1996).
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Figure 3.1.  A fluorogenic assay for transketolase activity.  Compound 1  is a 
donor  substrate  for  the  transketolase  reaction.  The  transfer  of  a  1,2- 
dihydroxyethyl  group  from  compound  1  to  an  acceptor  substrate  yields  a 
ketose  product  and  compound  2.  Compound  2  undergoes  rapid  p- 
elimination to form the highly-fluorescent compound umbellifrone.  "BSA" is 
an abbreviation  for  bovine  serum  albumin.  (Adapted  from Sevestre et al.f 
2003.)
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Two separate  approaches were  investigated:  (a)  a  spectrophotometric  assay 
based on a pH indicator and the pH increase that accompanies transketolase- 
mediated condensation (Mitra et al., 1998); and (b) a fast HPLC protocol based 
on  a  short  column.  Approach  (a)  has  been  successfully  employed  by  a 
number  of  groups  (for  example:  May  et al.,  2000).  Although  there  are  no 
examples of HPLC-based screens being used in directed evolution, they have 
been used  in combinatorial chemistry  (Ding et al., 1999; Mikami et al., 2001) 
and in the nutritional analysis of seeds from Arabidopsis mutants (Jander et al., 
2004).
The remainder of the chapter relates efforts to maximise the quantity of 
holotransketolase  in  each  screening  reaction.  As  the  kcat  values  of  active 
transketolase variants might be low, it was reasoned that higher holoenzyme 
concentrations  would  aid  their  identification.  The  aspects  of  transketolase 
production and reconstitution that were examined were: (a) the choice of host 
strain;  (b)  the  microwell  culture  process;  (c)  the  lytic  method;  and  (d)  the 
concentrations of cofactors in the reaction step.  As these aspects could not be 
optimised  using  the  target  reaction  (Figure  1.14),  the  p-HPA  and 
glycolaldehyde to L-erythrulose (and carbon dioxide) reaction was used as a 
model.  Reaction conditions  other than the concentrations of cofactors were 
maintained  at  departmental  standards  (refer  to  Section  1.1.3.4.),  i.e.  15 
minutes preincubation time, lOOmM substrates, 25°C temperature, and pH 7.5.
In  this  chapter  transketolase  activity  is  expressed  in  mkat.nv3 
(millikatals per cubic meter).  The "katal" is the Syst£me International unit for
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catalytic  activity  and  is  equal  to  one  mole  of  product  formed  per  second 
(Dybkaer, 2001).
3.2  Methods
3.2.1 Selection of the host strain
3.2.1.1 Transformation
E. coli JM107 and JM107 pQR711 were a gift from Dr. John Ward (Department 
of  Biochemistry,  UCL).  Streaked  plates  (Section  2.3.1)  and  glycerol  stocks 
(Section 2.3.4) were immediately prepared from both strains.
Plasmid DNA was extracted from an overnight culture (Section 2.3.2) 
of  E.  coli  JM107  pQR711  by  the  standard  procedure  (Section  2.3.6).  The 
resulting  pQR711  DNA  was  transformed  by  heat-shock  (Section  2.3.7)  into 
competent  cells  of  three  strains:  E.  coli  BL21-Gold(DE3),  JM109,  and  XL10- 
Gold.  lOpl aliquots of transformed cells were added to 90pl of LB medium 
and spread on LB Amp+  agar plates.  The plates were incubated overnight at 
37°C.
Overnight cultures (Section 2.3.2) were grown from individual colonies 
of E. coli BL21-Gold(DE3)  pQR711, JM109 pQR711,  and  XLIO-Gold  pQR711, 
and plasmid DNA was extracted (Section 2.3.6).  280ng of each DNA sample 
were added to 3pl of 10* NEBuffer 3 (New England Biolabs Inc.), lpl of the 
restriction  enzyme  Mlu  I  (New  England  Biolabs  Inc.),  and  sufficient  pure 
water to make a total volume of 30pl.  The samples were incubated at 37°C for 
one hour to permit digestion.  40ng of each digested sample were run on a
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0.7% (w/v) agarose gel (Section 2.3.10).
3.2.1.2 Confirmation of transketolase overexpression
Overnight  cultures  (Section  2.3.2)  were  grown  of  E.  coli  BL21-Gold(DE3), 
JM107, JM109, XLIO-Gold, and the corresponding pQR711  strains.  The final 
OD600 of each culture was measured  (Section 2.3.8.1) and an aliquot of each 
was diluted to l.OOODU.  These diluted samples were denatured and run on 
an SDS-PAGE gel (Section 2.3.12).
3.2.1.3 Reaction profiles
Shake flask cultures (Section 2.3.3)  of E. coli BL21-Gold(DE3), JM107, JM109, 
XLIO-Gold, and the corresponding pQR711 strains were prepared.  Aliquots 
of these cultures were  diluted  with LB medium to ODeoos  of 3.00ODU and 
lysed by sonication (Section 2.3.5).  0.5ml of each sonicate was added to 0.1ml 
of cofactor solution (Section 2.2.7) (LB medium replaced sonicate in a control 
sample).  After a 15 minute preincubation period the reactions were initiated 
by adding 0.4ml of substrate solution (Section 2.2.8).  The final concentrations 
in  each  reaction  were:  lOOmM  glycolaldehyde,  lOOmM  (3-HPA,  50mM  Tris 
buffer (pH 7.5), 9mM MgCh, and 2.5mM ThDP.  The reactions were allowed 
to proceed at 25°C for 90 minutes.  At frequent time points samples of each 
reaction were quenched and analysed for L-erythrulose (Section 2.3.9).
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3.2.1.4  Transketolase activity
Shake flask cultures (Section 2.3.3)  of E. coli BL21-Gold(DE3), JM107, JM109, 
XLIO-Gold,  and  the  corresponding  pQR711  strains,  were  prepared.  All 
strains  grew  to  similar  final  OD600S  (4-50DU).  Aliquots  of  the  wild-type 
cultures were  diluted with LB medium to ODeoos of 3.00ODU and  lysed by 
sonication  (Section 2.3.5).  Aliquots  of the  pQR711  cultures were  diluted  to 
ODeoos of 0.50ODU and sonicated.  150pl of each sonicate was added to 30pl 
of cofactor solution (Section 2.2.7).  Three replicate samples were prepared for 
each strain (LB medium replaced sonicate in three control samples).  After a 
15 minute preincubation period the reactions were initiated by adding 120pl 
of substrate solution (Section 2.2.8).  The final concentrations in each reaction 
were:  lOOmM  glycolaldehyde,  lOOmM  p-HPA,  50mM  Tris  buffer  (pH  7.5), 
9mM MgCb, and 2.5mM ThDP.  The E. coli JM107 pQR711, JM109 pQR711, 
and XLIO-Gold pQR711  reactions were quenched after five minutes at 25°C 
(Section  2.3.9).  The  remaining  reactions  were  quenched  after  a  further  55 
minutes  at  25°C.  The  concentration  of  L-erythrulose  in  each  quenched 
reaction  was  determined  by  HPLC  (Section  2.3.9)  and  the  corresponding 
transketolase activity value was calculated.
3.2.2  Microwell culture
Each well of three 96-well plates and three 384-well plates was filled with the 
appropriate volume of LB Amp+  medium (Table 3.1).  A QPix2 robot (Genetix 
Ltd.) was programmed to inoculate every well of the six plates with colonies
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of E. coli XLIO-Gold  pQR711.  Each plate was sealed by  taking an identical 
(but empty) plate, inverting it, and taping it over the top.  The sealed plates 
were  incubated  for  16  hours  at  various  agitation  speeds  on  a  Variomag 
Teleshake unit (Camlab Ltd.) in a 37°C incubator (Table 3.1).  A shake flask of 
E. coli XLIO-Gold pQR711 was prepared in parallel (Section 2.3.3).
After incubation, the uniformity of cell growth across each plate was 
analysed (Section 2.3.8.2).  The wells of each plate were pooled and the OD600 
was measured (Section 2.3.8.1).  The final OD600 of the shake flask culture was 
measured (Section 2.3.8.1).
3.2.3  Optimisation of cofactors
A  shake  flask  culture  (Section  2.3.3)  of  E.  coli  XLIO-Gold  pQR711  was 
prepared.  An aliquot of this culture was diluted with LB medium to an OD600 
of 0.50ODU and lysed by sonication (Section 2.3.5).  A 96-well plate was set 
up with a grid of wells containing increasing concentrations of ThDP across 
one axis and increasing concentrations of MgCL 6 H2O down the other.  The 
total volume  of cofactors  in each well  was 30pl.  150pl  of the  sonicate was 
pipetted into each well.  LB medium replaced sonicate in two control samples: 
one control had maximum cofactors and the other had none at all.  After a 15 
minute preincubation period the reactions were initiated by adding 1 2 0 pl of 
substrate  solution  (Section  2.2.8).  The final  concentrations  in each  reaction 
were: lOOmM glycolaldehyde, lOOmM p-HPA, 50mM Tris buffer (pH 7.5), 0- 
32mM Mg2+,  and 0-8mM ThDP.  The reactions were  allowed  to proceed  at
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Format Medium 
volume (pi)
Agitation
(rpm)
96-well 150 600
96-well 150 1000
96-well 150 1400
384-well 60 600
384-well 60 1000
384-well 60 1400
Table  3.1.  Candidate  micro  well  culture  formats.  "Medium  volume"  is 
volume of LB Amp+  medium per well.
Treatment Label
Sonicated by standard method (2.3.5) Sonication
Incubated at 25°C with 10% (v/v) BugBuster
for 30 minutes 10% BB 30min
for 1 hour 10% BB 60min
Incubated at 25°C with 20% (v/v) BugBuster 
for 30 minutes 20% BB 30min
for 1 hour 20% BB 60min
Cycles of freezing at -80°C and thawing at 25°C
1 cycle F/T* 1
2 cycles F/T* 2
3 cycles F/T* 3
No further treatment Not treated
Table  3.2.  Candidate  lytic  methods.  BugBuster  HT  Protein  Extraction 
Reagent is a proprietary lysing reagent sold by Novagen Inc.
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25°C for ten minutes.  Samples of each reaction were quenched and diluted 
1:4 by the addition of 0.2%  (v/v) TFA.  The concentration of L-erythrulose in 
each  quenched  reaction  was  determined  by  HPLC  (Section  2.3.9)  and  the 
corresponding transketolase activity value was calculated.
3.2.4  Lytic methods
A  shake  flask  culture  (Section  2.3.3)  of  E.  coli  XLIO-Gold  pQR711  was 
prepared.  This culture was diluted with LB medium to an OD600 of 3.41 ODU. 
lm l aliquots were pipetted into 1.5ml Eppendorf tubes and lysed by different 
methods (Table 3.2).  Three replicate samples were prepared using each lytic 
method.  After treatment the samples were diluted 1:6.82 by the addition of 
LB  medium.  150pl  of  each  diluted  sample  was  added  to  30pl  of cofactor 
solution (Section 2.2.7) (LB medium replaced lysate in three control samples). 
After a 15 minute preincubation period the reactions were initiated by adding 
120pl  of substrate  solution  (Section 2.2.8).  The  final  concentrations  in each 
reaction were: lOOmM glycolaldehyde, lOOmM p-HPA, 50mM Tris buffer (pH
7.5), 9mM Mg2+, and 2.5mM ThDP.  The reactions were allowed to proceed at 
25°C for ten minutes.  Samples of each reaction were quenched and diluted 
1:4 by the addition of 0.2%  (v/v) TFA.  The concentration of L-erythrulose in 
each  quenched  reaction  was  determined  by  HPLC  (Section  2.3.9)  and  the 
corresponding transketolase activity value was calculated.
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3.2.5  High-throughput assays for transketolase activity
3.2.5.1 Spectrophotometric assay
A shake flask culture  (Section 2.3.3)  of E.  coli JM107 pQR711  was  prepared 
and its final OD600 was measured (Section 2.3.8.1).  This culture was diluted 
with LB medium to  an OD600 of 3.00ODU and  lysed  by  sonication  (Section
2.3.5).  LB  medium  was  added  to  aliquots  of  this  sonicate  to  make  three 
dilutions:  1:2,  1:4,  and  1:8.  0.5ml  of  each  dilution  was  added  to  0.1ml  of 
cofactor solution (Section 2.2.7) in a polystyrene cuvette (LB medium replaced 
sonicate in a control  sample).  After a ten minute preincubation period  the 
reactions  were  initiated  by  adding  0.4ml  of  cresol  red  substrate  solution 
(Section  2.2.9).  The  final  concentrations  in  each  reaction  were:  50mM 
glycolaldehyde,  50mM  p-HPA,  9mM  MgCh,  2.5mM  ThDP,  and  lOmg.l*1  
cresol  red.  The  A573  of  each  reaction  was  monitored  in  a  UV2 
spectrophotometer.
3.2.52 High-throughput HPLC method
3.2.5.2.1 HPLC system
The same HPLC system was used as described in Section 2.3.9.
32.5.2.2  HPLC method
The mobile phase was 0.1% (v/v) trifluoroacetic acid (TFA) and the flow rate 
was 2ml.min-1.  Separation of the components was achieved using a 50mm PL 
Hi-Plex H guard column (Polymer Laboratories Ltd.).  The temperature of the 
column was maintained at 30°C by the chromatography oven.  The detector
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monitored  the  absorbance  of the  output stream from the column  at 210nm 
wavelength  (the  range  was  0.1 AU).  The  injection volume  was  lOpl  for  all 
samples.
3.2.52.3 Retention times and calibration curves
Retention time data and calibration curves were collected for L-erythrulose, 
glycolaldehyde, p-HPA, and pyruvate.
3.3 Results
3.3.1 Selection of host strain
E. coli JM107 pQR711 yields transketolase at a concentration of 168mg per litre 
of shake flask culture, corresponding to 23% of total cell protein (French and 
Ward, 1995).  However, E. coli JM107 was ruled out as a host for the mutant 
transketolase library because commercial competent cells were not available. 
Commercial  competent cells  are  preferable  for  library  construction  because 
their transformation efficiencies are several orders of magnitude greater than 
those prepared in the laboratory.  Several commercial strains of E. coli were 
investigated as potential hosts for the transketolase library: BL21-Gold(DE3), 
JM109, and XLIO-Gold (Table 3.3).
3.3.1.1 Transformation
pQR711 DNA was extracted from E. coli JM107 pQR711 and transformed into 
the commercial  strains  by  heat-shock.  To confirm  that the  transformations 
had  been  successful,  plasmid  DNA  was  extracted  from  these  new  strains,
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Strain Genotype
Original host for pQRTll 
JM107 el4~(McrA-) endAl gyrA96 thi-1 hsdR17 (rKn\K+) supE44 
relA A{lac-proAB) [F' traD36 proAB lacI<iZAM15]
Potential hosts for the library
BL21-Gold(DE3)
JM109
XLIO-Gold
F- ompT hsdS(r$- mB‘) dcm+  Tetr gal A(DE3) endA Hte 
el4-(McrA_) recAl endAl gyrA96 thi-1 hsdR17 (rKmic+) 
supE44 relA A(lac-proAB) [F' traD36 proAB lacI<iZAM15] 
Tetr A(mcrA)183 A(mcrCB-hsdSMR-mrr)173 endAl 
supE44 thi-1 recAl gyrA96 relAl lac Hte [F' proAB 
lac!<iZAM15 TnlO (Tetr) Amy Camr]
Table 3.3.  Gentotypes  of the  E. coli strains  BL21-Gold(DE3)/ JM107, JM109, 
and XLIO-Gold.  Genes that are listed signify mutant alleles.  Genes on the F' 
episome, however, are wild-type unless indicated otherwise,  (a) JM107 cells 
are endonuclease (endA) deficient, greatly improving the quality of miniprep 
DNA.  The  hsdR  mutation  prevents  cleavage  of  cloned  DNA  by  the  EcoK 
endonuclease  system,  (b)  BL21-Gold(DE3)  is  a  general  protein  expression 
strain that lacks  both the  Lon protease  and  the OmpT  protease, which can 
degrade proteins during purification,  (c) JM109 cells are genetically identical 
to JM107 cells except for being recombination deficient (recA).  This deficiency 
improves  insert  stability,  (d)  XLIO-Gold  cells  are  deficient  in  all  known 
restriction  systems  [A(mcrA)183  A(mcrCB-hsdSMR-mrr)173].  The  strain  is 
endonuclease  deficient (endA)  and  recombination  deficient  (recA).  The  Hte 
phenotype  increases  the  transformation  efficiency  of  ligated  and  large 
supercoiled DNA.
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linearised  by  the  restriction  enzyme  Mlu  I,  and  analysed  by  agarose  gel 
electrophoresis (Section 3.2.1.1) (Figure 3.2).  The digestion step was necessary 
to eliminate  gel bands caused by circular  DNA,  plasmid  dimers,  and  other 
molecular complexes.  All three of the new strains were found to harbour the 
pQR711 plasmid (5.4kbp).
3.3.12  Confirmation of transketolase overexpression
Cultures of E. coli BL21-Gold(DE3), JM107, JM109, XLIO-Gold, JM107 pQR711 
and  the  three  new  pQR711  strains  were  analysed  by  SDS-PAGE  (Section 
3.2.1.2).  Dark bands of ~70kDa were observed in the E. coli JM107 pQR711, 
JM109 pQR711, and XLIO-Gold pQR711 lanes (Figure 3.3).  A fainter band of 
the  same  molecular  mass  was  observed  in  the  £.  coli  B  BL21-Gold(DE3) 
pQR711 lane.  As 70kDa approximated the relative molecular mass of the E. 
coli  transketolase  monomer  (72.036kDa)  it  was  concluded  that  the  enzyme 
was  being  overexpressed  in  all  of  the  pQR711  strains.  However,  the 
expression  of  transketolase  in  the  E.  coli  BL21-Gold(DE3)  pQR711  strain 
appeared to be significantly lower than in the other strains.
3.3.1.3  Reaction profiles
Cultures  of  £.  coli  BL21-Gold(DE3),  JM107,  JM109,  XLIO-Gold,  and  the 
corresponding pQR711  strains were grown, diluted to the same final OD600, 
and sonicated.  Aliquots of these sonicates were incubated with the substrates 
P-HPA  and  glycolaldehyde  (both  lOOmM)  at  25°C  and  pH  7.5.  Over  the
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Linear pQR711 (5.4kbp)
Figure  3.2.  0.7%  agarose  gel  electrophoresis  of  linearised  plasmid  DNA
extracts.  Sample  lanes  are  £.  coli JM107  pQR711  ("J7p"),  BL21-Gold(DE3) 
pQR711 ("Bp"), JM109 pQR711 ("J9p"), and XLIO-Gold pQR711 ("Xp").  Lane 
"M" contains marker DNA (0.5-12kbp).  The 5.4kbp band in all of the sample 
lanes corresponds to linear pQR711 DNA.
200kDa
150kDa
lOOkDa
75kDa Transketolase
(72kDa) 50kDa
37kDa
25kDa
20kDa
Figure 3.3.  SDS-PAGE analysis of the new strains.  Sample lanes are E. coli 
BL21 -Gold(DE3)  ("B"),  JM107  ("J7"),  JM109  ("J9"),  XLIO-Gold  ("X"),  BL21- 
Gold(DE3)  pQR711  ("Bp"),  JM107  pQR711  ("J7p"),  JM109  pQR711  ("J9P")/ 
and  XLIO-Gold  pQR711  ("Xp").  "M"  lanes  contain  protein  standards  (20- 
250kDa).  The 70kDa band in the J7p, Bp, J9p, and Xp lanes corresponds to the 
transketolase monomer.
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course  of  90  minutes  the  synthesis  of  L-erythrulose  in  each  reaction  was 
monitored by HPLC (Section 3.2.1.3).
The  data  showed  that  the  pQR711  strains  of  E.  coli  generated 
considerably  more  L-erythrulose  from  the  substrates  than  the  wild-type 
strains  (Figure  3.4).  This observation proved  that the transketolase  protein 
being  overexpressed  by  the  pQR711  strains  was  functional.  The  highest 
activity was observed in the E. coli XL10 pQR711 sonicate; the JM107 pQR711 
and  JM109  pQR711  sonicates  had  comparable  activities,  while  the  BL21- 
Gold(DE3)  pQR711  sonicate had a substantially lower one.  These activities 
were quantitatively assessed in the next experiment.
3.3.2.4  Transketolase activity
Initial  reaction  velocity  data  were  collected  for  the  eight  strains  (Section 
3.2.1.4).  Sonicates were prepared and incubated with the substrates  p-HPA 
and  glycolaldehyde  (both  lOOmM)  at  25°C  and  pH  7.5.  The  transketolase 
concentrations  in  the  wild-type  reactions  were  equal  to  1.50ODU  culture 
sonicates and the transketolase concentrations in the pQR711 reactions were 
equal  to  0.25ODU  culture  sonicates.  The  E.  coli  JM107  pQR711,  JM109 
pQR711, and XLIO-Gold pQR711 reactions were quenched after five minutes 
of incubation and the remaining reactions were stopped after one hour.  The 
L-erythrulose concentration in each reaction was measured by HPLC and the 
corresponding  transketolase  activity  was  computed  (Figure  3.5). 
Transketolase  activity  was  calculated  as  "mkat.nv3  of  a  0.25ODU  culture
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Strain L-Eryt irulose conc. (mM) at time (minutes)
0.5 10 20 30 60 90
Wild-type strains 
JM107
BL21-Gold(DE3)
JM109
XLIO-Gold
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.83
0.71
0.78
0.89
1.26
0.96
1.42
1.58
2.95
1.71
2.68
2.64
4.76
2.52
4.47
pQRTll strains
1.68
0.00
1.60
3.27
33.98
5.42
32.27
92.70
62.55
11.74 
74.19
96.74
89.59
18.38
97.50
97.86
96.72
36.37
99.95
98.80
99.04
53.59
97.77
98.65
JM107 pQR711 
BL21-Gold(DE3) pQR711 
JM109 pQR711 
XLIO-Gold pQR711
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Figure 3.4.  Bioconversion of p-HPA and glycolaldehyde to L-erythrulose (and 
carbon  dioxide)  by  sonicates  of  the  new  strains.  lOOmM  each  of  the  two 
substrates were incubated with sonicates of £. coli JM107 pQR711  (•),  BL21- 
Gold(DE3)  pQR711  (o), JM109 pQR711  (▼ ),  XLIO-Gold  pQR711  (v ),  and  the 
corresponding wild-type strains.  The concentration of transketolase in each 
reaction  was  equal  to  that  of  a  sonicated  1.50ODU  culture.  The  control 
reaction did not produce detectable L-erythrulose.
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Strain Transketolase activity (mkat.nr3)
A B C Mean OM
Wild-type strains
JM107 0.089 0.086 0.085 0.087 0.0011
BL21-Gold(DE3) 0.106 0.129 0.132 0.122 0.0083
JM109 0.084 0.087 0.092 0.088 0.0025
XLIO-Gold 0.139 0.137 0.134 0.137 0.0015
pQR711 strains
JM107 pQR711 5.874 5.664 5.700 5.746 0.0649
BL21-Gold(DE3) pQR711 1.046 1.026 1.068 1.047 0.0123
JM109 pQR711 5.669 5.440 5.728 5.612 0.0879
XLIO-Gold pQR711 12.967 12.744 13.416 13.042 0.1976 1
14 n
JM107  BL21 -Gold (DE3)  JM109  XLIO-Gold
Figure 3.5.  Transketolase activity in sonicates of the new strains.  Cultures of 
E.  coli  JM107,  BL21-Gold(DE3),  JM109,  XLIO-Gold,  and  the  corresponding 
pQR711  strains were sonicated and analysed for transketolase activity.  The 
catalysed  reaction  was  lOOmM  p-HPA  and  lOOmM  glycolaldehyde  to  L- 
erythrulose (and carbon dioxide).  The activity values correspond to reactions 
containing the same concentration of transketolase as 0.25ODU culture lysates. 
Wild-type columns are on the left (coloured blue) and pQR711  columns are 
on the right (coloured red).  The error bars correspond to  ± o m .  The control 
reaction did not produce detectable L-erythrulose.
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sonicate" for two reasons: (a) to adjust for the concentration of sonicate in the 
reaction (six times more dilute in the pQR711 reactions); and (b) to adjust for 
the  length  of  the  incubation  period  (six  times  shorter  for  the  £.  coli JM107 
pQR711, JM109 pQR711, and XLIO-Gold pQR711 reactions).
E.  coli  BL21-Gold(DE3)  pQR711  sonicate  was  found  to  have  a  mean 
activity  approximately  six-fold  lower  (1.047mkat.nr3)  than  JM107  pQR711 
sonicate  (5.746mkat.nr3).  E.  coli JM109  pQR711  sonicate  had  a  comparable 
mean activity (5.612mkat.nr3)/ while XLIO-Gold pQR711  sonicate was found 
to  have  more  than  twice  the  mean  activity  (13.042mkat.nr3).  The  low 
activities  of the wild-type strains  (0.087-0.137mkat.nr3)  were  attributable to 
small amounts of transketolase protein being expressed from genomic copies 
of tkt.  These results agreed with the findings of the previous experiment.
3.3.2  Microwell culture
Microwell  culture  is  the  only  practical  way  of  individually  culturing  the 
variants of a mutant library for screening.  The principal questions concerning 
the application of microwell culture in this project were:  (a) could adequate 
cell densities be achieved?; (b) could cultures be grown to consistent densities 
across  a  plate?;  and  (c)  was  there  any  danger  of  external-  or  cross­
contamination?
Microwell culture was studied in two plate formats: 96 round-well and 
384 square-well (Section 3.2.2).  The wells of three plates of each format were 
filled with LB  Amp+   medium and  inoculated with individual colonies of E.
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coli XLIO-Gold  pQR711.  Each  plate  was  sealed  by  taking  an  identical  (but 
empty) plate, inverting it, and taping it over the top.  This method of sealing 
prevented evaporation, but trapped sufficient air above each culture to permit 
aerobic  growth.  The  sealed  plates  were  incubated  for  16  hours  at  various 
agitation speeds in a 37°C incubator.
The growth of bacteria across the plate was found to be uniform in all cases (a 
typical result is illustrated in Figures 3.6 and 3.7).  Pooling the well cultures 
from  each  plate  and  measuring  the  OD600  in  a  cuvette  revealed  that  the 
highest  cell  densities  were  obtained  in  96-well  plate  cultures  (Figure  3.8). 
Final OD600 increased with agitation speed from 4.140DU at 600rpm, through 
4.150DU at lOOOrpm, to 4.530DU at 1400rpm.  This latter value was close to 
that achieved in a shake flask (4.860DU).  The final OD600S of the cultures in 
the 384-well plates were found to be lower: 1.480DU at 600rpm, 1.910DU at 
lOOOrpm, and 3.410DU at 1400rpm.  Again, turbidity was found to increase 
with agitation speed.
Further experiments revealed that the risk of a microwell culture being 
contaminated by external sources or neighbouring wells was virtually nil.
3.3.3  Optimisation of cofactors
To  determine  the  optimum  cofactor  concentrations  for  transketolase 
activity aliquots of an E. coli XLIO-Gold pQR711 sonicate were incubated with 
the  substrates  p-HPA  and  glycolaldehyde  (both  lOOmM),  and  variable 
concentrations  of  Mg2+  (0-32mM)  and  ThDP  (0-8mM)  at  25°C  and  pH  7.5
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Figure 3.6.  Uniform growth across the 1400rpm 384-well culture plate.  There 
was no discemable pattern to the growth.  Wells A10 and 19 failed to grow.
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Figure 3.7.  Histogram of the optical densities of wells in the 1400rpm 384- 
well culture plate.  90% of the final OD6oos fell inside the range 3.20-3.66ODU. 
The mean final ODeoo was 3.410DU.
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Format Medium
volume
Agitation
(rpm)
ODeoo
JODU)
96-well
96-well
150pl
150pl
600
1000
4.14
4.15
96-well 150pl 1400 4.53
384-well 60pl 600 1.48
384-well 60pl 1000 1.91
384-well 60pl 1400 3.41
1 Shake flask 50ml 220 4.86
6 i
5  -I
96-well  96-well  96-well  384-well  384-well  384-well  Shake
600rpm  lOOOrpm  1400rpm  600rpm  lOOOrpm  1400rpm  flask
Figure 3.8.  The effects of plate format and agitation speed on the OD600 of 
pooled microwell cultures.
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(Section 3.2.3).  The concentration of transketolase in each reaction was equal 
to  a  0.25ODU  culture  sonicate.  The  reactions  were  quenched  after  ten 
minutes and analysed for L-erythrulose.  Transketolase activity values were 
then calculated.
The  results  showed  that  transketolase  activity  was  dramatically 
enhanced by the addition of ThDP (Figure 3.9).  At OmM added Mg2+, adding 
just 0.5mM ThDP increased activity 579% from 1.12mkat.m*3 to 7.61mkat.nr3. 
Higher concentrations produced more modest increases in activity with the 
highest,  8mM,  yielding an activity  of 10.llmkat.nr3  (at OmM  added  Mg2+). 
This pattern  of behaviour was observed  at all concentrations  of Mg2+.  The 
addition of Mg2+  appeared to affect activity in a similar fashion with initial 
increments in concentration having the most effect: activity was boosted 24% 
from 7.61mkat.nr3 to 9.44mkat.nr3 by adding 0.5mM Mg2+ to the reaction (at 
0.5mM  ThDP).  Again,  higher  concentrations  produced  more  modest 
increases in activity with 32mM Mg2+ yielding an activity of 11.43mkat.nv3 (at 
0.5mM  added  ThDP).  This  pattern  of  behaviour  was  observed  at  all 
concentrations of ThDP except at OmM (added).
The highest transketolase activity was observed when 8mM ThDP and 
32mM Mg2+ were added (12.91mkat.nr3).
3.3.4  Lytic methods
The  following  methods  were  compared  for  their  effectiveness  at  releasing 
active transketolase from E. coli XLIO-Gold pQR711: sonication, a proprietary
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I  ThDP Transketolase activity (mkat.nrr3) ,at Mg2+conc. (mM)
1   (mM) 0.0 0.5 1.0 2.0 4.0 8.0 16.0 32.0  ||
0.0 1.12 1.13 1.13 1.13 1.14 1.18 1.18 1.17
0.5 7.61 9.44 10.19 10.80 11.09 11.30 11.45 11.43
1.0 8.92 10.24 10.83 11.40 11.73 11.94 11.93 11.90
2.0 9.72 10.62 11.30 11.70 12.00 12.18 12.37 12.40
4.0 10.15 10.86 11.40 11.94 12.25 12.50 12.79 12.85
8.0 10.11 10.79 11.32 11.89 12.31 12.65 12.88 12.91
nCentratio» (mM)
Figure 3.9.  The effects of cofactors on transketolase activity.  A culture of E. 
coli XL10  pQR711  was  sonicated  and  analysed  for  transketolase  activity  at 
different  concentrations  of  ThDP  and  Mg2+.  The  catalysed  reaction  was 
lOOmM  p~HPA  and  lOOmM  glycolaldehyde  to  L-erythrulose  (and  carbon 
dioxide).  The concentration of free transketolase in each reaction was equal to 
that of a  0.25ODU culture sonicate.  The control reactions did  not produce 
detectable L-erythrulose.
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lysing reagent, and repeated cycles of freezing and thawing (Section 3.2.4).
A shake flask culture of E. coli XLIO-Gold pQR711  was prepared and 
diluted  with  LB  medium to  an OD600  of 3.41 ODU:  equal  to  the mean final 
optical density previously observed for a microwell culture grown in a 384- 
well  plate  (incubated  at 37°C  and  1400rpm for  16 hours)  (Figure 3.8).  1ml 
aliquots  were  pipetted  into  1.5ml  Eppendorf  tubes  and  lysed  by  different 
methods  (Table  3.2).  The  efficacy  of  each  method  at  releasing  active 
transketolase was then assessed.  The samples were diluted with LB medium 
and added to the substrates p-HPA and glycolaldehyde (both lOOmM) at 25°C 
and  pH  7.5.  The  reactions  were  quenched  after  ten  minutes  and  the 
concentration  of  L-erythrulose  in  each  one  was  determined  by  HPLC. 
Transketolase activity values were then calculated (Figure 3.10).
Sonication released the greatest amount of active transketolase: a mean 
transketolase  activity  of  12.40mkat.nr3  was  observed  in  the  subsequent 
analytical reactions.  The reactions containing untreated cells had the lowest 
mean  activity:  only  7.49mkat.nr3.  The  remaining  lytic  methods  yielded 
samples with intermediate activities.  A single cycle of freeze/ thaw released 
sufficient transketolase to boost the mean activity  to 8.54mkat.nv3.  Further 
cycles  increased  this  activity  to  9.45mkat.nr3  (two  cycles)  and  9.41mkat.nr3 
(three cycles).  A mean activity of 8.13mkat.nr3 was observed with 10% (v/v) 
BugBuster  Reagent after 30  minutes,  rising  to  8.95mkat.nr3  after  one  hour. 
This  pattern  was  also  observed  with  a  BugBuster  Reagent concentration of 
20%  (v/v):  a  mean activity  of 8.49mkat.nr3  was  recorded  after 30 minutes,
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Method Transketolase activity (mkat.nr3)
A B C Mean OM
Sonication 11.98 12.82 12.40 12.40 0.242
10% BB 30min 8.26 7.90 8.22 8.13 0.115
20% BB 30min 8.79 8.41 8.26 8.49 0.158
10% BB 60min 8.39 9.21 9.25 8.95 0.280
20% BB 60min 9.10 8.64 9.33 9.02 0.203
F/Tx 1 8.59 8.80 8.24 8.54 0.164
F/Tx 2 9.59 9.54 9.22 9.45 0.117
F/Tx 3 9.70 9.15 9.37 9.41 0.160
Not treated 7.71 7.48 7.28 7.49 0.123
14 -|
Soni-  10% BB  20% BB  10% BB  20% BB  F/T * 1  F/T x 2  F/T x 3  Not 
cation  30min  30min  60min  60min  treated
Figure  3.10.  Comparison of lytic  methods.  Aliquots  of a  3.410DU  E.  coli 
XL10-Gold  pQR711  culture  were  lysed  by  different  methods,  diluted,  and 
analysed  for  transketolase  activity  (overall  dilution  1:13.64).  The catalysed 
reaction  was  lOOmM  p-HPA  and  lOOmM  glycolaldehyde  to  L-erythrulose 
(and carbon dioxide).  "n%  BB" is an abbreviation for "n%  (v/v) BugBuster 
HT Protein Extraction Reagent".  "F/T x n" is an abbreviation for "n cycles of 
freezing at -80°C and thawing at 25°C".  The error bars correspond to  ±om . 
The control reaction did not produce detectable L-erythrulose.
99Chapter 3 - High-throughput screen
rising to 9.02mkat.m-3 after one hour.
3.3.5 High-throughput assays for transketolase activity
Two  alternative  approaches  to  quantifying  transketolase  activity  in a  high- 
throughput  manner  were  investigated:  (a)  a  spectrophotometric  assay 
(Section 3.2.5.1); and (b) a fast HPLC assay (Section 3.2.5.2).
3.3.5.1  Spectrophotometric assay
The net result of the transketolase-catalysed condensation of a molecule of (3- 
HPA (or pyruvate) with an aldehyde is the consumption of one proton.  The 
rise  in  pH  that  this  process  causes  in  the  absence  of  a  buffer  has  been 
observed  by  Mitra  and  co-workers  (1998).  It  was  hoped  that  this 
phenomenon  would  permit  transketolase  activity  to  be  ascertained  by 
spectrophotometric  means:  a  pH  indicator  present  in  the  reaction  would 
change colour as the pH shifted.  Such an assay would allow several hundred 
transketolase  variants  to  be  simultaneously  screened  for  activity  in  a 
transparent  384-well  plate.  The  pH  indicator  chosen  to  investigate  the 
potential  of  this  approach  was  cresol  red.  The  A573  of  this  compound 
increases with alkalinity from pH 7.5 (it visibly changes in colour from orange 
to purple).
Aliquots  of  an  E.  coli JM107  pQR711  sonicate  were  diluted  with  LB 
medium  to  form  a  set  of  three  strengths.  These  diluted  sonicates  were 
incubated with 50mM p-HPA, 50mM glycolaldehyde, and lOmg.L1  cresol red
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at  25°C  and  pH  7.5  in  the  absence  of  a  buffer.  The  concentration  of 
transketolase in each reaction was equal to either a 0.1875ODU, 0.375ODU, or 
0.75ODU culture sonicate.  The  pH  of each reaction was monitored by  A573 
(Figure 3.11).
A573  was  found  to  increase  in all  of the  reactions  over  60  minutes  - 
including  the  control.  The  relationship  between  time  and  absorbance  was 
most linear in the first 15  minutes  of each reaction so lines of best fit were 
fitted to these data.  The rate of change in A573 of the control reaction over this 
period  was  calculated  to  be  1.69mAU.min-1:  the  baseline  rate  of  change. 
Deducting this value from the sonicate reactions yielded the following rates of 
change:  2.33mAU.min-1   for  the  0.1875ODU  reaction,  S.ObmAU.min*1   for  the 
0.375ODU  reaction,  and  4.26mAU.min1   for  the  0.75ODU  reaction.  The 
observed  correlation  between  rate  of  change  in  A573  and  concentration  of 
transketolase  suggested  that  a  spectrophotometric  assay  for  transketolase 
activity  might  be  possible.  However,  further  experiments  with  this  assay 
proved it to be highly erratic: results could not be reproduced day to day.  In 
fact, A573 was occasionally observed to decrease over time!
3.3.5.2  High-throughput HPLC method
The HPLC method used  elsewhere  in this thesis to determine transketolase 
activity  (Section  2.3.9)  is  a  slow  procedure  (^131  samples  per  day).  To 
develop  a  faster  method  for  screening  the  300mm  analytical  column  was 
replaced  with  a  50mm guard  column containing a  similar stationary  phase
101Chapter 3 - High-throughput screen
0.6  -i
0.5  -
0.4  -
<
<
0.2  -
0.1  -
0.0
0 10 20 30 60 40 50
Time (min)
Figure  3.11.  High-throughput  spectrophotometric  assay  for  transketolase 
activity.  Dilutions  of  a  3.00ODU  E.  coli  JM107  pQR711  sonicate  were 
incubated with 50mM p-HPA and 50mM glycolaldehyde in the absence of a 
buffer.  The pH of each reaction was monitored by measuring the A573 of an 
incorporated  pH  indicator  (cresol  red).  The  data  illustrated  in  the  graph 
correspond  to  the  control  reaction  (solid)  and  reactions  with  the  following 
overall dilutions of sonicate: 1:4 (dotted), 1:8 (dashed), and 1:16 (dash-dot-dot).
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(PL Hi-Plex H guard column, Polymer Laboratories Ltd.).  The intended role 
of this column is to protect a longer analytical column from degradation by 
acting as a trap for highly-retained sample components and particulate matter. 
It  was  discovered,  however,  that  it  was  capable  of  a  modest  degree  of 
separation itself.
Mixtures  of  p-HPA  and  L-erythrulose  passed  through  the  column 
could be resolved: these compounds had retention times of 0.53 minutes and 
0.66 minutes, respectively (Figure 3.12).  Glycolaldehyde was found to have 
the  same  retention  time  as  L-erythrulose,  but  its  absorbance  at  210nm 
wavelength was very low.  Pyruvate yielded a strong peak at 0.59 minutes: 
0.06  minutes  later  than  p-HPA  (Figure  3.13).  (S)-3,4-dihyroxybutan-2-one 
could not be  obtained from any  supplier  so  its  retention time could  not be 
determined.5  It  was  calculated  that  the  fast  analysis  time  of  this  HPLC 
method (1.2 minutes) would permit ^1200 mutants a day to be screened: 817% 
faster than the 11 minute protocol.
Calibration curves for L-erythrulose, p-HPA, and pyruvate were found 
to be relatively linear up to 25mM concentration (Figure 3.14).  The ordinate 
data in these curves is "detector response", not "peak area" as preferred.  The 
PeakNet 5.1 software could not provide reliable peak height or area data for 
the wide peaks so a simple program was written in Java (Sun Microsystems 
Inc.) to find these peaks and output the maximum detector response in each 
case.
5 It was estimated to be around 0.72 minutes: 0.06 minutes later than L-erythrulose.
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Figure  3.12.  High-throughput  HPLC  analysis  of  the  p-HPA  and 
glycolaldehyde  to  L-erythrulose  (and  carbon  dioxide)  reaction. 
Chromatograms of 25mM p-HPA (solid), 25mM glycolaldehyde (dotted), and 
25mM L-erythrulose  (dashed)  are  superimposed.  The  retention times  of p- 
HPA and L-erythrulose are 0.53 minutes and 0.66 minutes, respectively.  The 
retention  time  for  glycolaldehyde  is  0.66  minutes  as  well,  but  its  peak  is 
extremely small due to poor absorbance at 210nm wavelength.
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Figure  3.13.  High-throughput  HPLC  analysis  of  the  pyruvate  and 
glycolaldehyde to (S)-3,4-dihydroxybutan-2-one (and carbon dioxide) reaction. 
Chromatograms  of 25mM  pyruvate  (solid)  and  glycolaldehyde  (dotted)  are 
superimposed.  The main peak in the pyruvate chromatogram occurs at 0.59 
minutes  and  a  smaller  peak  occurs  at  0.84  minutes  (an  impurity). 
Glycolaldehyde does not yield an identifiable peak.  (S)-3,4-dihydroxybutan- 
2-one could not be purchased; it was anticipated that its peak would occur at 
0.72 minutes (arrow).
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Figure  3.14.  Calibration  curves  for  transketolase  reaction  components 
separated  by  high-throughput  HPLC.  The  relationships  between 
concentration  and  detector  response  are  approximately  linear  for  L- 
erythrulose (•), p-HPA (o), and pyruvate (v) with R2 values of 0.9993, 0.9997, 
and 0.9993, respectively.  Above 25mM the relationships become more curved.
106Chapter 3 - High-throughput screen
3.4  Discussion
The  goal  of  this  project  was  to  isolate  mutants  of  transketolase  that  were 
capable  of  catalysing  the  transfer  of  a  C2  moiety  from  pyruvate  to 
glycolaldehyde,  yielding  (S)-3,4-dihydroxybutan-2-one  (and  carbon dioxide) 
(Figure 1.14).  The mutagenesis phase of this project would yield an array of 
pQR711  plasmids with mutations  in the  tkt  gene  (this library  is designated 
"pQR711tktP" in this chapter).  In order that members encoding transketolase 
variants with the desired activity could be identified, this gene library needed 
to be expressed.  E. coli was chosen for this role.
Following  the  transformation  of  pQR711tktn  into  E.  coli,  clones  expressing 
active transketolase variants needed to be identified.  A selection-based test 
could not be used as there was no obvious way of linking cell survival to the 
desired activity.  Consequently, a screen was required.  It was envisaged that 
this screen would comprise four steps: (1) the microwell culture of individual 
E.  coli  colonies;  (2)  lysis  of  the  cultures;  (3)  incubation  with  the  target 
substrates  (pyruvate  and  glycolaldehyde);  and  finally  (4)  high-throughput 
analysis for the target activity.
3.4.1  Selection of host strain
The pQR711 plasmid was transformed into the E. coli strains BL21-Gold(DE3), 
JM109, and XL10-Gold by heat-shock.  An agarose gel (Section 3.3.1.1) and an 
SDS-PAGE analysis (Section 3.3.1.2) confirmed that these transformations had 
been successful and that transketolase was being overexpressed in all of the
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strains.
E.  coli  JM107  pQR711  (French  and  Ward,  1995)  has  been  used  in  a 
number of experimental biotransformations as the source of transketolase.  E. 
coli JM107 is not, however, an expression strain:  it is a cloning strain (Table
3.3).  Thus,  it was expected  that transforming the  pQR711  plasmid  into the 
expression  strain  E.  coli  BL21-Gold(DE3)  (Table  3.1)  would  increase 
transketolase yield.  The results of Sections 3.3.1.2 to 3.3.1.4 clearly disprove 
this hypothesis.  E. coli BL21-Gold(DE3) pQR711 sonicate was found to have a 
transketolase  activity  six  times  less  than the  original JM107 pQR711  strain, 
adjusting for culture turbidity (Section 3.3.1.4).  Another cloning strain, E. coli 
XL10-Gold  pQR711,  yielded  the  highest  transketolase  activity:  more  than 
double that of the original strain, adjusting for culture turbidity.  E. coli JM109 
pQR711  sonicate  was  found  to  have  similar transketolase  activity  to JM107 
pQR711 sonicate, but JM107 and JM109 are almost identical genetically (Table
3.3), so this result was not surprising.
As  E.  coli XL10-Gold  pQR711  sonicate  had  the  greatest transketolase 
activity out of the strains tested, adjusting for culture turbidity, it was chosen 
as the host for the pQR711tktJ1  library.6
3.4.2  Microwell culture
The microwell culture method described in Section 3.3.2 can be summarised 
as follows:  (1)  the  wells  of a  96-  or 384-well  plate  are filled  with LB  Amp+
6 It was  reasoned  that  using  this  host would  maximise  the  activities  of any  active variant 
cultures.
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medium (150pl or 60pl, respectively);  (2)  a Qpix2 robot is used to inoculate 
each well of this "culture plate" with colonies of E. coli XL10-Gold pQR711; (3) 
the culture plate is sealed with an identical, inverted plate and taped together; 
and  finally  (4)  the  assembly  is  taped  onto  a  Variomag  Teleshake  unit  and 
agitated  at  speeds  of  600-1400rpm  for  16  hours  in  a  37°C  environment. 
Sealing the culture plate with an inverted plate proved to be an effective way 
of preventing cross-contamination of well cultures and also contamination by 
external  sources.  This  approach  also  prevented  evaporation  of  the  well 
cultures and thus ensured uniform growth across every plate.  The airspace 
above  each  culture  was  quite  limited,  but  growth  appeared  to  be  aerobic. 
Further experiments would be needed to confirm this.
The  well  cultures  in  both  96-  and  384-well  plates  increased  in  final 
optical density with agitation speed (600rpm to 1400rpm).  This observation 
can  be  explained  by  the  increased  mixing  that  occurred  at  higher  speeds: 
settling of the cells was reduced and oxygen transfer from the headspace was 
increased.  The reduced mixing that occurs in smaller wells explains the low 
turbidities of 384-well plate cultures compared to 96-well plate cultures.  It is 
likely  that  the  cell  density  of  384-well  plate  cultures  could  be  boosted  by 
increased agitation.7
Based on the results of this experiment, the following conditions were 
chosen for  the  microwell  culture  of  E.  coli XLIO-Gold  pQR711tktF:  384-well 
plates and 1400rpm agitation.  The average final OD600 of well cultures when
71400rpm was the upper limit for the apparatus used.
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grown  under  these  conditions  was  3.410DU.  Although  slightly  higher 
turbidities  (and,  therefore,  higher  yields  of  transketolase)  could  have  been 
achieved  in  96-well  plates,  this  advantage  was  offset  by  the  increased 
handling required for the library (four times the number of culture plates).
3.4.3  Optimisation of cofactors
To ensure that the highest possible activities were observed in the screening 
reactions,  the  concentrations  of  cofactors  needed  to  be  optimised.  The 
transketolase  activity  of  E.  coli XLIO-Gold  pQR711  sonicate  was  studied  at 
various concentrations of ThDP and Mg2+ to determine these optima (Section
3.3.3).
Transketolase  activity  was  found  to  dramatically  increase  in  the 
presence  of ThDP.  The  addition  of just 0.5mM  ThDP  to  E.  coli XLIO-Gold 
pQR711  sonicate had a significant effect:  a 579%  rise in activity when OmM 
Mg2+  was  present.  Higher  concentrations  of  ThDP  were  found  to  boost 
transketolase activity further, but with diminishing gains: a 16-fold increase in 
ThDP concentration (8mM) yielded an overall rise in activity of only 803% (at 
OmM Mg2+).  This pattern of behaviour was observed at all concentrations of 
Mg2+.  The  addition  of 0.5mM  Mg2+   to  the  sonicate  was  found  to  improve 
transketolase activity at all concentrations of ThDP, except OmM.  Again, the 
increases in activity levelled-off with increasing Mg2+ concentration: at 0.5mM 
ThDP, the addition of 0.5mM Mg2+ yielded a rise in activity of 24%, while 64- 
fold more Mg2+ (32mM) yielded only a 50% rise.
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The huge rises in transketolase activity that accompanied the addition 
of cofactors suggest that the majority of transketolase protein in the sonicate 
was  in  the  apo  from  (unbound  to  cofactors).  Furthermore,  it  may  be 
concluded  that  ThDP  was  much  more  scarce  in  the  sonicate  than  divalent 
cations.  This  conclusion  is  supported  by  four  observations:  (a)
apotransketolase requires equal molar amounts of ThDP and a divalent cation 
to form the holoenzyme; (b) the KdS of ThDP and Mg2+ were much lower than 
the cofactor concentrations tested  (Sprenger et ah,  1995);8 (c)  the addition of 
ThDP had a much more dramatic  effect on the transketolase activity of the 
sonicate than the addition of Mg2+; and (d) at OmM ThDP the addition of Mg2+  
had  no  effect  on  transketolase  activity  (i.e.  ThDP  concentration  was  the 
limiting factor).  The near absence of ThDP from the sonicate can be explained 
by the fact that it was at physiological concentration inside the  E. coli cells, 
and  therefore  at  even  lower  concentration  in  the  bulk  sonicate.  Divalent 
cations were present in the sonicate courtesy of the growth medium.  Yeast 
extract typically contains <0.10% (w/w) Mg2+ and <0.05% (w/w) Ca2+ (Merck, 
2004),  equating  to  <0.206mM  and  <0.062mM,  respectively,  in  the  growth 
medium.
The greatest transketolase activity was observed when 8mM ThDP and 
32mM Mg2+ were added to the reaction (12.91mkat.m-3).  However, £90%  of 
this activity was achieved with far lower concentrations of cofactors:  £lmM 
ThDP and £2mM Mg2+.
8 For  ThDP  concentrations  >0.1mM  the  Kd  of  Mg2+   is  <8.7pM.  For  Mg2+   concentrations 
>0.1mM the Kd of ThDP is <8pM.
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It was anticipated that the screening reactions would contain microwell 
culture  lysate  and  screening  solution  (substrates,  cofactors,  and  buffer)  in 
equal  amounts  (1:1).  The  concentration  of  mutant  transketolase  in  each 
reaction  would  be  equal  to  a  1.705ODU  culture  lysate  (3.410DU/2  = 
1.705ODU): 6.82-fold greater than that used in this experiment.  Theoretically, 
this increased transketolase concentration should not require higher cofactor 
concentrations to maintain 90% activity as it is still very small in comparison 
(micromolar  versus  millimolar).  Nevertheless,  the  cofactor  concentrations 
were scaled up for the screening reactions as a precaution (7mM ThDP and 
14mM Mg2+).
3.4.4  Lytic methods
To  determine  the  best method  for  lysing  the  E.  coli XLIO-Gold  pQR711tkti1  
microwell cultures, aliquots of a 3.410DU E. coli XLIO-Gold pQR711 culture 
were subjected to various lytic treatments and tested for transketolase activity 
(Section 3.3.4).
Sonication  was  found  to  be  the  most  effective  method  at  releasing 
active  transketolase:  the  subsequent  reactions  had  the  greatest  mean 
transketolase  activity.  Untreated  cells  had  the  lowest  mean  transketolase 
activity: 60% of the sonication value.  The remaining methods yielded lysates 
with  intermediate  activities.  The  mean  transketolase  activity  of  cultures 
treated to a single cycle of freeze/thaw was found to be 69% of the sonication 
value.  A second cycle increased this activity to 76%, but a third cycle yielded
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no further  improvement.  Incubating the  E.  coli XLIO-Gold  pQR711  culture 
with  10%  (v/v)  BugBuster  Reagent  at  room  temperature  yielded  a  mean 
transketolase activity of 66%  after 30 minutes, rising to 72%  after one hour. 
Similarly, incubating the culture with 20% (v/v) BugBuster Reagent yielded a 
mean transketolase activity of 68%  after 30 minutes, rising to 73%  after one 
hour.  It was concluded that BugBuster Reagent released  transketolase in a 
time-dependent manner, with greater amounts being released over time.
As sonication lysed the cells most effectively, it would have made the 
best choice for lysing the E. coli XLIO-Gold pQR711tkt^ library.  However, the 
available  equipment  was  too  slow  and  unwieldy  for  high-throughput 
application.  Incubating  cells  with  BugBuster  Reagent  yielded  only  small 
increases  in  mean  transketolase  activity  over  that of untreated  cells,  so  the 
extra effort (pipetting) that would have been required in the screening phase 
was  not  justifiable.  Subjecting  culture  aliquots  to  cycles  of  freezing  and 
thawing was not as labour-intensive, but did require significant amounts of 
time for the freezing periods.  The transketolase activity yielded by a single 
freeze/ thaw cycle was considered the best possible return for time and effort. 
Consequently,  this method was chosen for processing the  E. coli XLIO-Gold 
pQR711tkb1  library.
3.4.5  High-throughput assays for transketolase activity
The  experiment  described  in  Section  3.3.5.1  demonstrated  a  relationship 
between rate  of  A573  change  and  transketolase  concentration  in  unbuffered
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reactions containing p-HPA, glycolaldehyde, cofactors, and the pH indicator 
cresol red.  Unfortunately, repetitions of this experiment proved that the assay 
was highly unreliable.  A possible explanation for this behaviour is that the 
number of protons provided by dissolved carbon dioxide in each sample was 
significant compared to the number consumed by the reaction.  The following 
experiments  should  be  performed  to  understand  this  variability  better:  (a) 
monitor  one  or  more  reactions  by  A573  and  HPLC  analysis  (Section  2.3.9) 
simultaneously;  and  (b)  monitor  the  A573  and  dissolved  carbon  dioxide 
concentration9 of one or more reactions simultaneously.  The first experiment 
would demonstrate whether or not transketolase-mediated condensation was 
actually  occurring  in  the  unbuffered  samples  and  the  second  would 
determine  whether  or  not  dissolved  carbon  dioxide  was  contributing  to 
changes in A573.  If the results of these experiments could be used to reduce 
the  variability  of  the  spectrophotometric  assay,  it  would  be  an  extremely 
powerful tool for screening transketolase activity.
In contrast, the novel HPLC method described in Section 3.3.5.2 proved 
to a highly reliable screen for transketolase activity.  It successfully resolved 
mixtures of p-HPA (donor substrate) and L-erythrulose (product) in under 1.2 
minutes.10  Although (S)-3,4-dihydroxybutan-2-one could not obtained, it was 
anticipated  that  mixtures  of  this  compound  (the  desired  product)  with 
pyruvate (the desired donor substrate) would be resolved in a similar manner: 
they  have  similar  chemical  structures  to  L-erythrulose  and  p-HPA
9 An in situ probe could be used to do this.
10 Glycolaldehyde was invisible due to a very low extinction coefficient at 210nm wavelength.
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(respectively),  lacking a single  hydroxyl  group  in each case.  This chemical 
change caused pyruvate to have a retention time 0.06 minutes greater than f> - 
HPA; thus, it was expected that (S)-3,4-dihydroxybutan-2-one would have a 
retention time approximately 0.06 minutes greater than L-erythrulose.  As the 
precise  figure  was  unknown  it  was  decided  that  target  activity  would  be 
initially  identified  in  the  screening  reactions  by  pyruvate  depletion,  rather 
than  product  formation.  The  relationship  between  pyruvate  concentration 
and detector response (A210) was linear up to 25mM,  so it was decided that 
these screening reactions would be diluted and quenched 4-fold (lOOmM/4 = 
25mM) before analysis.
3.4.6  Screening procedure
The procedure for screening the pQR711tkU library is summarised in Figure 
3.15.  The processes highlighted in blue have been developed in this chapter 
to achieve two goals:  (a)  to maximise the yield  of holotransketolase in each 
screening reaction (and therefore activity); and (b) to allow variants with the 
desired  activity  to  be  identified.  Using  this  protocol  a  384-well  plate 
containing 380 screening reactions (plus four controls) could be screened for 
the target activity in 11.68 hours (4 hours for reaction and 7.68 hours for fast 
HPLC analysis).
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Pipette 60pl LB Amp+  into every 
well of 384-well plate A
Transform pQRZlltkh1  into £. coli 
XLIO-Gold competent cells
Pick E. coli XLIO-Gold pQRZlltkh1  
colonies into plate A (Qpix2 robot)
Microwell culture of plate A: 
1400rpm, 37°C, 16 hours
Pipette 40pl of eacl 
plate A to 3&
i well culture from 
Lwell plate B
>r
Lyse well cultures in plate B by 
freezing at -80°C and thawing
>r
Pipette 40pl of screening solution 
into each well of plate B
>r
Incubate plate B a 
to permit reac
125°C for 4 hours 
tions to occur
Pipette 20pl of 40% (v/v) glycerol 
into each well of plate A
Store plate A at -80°C 
(Master Plate)
Pipette 75pl of 0.2% (v/v) TFA into 
each well of 384-well plate C
Pipette 25pl of each plate B reaction 
into the corresponding plate C well
Analyse each quenched reaction for 
pyruvate depletion by fast HPLC
Cherry-pick transketolase variants^ 
with the desired activity from the  1^- 
Master Plate (Qpix2 robot)
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Figure 3.15.  (Previous page.)  Screening system for identifying transketolase 
variants capable  of catalysing the  synthesis  of (S)-3,4-dihydroxybutan-2-one 
(and  carbon  dioxide)  from  pyruvate  and  glycolaldehyde.  Red  processes 
involve liquid handling.  Blue processes are novel.  Green processes involve 
the Qpix2 robot.  Yellow processes are incubation or storage steps at specified 
temperatures.  The  screening solution contains  the  substrates  pyruvate  and 
glycolaldehyde (both 200mM), lOOmM Tris buffer (pH 7.5), 28mM MgCh, and 
14mM ThDP.  Four wells are set aside for reaction controls in plate B: E. coli 
XLIO-Gold pQR711  culture replaces the variant culture.  In total, 378  E. coli 
XLIO-Gold  pQR711tkt>1   colonies  require  four  384-well  plates  and 
approximately 1600 pipette tips to be screened for the desired activity.
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4.1  Introduction
Meshalkina  and  co-workers  (1995)  have  demonstrated  that  1-hydroxyethyl 
ThDP, unlike 1,2-dihydroxyethyl ThDP, is not a viable reaction intermediate 
for transketolase-mediated condensation.  Rather than being transferred to the 
acceptor substrate, the 1-hydroxyethyl moiety is split from the ThDP molecule 
and released as a free aldehyde (acetaldehyde).  1-hydroxyethyl ThDP is the 
intermediate of the target reaction (Figures 1.13 and 4.1), so this activity had 
to be eliminated from transketolase for the project goal to be achieved.
The second engineering challenge was to modify transketolase so that 
it was capable of synthesising 1-hydroxyethyl ThDP from pyruvate and ThDP 
in  the  first  place.  Wild-type  transketolase  does  not  exhibit  this  activity, 
although  it  is  observed  in  other  ThDP-dependent  enzymes  such  as 
acetolactate  synthase  (EC  2.2.1.6),  l-deoxy-D-xylulose-5-phosphate  (DXP) 
synthase  (EC  2.2.1.7),  pyruvate  decarboxylase  (EC  4.1.1.1),  and  pyruvate 
dehydrogenase (lipoamide) (EC 1.2.4.1).
It was proposed that these two refinements could be brought about by 
modification of the residues in the active site of transketolase that lie close to 
the C2-hydroxyl  group  of the reaction intermediate.  One  possible route to 
these changes would be through rational protein engineering of the active site 
using the protein sequences and/or crystal structures of acetolactate synthase, 
DXP  synthase,  pyruvate  decarboxylase,  and  pyruvate  dehydrogenase 
(lipoamide)  as  maps.  However,  the  difficulties  associated  with  rational
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Figure 4.1.  Formation of a-carbanion/ enamine compounds from ThDP and
(a)  p~HPA or  (b)  pyruvate.  The a-carbanion/ enamine formed  in (a)  is 1,2- 
dihydroxyethyl ThDP (the 1,2-dihydroxyethyl group is coloured red) and in
(b)  is  1-hydroxyethyl  ThDP  (the  1-hydroxyethyl  group  is  coloured  blue). 
Mechanism  (b)  is  observed  in  several  ThDP-dependent  enzymes  including 
acetolactate synthase,  DXP synthase,  pyruvate decarboxylase, and  pyruvate 
dehydrogenase (lipoamide).
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engineering  (refer  to  Section  1.2)  led  to  directed  evolution  being  chosen 
instead to implement these modifications.
The method of mutagenesis selected for this approach was epPCR.  The 
reasons  for  this  selection  were  threefold:  (a)  it  is  a  non-recombinative 
technique that is suited to the "fine-tuning" of enzyme characteristics (refer to 
Section 1.2.2); (b) it allows mutations to be spread across defined stretches of 
amino acids; and (c) it allows the density of mutations to be modulated.  The 
other  popular  non-recombinative  mutagenesis  method  -  random 
oligonucleotide mutagenesis - does not have features (b) and (c) and creates 
massive  libraries  due  to  the  complete  randomisation  of  codons.  A 
transketolase library  generated  by  this method would  only be screenable if 
three residues or fewer were targeted.11  The targets for mutagenesis in this 
project were larger than three residues so this approach was rejected.
As  epPCR  is  used  to  mutate  entire  genes  the  protocol  had  to  be 
modified  for  use  with  small  targets.  The  development  of  this  method  - 
focused epPCR (fepPCR) - is described in Chapter 5.  By "focusing" mutation 
in this way  it was  reasoned  that higher  mutational  loads  could be  applied 
while maintaining library size.
This chapter describes the results of three activities: (a) the selection of 
target sites; (b) the design of primers for the fepPCR of these targets; and (c) 
the estimation of desired mutation rates and library sizes.
1 1  The full complement of 20 naturally-occurring amino acids are available at each of the three 
positions so there are 8000 unique protein sequences (203 = 8000).
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4.2  Methods
4.2.1 Selection of target sites
The  PDB  structure  file  1GPU  describes  the  structure  of  S.  cerevisiae 
transketolase  in  complex  with  the  reaction  intermediate  1,2-dihydroxyethyl 
ThDP  (Fiedler  et al.f  2002).  RasMol  2.7  (Sayle  and  Milner-White,  1995),  a 
molecular-modelling package,  was used  to  inspect this  structure  and locate 
residues  in  close  proximity  to  the  C2-hydroxyl  group  of  the  1,2- 
dihydroxyethyl moiety.
4.2.2 Primer design
The nucleotide sequence of tkt (Sprenger, 1993) was used to devise primers for 
the PCR-based amplification of target sites A, B, and C.  The software package 
AnnHyb 3.5 (Friard, 2004) was used to ensure that the physical properties of 
these primers were conducive to PCR.
4.2.3 Estimation of library size and coverage
The sizes of pQR711 libraries with mutations in target A (pQR711 Ah), target B 
(pQR711Bn), target C (pQR7110), and all three targets (pQR711ABO) were 
estimated  using  the  formulae  detailed  in  Section  1.2.3.1.  The  numbers  of 
transformants required for 90% coverage of each library were estimated using 
the formulae detailed in Section 1.2.3.2.
121Chapter 4 - Library design
4.3  Results
4.3.1  Selection of target sites
It was  reasoned  that  the  residues  closest  to  the  C2-hydroxyl  group  of  1,2- 
dihydroxyethyl ThDP were the most likely to be responsible for: (a) splitting 
1-hydroxyethyl ThDP into acetaldehyde and ThDP; and (b) not permitting the 
synthesis of 1-hydroxyethyl ThDP from pyruvate and ThDP in the first place. 
A structure of E. coli transketolase in complex with 1,2-dihydroxyethyl ThDP 
would have been ideal for identifying these residues.  Such a structure did not 
exist, so the structure of the highly-homologous S. cerevisiae transketolase (see 
Figure 1.2) was used instead  (PDB  structure file 1GPU).  It was anticipated 
that  after  the  residues  of  interest  had  been  identified  in  S.  cerevisiae 
transketolase,  the  corresponding  residues  in  E.  coli  transketolase  would  be 
located.
The residues measured to be closest to the C2-hydroxyl group of 1,2- 
dihydroxyethyl  ThDP  were,  in  order  of  proximity,  Hisl03,  His  481,  His69, 
Glyll6,  His30,  Asp477,  Leull8,  and  Proll7  (Section  4.2.1)  (Table  4.1). 
Residues His69,  Glyll6,  Proll7,  and  Leull8  were  eliminated  as targets for 
mutagenesis because their side-chains were observed to face away from the 
hydroxyl  group.  It was believed that modification of these residues would 
have little  impact on activities  (a)  and  (b).  The  remaining residues  (His30, 
Hisl03,  Asp477,  and  His481)  were  chosen  as  the  primary  targets  for 
mutagenesis.  Flanking residues were incorporated into the targets to permit 
movement of the primary residues.  The overall targets are recorded in Table
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Residue Distance
(A)
Side-chain facing 
towards C2-hydroxyl?
His30 4.55 Yes
His69 3.40 No
Hisl03 2.76 Yes
Glyll6 3.84 No
Proll7 5.93 No
Leull8 5.81 No
Asp477 5.61 Yes
His481 3.33 Yes
Table 4.1.  Residues  of transketolase in close  proximity  to  the C2-hydroxyl 
group of 1,2-dihydroxy  ethyl ThDP.  "Distance"  is  the  distance between the 
oxygen atom of the C2-hydroxyl group and the closest atom of the residue. 
(Based on PDB structure file 1GPU.)
Residue Primary/ Residue number
identity flanking S. cerevisiae E. coli
Target A
Ser Flanking 28 24
Gly Flanking 29 25
His Primary 30 26
Target B
Gly Flanking 102 99
His Primary 103 100
Pro Flanking 104 101
Target C
Asp Primary 477 469
Gly Flanking 478 470
Pro Flanking 479 471
Thr Flanking 480 472
His Primary 481 473
Table  4.2.  Residues  in  targets  A,  B,  and  C.  The  residue  identities  are 
conserved in the S. cerevisiae and E. coli transketolases.  "Primary" residues are 
those residues closest to the C2-hydroxyl group of 1,2-dihydroxy  ethyl ThDP. 
"Flanking" residues sit either-side of the primary residues.
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4.2  and  depicted  in  Figure  4.2a.  These  targets  were  identified  in  E.  coli 
transketolase by  studying its  sequence  and  crystal  structure  (PDB  structure 
file 1QGD) (Table 4.2 and Figure 4.2b).
4.3.2 Primer design
Oligonucleotide  primers  for  the  fepPCR  amplification  of  the  discontinuous 
target sequences were designed using the  E. coli tkt sequence  (Section 4.2.2) 
(Figure  4.3).  The  primers  were  devised  so  that  each  tried  to  meet  the 
following criteria (Innis et al, 1990): (a) 17-28 bases in length; (b) 50-60% G/C 
content; (c) melting temperature (Tm) of 55-80°C (target was 60°C); and (d) no 
significant secondary structure.  The sequences and physical properties of the 
primers are recorded in Table 4.3.
4.3.3 Estimation of library size and coverage
It was believed that a library of pQR711 plasmids with point mutations in the 
target  sites  A,  B,  and  C  would  be  the  most  likely  to  yield  mutants  of 
transketolase with the desired activity (Figure 1.14).  It was envisaged that the 
construction  of  this  library  (pQR711ABC^)  would  be  followed  by  its 
transformation into E. coli XLIO-Gold and subsequent screening (Chapter 3). 
FepPCR  (Chapter  5)  mutates  bases  at random,  so  the  pQR711ABCn  library 
would be made up of variants with varying numbers of point mutations, i.e. 
some would contain no point mutations while others would contain one, two, 
three  or more.  In  effect,  the  library  would  be  a  mixture  of four  (or  more)
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(a)  S. cerevisiae transketolase in complex with 1,2-dihydroxyethyl ThDP
(b) E. coli transketolase in complex with ThDP
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Figure  4.2.  (Previous  page.)  The  active  sites  of  S.  cerevisiae  and  E.  coli 
transketolases.  The two diagrams are: (a) S. cerevisiae transketolase interacting 
with  1,2-dihydroxyethyl  ThDP  and  Ca2+;  and  (b)  E.  coli  transketolase 
interacting with ThDP and Ca2+.  In each case one monomer of the enzyme is 
coloured green, the other is coloured yellow, and the Ca2+ ion is a cyan CPK 
sphere.  The  1,2-dihydroxyethyl  ThDP  and  ThDP  molecules  are  shown  as 
"stick"  models, as are the target sites (Table 4.2).  Target A is coloured red, 
target B is coloured blue, and target C is coloured magenta.  In (a) the oxygen 
atom of the C2-hydroxyl group of the 1,2-dihydroxyethyl moiety is identified 
by a white arrow.  (Created from the PDB structure files 1GPU and 1QGD. 
The second phosphate group of 1,2-dihydroxyethyl ThDP was missing from 
the first file.)
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Figure 4.3.  (Previous two pages.)  Nucleotide sequence of the E. coli tkt gene. 
The corresponding sequence of residues in the transketolase protein is shown 
below the nucleotide sequence.  The three target sites are shaded red (A), blue 
(B), and magenta (C).  Target A is residues Ser24-His26 (nucleotides 70-78). 
Target B is residues Gly99-Prol01 (nucleotides 295-303).  Target C is residues 
Asp469-His473 (nucleotides 1405-1419).  (Sequence data from Sprenger, 1993.)
Primer Sequence (5' — ►  3') Length (bases) Tm(°C)
Target A
tktAF A T G G A C G C A G T A C A G A A A G C C A A A 24 59.0
tktAR C C C A T A G G G G C C C C C G G 17 60.6
Target B
tktBF G T C A G C T G C A C T C T A A A A C T C C G 23 57.8
tktBR A C C A G C G G T G T A A C C C A C T T C 21 58.8
Target C 
tktCF A C T C C A T C G G T C T G G G C G A A 20 59.8
tktCR C G A C C T G C T C A A C C G G C T G 19 60.2
Table 4.3.  Forward and reverse primers for the mutagenesis of the target sites. 
Forward primers have an "F" suffix, while reverse primers have an "R" suffix. 
Each  Tm  was  calculated  for  a  primer  concentration  of  250nM  and  a  salt 
concentration of 50mM.
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different  "sublibraries",  each  with  a  different  point  mutation  rate  and  size 
(Patrick  et  al.,  2003).  Screening  a  particular  number  of  E.  coli  XLIO-Gold 
pQR711ABO  transformants  would,  therefore,  cover  these  sublibraries  to 
varying extents.  The level of coverage in each case would be dependent upon 
the  size  of  the  sublibrary  and  the  proportion  of  the  overall  library  that  it 
constitutes.  This section presents the calculations performed to estimate the 
size  of  each  pQR711ABO  sublibrary  and  the  corresponding  number  of 
relevant transformants required to achieve 90% coverage (Section 4.2.3).
This section also includes similar calculations for three further libraries 
with point mutations limited to the individual targets (PQR711A11 , pQR711BP, 
and pQR7110).  It was decided that the lpmpv sublibraries of these targets 
would be screened before construction of library PQR711AB01  to determine 
whether single mutations were capable if yielding the desired activity.
4.3.3.2  Sublibrary sizes
Using the  formula  in Section  1.2.3.1  the  sizes  of the  pQR711AH,  pQR711BF, 
and pQR7110 lpmpv sublibraries were estimated to be 18,18, and 30 unique 
protein sequences, respectively (Table 4.4).
The numbers of unique protein sequences in the pQR711ABO 1, 2, and 
3 point mutations  per variant (pmpv)  sublibraries were estimated  to be 66, 
1967, and 3.53 x 104 unique protein sequences, respectively (Table 4.5).  As the 
combined length of targets A, B, and C was short (33 bases) the probability of 
multiple point mutations occurring in the same codon was found  to be not
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Library
Target length Number of point 
mutations 
(*)
Number of unique 
nucleotide 
sequences (V)
Number of 
unique protein 
sequences (W)
Bases
(N)
Residues
(N/3)
pQR711AP 9 3 1 27 18
pQR711BP 9 3 1 27 18
| pQR7110 15 5 1 45 30
Table  4.4.  Sizes  of  the  pQR711AP,  PQR711BP,  and  pQR7110  lpmpv 
sublibraries.  Sublibraries with point mutation rates higher than lpmpv were 
not  expected  to  feature  significantly  in  the  overall  libraries.  (See  Section 
1.2.3.1 for the formula used to calculate these data.  Note that the numbers of 
unique protein sequences are estimates.)
Number of point 
mutations
(*)
Probability of 
mutations 
cooperating
Number of unique 
nucleotide 
sequences (V)
Number of 
unique protein 
sequences (W)
1 0.000 99 66
2 0.042 4752 1967
3 0.127 1.47 x 1Q 5 3.53 x 104
Table  4.5.  Sizes  of  the  pQR711ABO  1,  2,  and  3pmpv  sublibraries.  The 
overall length of the three target sites is 11 residues (33 bases).  "Probability of 
mutations cooperating" is the probability that more than one point mutation 
will occur in a codon.  (See section 1.2.3.1 for the formulae used to calculate 
these data.  Note that the numbers of unique protein sequences are estimates.)
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insignificant  in  both  the  2  and  3pmpv  sublibraries:  0.042  and  0.127, 
respectively.  The  calculated  sizes  of  the  2  and  3pmpv  sublibraries  were, 
therefore, slight underestimates.
4.3.3.2  Sublibrary coverage
The numbers of transformants required for 90%  coverage of the pQR711AH, 
pQR711B^,  and  pQR7110  lpmpv  sublibraries  were  calculated  from  the 
sublibrary sizes.  The results were: 42 for pQR711AH, 42 for pQR711B^, and 69 
for  pQR7110  (Figure  4.4).  Note  that  these  are  numbers  of  transformants 
withthe correct number of point mutations (lpmpv).  In order that these figures 
could be converted into numbers of transformants selected at random from the 
library, the sublibrary compositions of the libraries needed to be determined 
by sequencing (refer to Section 5.4).  The multiplier in each case would be the 
reciprocal  of  the  proportion  of  the  library  that  the  lpmpv  sublibrary 
constitutes.
The  numbers  of  transformants  required  for  90%  coverage  of  the 
pQR711ABO sublibraries were calculated to be: 152 for the lpmpv sublibrary, 
4536  for  the  2pmpv  sublibrary,  and  8.13  x  104  for  the  3pmpv  sublibrary 
(Figure  4.5).  Again,  these  are  numbers  of  transformants  with  the  correct 
numbers of  point mutations.
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Figure  4.4.  Numbers  of  transformants  needed  for  90%  coverage  of  the 
pQR711AH, pQR711BM, and pQR7110 lpmpv sublibraries.  These sublibraries 
contain approximately 19, 19, and 31 unique protein sequences, respectively. 
90% coverage of each of these sublibraries requires the following numbers of 
relevant transformants to be  analysed:  (a)  42 for the  lpmpv  sublibraries of 
PQR711AV1   and  pQR711BH  (solid);  and  (b)  69  for  the  lpmpv  sublibrary  of 
pQR7110 (dotted).  (See Section 1.2.3.2 for the formula used to calculate these 
curves.)
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Figure  4.5.  Numbers  of  transformants  needed  for  90%  coverage  of  three 
pQR711ABO sublibraries.  pQR711ABCH sublibraries with 1, 2, and 3pmpv 
have  approximately  68,  2121,  and  3.95  x  104  unique  protein  sequences, 
respectively.  90%  coverage  of  each  of  these  libraries  would  require  the 
following numbers of relevant transformants to be analysed:  (a) 152 for the 
lpmpv sublibrary (solid); (b) 4536 for the 2pmpv sublibrary (dotted); and (c) 
8.13  x  104  for  the  3pmpv  sublibrary  (dashed).  (See  Section  1.2.3.2  for  the 
formula used to calculate these curves.)
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4.4  Discussion
E. coli transketolase requires two modifications for it to be able to catalyse the 
desired reaction (Figure 1.14):  (a)  the addition of the ability to synthesise 1- 
hydroxyethyl ThDP from pyruvate and ThDP; and (b) the elimination of the 
activity that splits this compound into acetaldehyde and ThDP.  In this project 
it  was  anticipated  that  these  modifications  would  be  brought  about  by 
changing  the  residues  that  lie  closest  to  the  C2-hydroxyl  group  of  the 
standard  reaction  intermediate  (1,2-dihydroxyethyl  ThDP).  These  residues 
were located in S. cerevisiae transketolase by inspecting a crystal structure file 
of the protein in complex with 1,2-dihydroxyethyl ThDP (Section 4.3.1).  Of 
the residues considered, His30, Hisl03, Asp477, and His481 were singled out 
for directed evolution.  These residues were identified in E. coli transketolase 
(His26, HislOO, Asp469, and His473) and the targets were expanded to include 
flanking  residues.  Overall,  the  target  sequences  chosen  were:  Ser24-His26 
(target A), Gly99-Prol01 (target B), and Asp469-His473 (target C).
The method  chosen to  mutate  these  target sequences  was fepPCR,  a 
focused version of epPCR (refer to Chapter 5).  Focusing mutation from the 
whole gene to these sequences would allow a very high mutation rate to be 
applied, while maintaining a reasonable library size.  It was believed that this 
approach  would  yield  combinations  of  substitutions  that  operated 
synergistically.12
Primer oligonucleotides were constructed to flank the target sequences
12 These  combinations  might  not  be  identified  by  making  single  amino  acid  substitutions 
because the intermediates may be unfavourable.
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so that fepPCR could be performed (Section 4.3.2).  Each primer was designed 
to have a Tm of approximately 60°C and no significant secondary structure.
Initially, three small libraries with mutations limited to either target A 
(pQR711AP),  target  B  (PQR711B11 ),  or  target  C  (pQR711C>1 )  would  be 
generated  with these  primers  and  screened  for  the  desired  activity  (Figure 
1.14).  The numbers of relevant transformants required for 90%  coverage of 
each  lpmpv  sublibrary  were  estimated  to  be:  42  for  pQR711Ai*,  42  for 
pQR711B>\ and 69 for pQR711C^ (Section 4.3.3.2).  It was anticipated that all 
three  libraries  could,  therefore,  be  screened  in  the  space  of a  day  (refer  to 
Section 3.4.6).
Next,  variants  with  multiple  mutations  across  all  three  targets 
(pQR711ABCn) would be generated and screened.  The numbers of relevant 
transformants  required  for  90%  coverage  of  each  of  the  three  smallest 
sublibraries were calculated to be: 152 for the lpmpv sublibrary, 4536 for the 
2pmpv sublibrary, and 8.13 x 104 for the 3pmpv sublibrary (Section 4.3.3.2).  If 
the protocol devised in Chapter 3 was used to screen these sublibraries, 90% 
coverage of each would be achieved in £l, £12, and £212 days, respectively 
(380 screening reactions per day).  Based on these figures 90% coverage of the 
3pmpv  sublibrary  was  rejected  as  an  unrealistic  project  goal  and  90% 
coverage of the 2pmpv sublibrary was chosen instead.
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5.1  Introduction
Error-prone PCR (epPCR) followed by ligation (epPCR-ligation) is a popular 
methodology for generating plasmid libraries.  A gene is amplified by PCR 
under  conditions  that  reduce  the  fidelity  of  the  DNAP  and  the  mutated 
product is ligated into a vector.  There are, however, two significant problems 
with  this  approach:  (a)  mutations  are  spread  across  the  entire  gene  so  the 
majority have little chance of affecting the enzyme's characteristics (Clackson 
et ah,  1998);  and  (b)  ligation is  extremely  labour-intensive  and  occasionally 
impossible.
Another  commonly-used  protocol  for  generating  plasmid  libraries  is 
random oligonucleotide mutagenesis.  Oligonucleotides that encode a specific 
region  of  a  plasmid-borne  gene  are  synthesised  with  certain  codons 
randomised  and  extended  into  whole  plasmids  using a  PCR-based  cloning 
method  such  as  QuikChange  (Stratagene  Ltd.).  Two  drawbacks  with  this 
approach are: (a) the level of mutation in the library cannot be varied unless 
new oligonucleotides are designed and synthesised; and (b) extremely large 
libraries are generated by the randomisation of just a few codons.
The  mutagenesis  targets  in  this  project  were  discontinuous  and 
extremely  short  (Table  4.2)  so  epPCR-ligation was  not a  viable  method  for 
library construction.  Random nucleotide mutagenesis-QuikChange was not 
suitable either because the mutation density would be much too high for 11
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residues.13
In  order  that  the  desired  libraries  could  be  constructed  a  novel 
technique  was  developed:  focused  epPCR  (fepPCR).  FepPCR  is  the  PCR- 
based amplification of a short, defined region in a gene under conditions that 
drastically lower the fidelity of the DNAP.  In other words: fepPCR is epPCR 
of diminutive targets with higher mutation densities.  The small size of the 
product means that it may be cloned into plasmids by QuikChange SDM, thus 
avoiding the gruelling process of ligation.
This chapter describes the results of subjecting the target B site in tkt to 
fepPCR  and  cloning  the  product  into  whole  plasmids.  Two  different 
QuikChange  methods  were  examined  and  compared  for  this  cloning  step: 
QuikChange Site-Directed  Mutagenesis  (SDM)  and  QuikChange  Multi Site- 
Directed Mutagenesis (MSDM).
5.2  Methods
5.2.1 FepPCR amplification of target B
5.2.1.1 Amplification of target B at various concentrations ofMn2 +
11 50pl PCR reactions were set up containing the following (Table 5.1): 5U Taq 
DNAP (Roche Diagnostics Ltd.), Taq DNAP buffer (Roche Diagnostics), 50ng 
pQR711  DNA,  0.5pM primer tktBF  (5'-GTCAGCTGCACTCTAAAACTCCG- 
3')  (Cruachem  Ltd.),  0.5pM  primer  tktBR  (5'- 
ACCAGCGGTGTAACCCACTTC-3')  (Cruachem  Ltd.),  0.2mM  each
13 Randomising  11  residues  would  lead  to  a  library  size  of  2.05  *  1014  unique  protein
sequences (2011 = 2.05 x 1014): too large for any known screening or selection system to handle.
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Reagent Volume (pi) Final
amoun^conc.
ddH20 23
10* Taq DNAP buffer 5
MgCl2 3 1.5mM
MnCl2 10 0-1 mM
dNTPs 1 0.2mM each
tktBF 1 0.5pM
tktBR 1 0.5pM
pQR711 DNA 5 50ng
Taq DNAP 1 5U
Total 50
Table 5.1.  The components of each fepPCR reaction.  Each reaction contained 
a different concentration of MnCh.
Phase Cycles Step(s) Temperature (°C)
ll
Duration (min)
1 1 Initial denaturation 94 3
2 25 Denaturation 94 1
Annealing 55 1
Extension 72 1
3 1 Final extension 72 5
Final hold 4 O O
Table 5.2.  Program of temperature cycling used for fepPCR.  (Modified from 
Roche Diagnostics Ltd., 2000.)
(a)
(b)
i
S’ *.. -GGTNACC. •  - 3 '  
3-*. •  • CCANTGG •  •  -S1
T
p<2R711  E7E  GTCAGCTGCACTCTAAAACTCCl 
CAGTCGACGTGAGATTTTGAGG*
GAAGTGGGTTACACCGCTGGT  3E4 
CTTCACCCAATGTGGCGACCA
I
Figure  5.1.  Recognition site of the restriction enzyme  BstE  II (a) in general 
and (b) in target B.  The enzyme cleaves the sequence at the points indicated 
by the arrows.  Target B is shaded blue.
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deoxynucleoside triphosphate  (dATP,  dCTP,  dGTP,  and  dTTP),  and 1.5mM 
MgCb  in  pure  water.  MnCb  was  added  to  the  reactions  at  varying 
concentrations  (0-lmM).  A  control  reaction  was  set  up  containing  every 
component except Taq DNAP.
The reactions were submitted to a program of temperature cycling in a 
TechGene  thermal  cycler  (Techne  Ltd.)  (Table  5.2).  Following fepPCR,  the 
samples  were  purified  using  QIAquick  nucleotide  removal  kits  (QIAGEN 
Ltd.).  The purified samples were run on a 2.0% (w/v) agarose gel.
5.2.3.2 Mutation densities of the products from reactions BO.O to B1.0
A "cutting solution" was prepared by adding 30pl of the restriction enzyme 
BstE II (New England Biolabs Ltd.)  (Figure 5.1) and 30pl of 10x  NEBuffer 3 
(New England Biolabs Ltd.) to 90pl of pure water.  lOpl of this solution was 
added  to  lOpl  of  each  purified  fepPCR  reaction.  The  digestions  were 
incubated  at  37°C  for  two  hours  and  then  analysed  on  three  separate 
polyacrylamide gels.
5.2.2 Generation of E. coli XLIO-Gold pQR711Bn libraries by two different 
methods
5.2.2.3  QuikChange SDM
A  variation  of  the  QuikChange  SDM  protocol  (Stratagene  Ltd.,  2003a)  was 
used.  A 50pl PCR reaction was made up containing the following (see Table 
5.3):  2.5U  PJuTurbo  DNAP  (Stratagene  Ltd.),  PfuTurbo  DNAP  buffer 
(Stratagene Ltd.), 150ng pQR711 DNA, and lpl of dNTP solution (Stratagene
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Reagent Volume (pi)
Final
amount
ddH20 34
10* PfuTurbo DNAP buffer 5
dNTP mix 1
0.7mM Mn2+  fepPCR product 5 250ng
pQR711 DNA 5 150ng
PfuTurbo DNAP 1 2.5U
Total 51
Table  5.3.  The  components  of  the  QuikChange  SDM  reaction.  The 
concentration of dNTPs in the dNTP mix is not specified by Stratagene Ltd.
Phase Cycles Step(s) Temperature (°C) Duration (min)
1 1 Initial denaturation 95 0.5
2 18 Denaturation 95 0.5
Annealing 55 1.0
Extension 68 12.0
3 1 Final hold 4 00
Table  5.4.  Program  of  temperature  cycling  used  for  QuikChange  SDM. 
(Modified from Stratagene Ltd., 2003a.)
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Ltd.) in pure water.  250ng of DNA from the purified 0.7mM Mn2+ fepPCR 
reaction  (B0.7)  replaced  the  usual  mutagenic  primers.  The  QuikChange 
reaction was submitted to a program of temperature cycling in a TechGene 
thermal cycler (Techne Ltd.) (Table 5.4).
The  QuikChange  reaction  was  digested  with  10U  Dpn  I  (Stratagene 
Ltd.) for 2 hours at 37°C.  lpl of the digestion was transformed into competent 
E. coli XLIO-Gold  cells  by  heat-shock  (Section 2.3.7).  The  transformed cells 
were spread on LB  Amp+   agar.  Plasmid DNA was prepared (Section 2.3.6) 
from  overnight  cultures  (Section  2.3.2)  of  10  colonies  and  sequenced  with 
primer TKN (Section 2.3.13).
5.2.22 QuikChange MSDM
A variation of the QuikChange MSDM protocol (Stratagene Ltd., 2003b) was 
used.  A 25pl PCR reaction was made up containing the following (see Table 
5.5):  2.5U  QuikChange  Multi  enzyme  blend  (Stratagene  Ltd.),  QuikChange 
Multi  reaction buffer  (Stratagene  Ltd.),  0.75pl  QuikSolution,  150ng pQR711 
DNA,  and  lpl  of dNTP solution  (Stratagene  Ltd.)  in pure water.  lOOng of 
DNA  from  the  purified  0.7mM  Mn2+  fepPCR  reaction  (B0.7)  replaced  the 
usual  mutagenic  primers.  The  QuikChange  reaction  was  submitted  to  a 
program of temperature cycling in a TechGene thermal cycler (Techne Ltd.) 
(Table 5.6).
The  QuikChange  reaction  was  digested  with  10U  Dpn  I  (Stratagene 
Ltd.)  for  2  hours  at  37°C.  1.5pl  of  the  digestion  was  transformed  into
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|  Reagent Volume (pi) Amount
ddH20 10.5
10 x QuikChange Multi reaction buffer 2.5
QuikSolution 0.75
| dNTP mix 1
I  0.7mM Mn2+ fepPCR product 5 lOOng
pQR711 DNA 5 150ng
[ QuikChange Multi enzyme blend 1 2.5U
| Total 25
Table 5.5.  The components of the QuikChange MSDM.  The compositions of 
QuikSolution  and  QuikChange  Multi  enzyme  blend  are  not  revealed  by 
Stratagene  Ltd.  The  concentrations  of  dNTPs  in  the  dNTP  mix  are  also 
unknown.
Phase Cycles Step(s) Temperature (°C) Duration (min)
1 1 Initial denaturation 95 1
2 30 Denaturation 95 1
Annealing 55 1
Extension 65 12.0
3 1 Final hold 4 00
Table  5.6.  Program  of  temperature  cycling  used  for  QuikChange  MSDM. 
(Modified from Stratagene Ltd., 2003b.)
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competent  E.  coli  XLIO-Gold  cells  by  heat-shock  (Section  2.3.7).  The 
transformed cells were spread on LB Amp+  agar.  Plasmid DNA was prepared 
(Section  2.3.6)  from  overnight  cultures  (Section  2.3.2)  of  20  colonies  and 
sequenced with primer TKN (Section 2.3.13).
5.3  Results
5.3.1 FepPCR amplification of target B
5.3.1.1 Amplification of target B at various concentrations ofMn2 +
Target  B  (refer  to  Chapter  4)  was  chosen  as  the  model  sequence  for  the 
development  of  fepPCR.  11  fepPCR  reactions  (BO.O  to  B1.0)  were  set  up 
containing the following: Taq DNAP, Taq DNAP buffer, pQR711 DNA, primer 
tktBF, primer tktBR, each deoxynucleoside triphosphate (dATP, dCTP, dGTP, 
and dTTP), and Mg2+  (Section 5.2.1.1).  To reduce the fidelity of the DNAP, 
and  thus  achieve  "error-prone"  PCR,  Mn2+  was  added  to  the  reactions 
(Beckman et ah, 1985; Cadwell et al., 1995).  To generate a range of mutation 
rates  in  the  reactions  the  concentration  of  Mn2+  was  increased  in  O.lmM 
increments from OmM in reaction BO.O to ImM in reaction B1.0.
The reactions were submitted to a program of temperature cycling and 
then purified.  Agarose gel electrophoresis revealed  that the 53bp fragment 
had  been  amplified  in  the  first  eight  reactions  (BO.O  to  B0.7)  with  Mn2+  
concentrations higher than 0.7mM inhibiting fepPCR (Figure 5.2).
5.3.12 Mutation densities of the products from reactions BO.O to B1.0
The mutation densities  of the  products from fepPCR  reactions  BO.O to  B1.0
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M  BO.O  B0.1  B0.2  BO.3  B0.4  B0.5  B0.6  B0.7  B0.8  M
2kbp  ------
1.5k bp
Ikbp  ------
750bp  ------
300bp  ------
300bp  ------
150  bp  —
50bp------ Target B product (531
M  B0.9  B1.0  BC  M
2kbp  ------
1.5 kbp------
lkbp
750bp  ------
500bp  —
300bp  ------
150bp  ------
50bp------
Figure  5.2.  2.0%  agarose  gel  electrophoresis  of  target  B  fepPCR reactions. 
Sample lanes  "BO.O"  to  "B1.0"  contain the corresponding fepPCR reactions. 
Lane  "BC"  contains  the  control  reaction  (no  Taq  DNAP).  All  "M"  lanes 
contain marker DNA (50-2000bp).  The 53bp band in lanes "BO.O"  to "B0.7" 
corresponds to the fepPCR product of target B.
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were  gauged  by  digesting  them  with  the  restriction  enzyme  BstE  II  and 
analysing  the  resulting  fragments  by  polyacrylamide  gel  electrophoresis 
(Section  5.2.1.2).  It  was  reasoned  that  mutations  occurring  in  the  BstE  II 
recognition  site  in  target  B  (Figure  5.1b)  would  preclude  cleavage,  so  the 
proportion of undigested product would increase with mutation density.
Three 4-20%  gradient TBE replicate gels were run and the pattern of 
bands on each gel appeared to be identical (one gel is shown in Figure 5.3).  A 
band corresponding to the undigested target B fepPCR product  (53bp) was 
observed  in  sample  lanes  BO.O  to  B0.7.  This  band  appeared  to  increase  in 
intensity with increasing Mn2+ concentration.  Conversely, a second band was 
observed to decrease in intensity from lane B0.3 to B0.7.  It was believed that 
this  band  corresponded  to  the  digested  product  (two  24bp  fragments  with 
staggered  ends).  Neither  of  the  bands  were  seen  when  the  Mn2+  
concentration was >0.7mM because fepPCR was prevented.
The proportion of undigested product in each treated reaction (U) was 
determined quantitatively through the use of the software package Quantity 
One  (Bio-Rad  Laboratories).  In  each  case  the  peak  intensities  of  the 
undigested band and the fragment band were measured and U was calculated 
by dividing the former value by the sum of both values.  Figure 5.4 records 
the  U values  computed  for  the  BO.O  to  B0.7 sample  lanes  of all  three  gels. 
Mean U was observed to jump from 0%  at 0.2mM Mn2+ to 16.6%  at 0.3mM; 
subsequent increments  of O.lmM  yielded  progressively  smaller increases  in 
mean  U.  Mean  U reached  a  maximum at 0.7mM  Mn2+  when 40.0%  of the
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M  BO .O  B0.1  B0.2 BO.3  B0.4  B0.5  B0.6 B0.7  B0.8 B0.9 B1.0  M
Undigested product (53bp) 
Digested product
Figure  5.3.  Polyacrylamide  gel  electrophoresis  of  the  target  B  fepPCR 
reactions following digestion with restriction enzyme  BstE  II.  Sample lanes 
"BO.O" to "B1.0" contain the corresponding digested fepPCR reactions.  Both 
"M" lanes contain marker DNA (50-2000bp).  The 53bp band in lanes "BO.O" 
to "BO.7" corresponds to the fepPCR product of target B.  The second band in 
lanes "B0.2"  to "B0.7"  corresponds to the digested fragments of the target B 
fepPCR product.
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1   Mn2+  conc. 
(mM)
Proportion of product mutated in BsfEII site (%)  j|
A B C Mean ±oM
0.0 0.000 0.000 0.000 0.000 0.000
0.1 0.000 0.000 0.000 0.000 0.000
0.2 0.000 0.000 0.000 0.000 0.000
0.3 15.022 17.579 17.061 16.554 0.780
0.4 24.205 25.239 26.474 25.306 0.656
0.5 31.917 35.695 32.347 33.320 1.194
0.6 36.969 39.163 37.059 37.730 0.717
0.7 42.805 39.161 38.037 40.001 1.439
50  n
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H  30  - 
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20  -
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Mn2+  conc. (mM)
Figure  5.4.  The  effect of Mn2+  concentration on the  proportion  of target B 
fepPCR  product  with  mutated  BstE  II  recognition  sites.  The  error  bars 
correspond to ± o m .
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product had mutations in the BstE II recognition site.
5.3.2  Generation of E.  coli XLIO-Gold pQR711Bn colonies by two different 
methods
The conventional method for cloning epPCR fragments is ligation (Miyazaki 
and Takenouchi, 2002).  This method is, however, extremely labour-intensive 
because the concentrations of the DNA insert and the vector must be carefully 
optimized.  Even  then,  the  resulting  library  is  often  plagued  by 
phagemids/plasmids  with  no  inserts  and  phagemids/plasmids  with  more 
than  one  (Miyazaki  and  Takenouchi,  2002).  In  this  project  an  alternative 
approach for cloning was explored: QuikChange.  The QuikChange SDM kit 
(Stratagene  Ltd.,  2003a)  is  typically  used  for  the  SDM  of  plasmids:  two 
complementary  oligonucleotides  containing  the  desired  mutation  are 
extended  into  whole  plasmids  using  the  wild-type  plasmid  as  a  template 
(Figure 5.5).  As the fepPCR products of targets A, B, and C would be similar 
in  size  to  typical  mutagenic  primers  (normally  25-45  nucleotides),  it  was 
reasoned  that QuikChange  SDM  could  be  used  for  the  cloning  step.  This 
approach  would  be  tested  by  constructing  a  pQR711B^  library  from  the 
purified product of a target B fepPCR reaction.  If it proved to be successful 
then libraries pQR711An and pQR7110 would be generated in the same way. 
Library  pQR711ABC^  would  be  constructed  by  sequential  mutation  of  the 
three targets:  (1)  target  A  (pQR711A>1 );  then  (2)  target B  (pQR711AB^);  and 
finally (3) target C (pQR711 ABO1 ).
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Step 1
Plasmid Preparation
Step 2
Temperature Cycling
Mutagenic
primers
Step 3 
Digestion
Step 4
Transformation
Mutated plasmid 
(contains nicked 
circular strands)
Gene in plasmid w ith 
target site ((§ )) for m utation
Denature the plasmid and anneal the 
oligonucleotide prim ers ( « ') containing 
the desired mutation (x)
Using the nonstrand-displacing 
action of PfuT urbo DNA polymerase, 
extend and incorporate the 
mutagenic prim ers resulting 
in nicked circular strands
Digest the methylated, nonmutated 
parental DNA template w ith Dpn I
Transform  the circular, nicked dsDNA 
into X L 1  -Blue supercompetent cells
After transformation, the X L 1  -Blue 
supercompetent cells repair the 
nicks in the mutated plasmid
Figure 5.5.  Overview of the QuikChange SDM method.  (Reproduced from 
Stratagene Ltd., 2003a.)
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Stratagene  Ltd.  markets  a  variation  of  the  QuikChange  Site-Directed 
Mutagenesis  (SDM)  kit  known  as  the  QuikChange  Multi  Site-Directed 
Mutagenesis (MSDM) kit (Figure 5.6).  It differs from QuikChange SDM in its 
ability  to  mutate  up  to  five  sites  simultaneously  (compared  to  one).  The 
advantage of this system over the standard SDM kit was immediately clear: 
targets A, B, and C could be mutated simultaneously, eliminating the need for 
sequential  mutagenesis.  Initially,  however,  QuikChange  MSDM  was 
examined and compared to QuikChange SDM for its efficacy at generating a 
suitable  pQR711B^  library  from  the  purified  product  of a  target B  fepPCR 
reaction.
5.3.2.2  QuikChange SDM
A variation  of  the  QuikChange  SDM  protocol  (Stratagene  Ltd.,  2003a)  was 
used (Section 5.2.2.1).  A PCR reaction was made up containing the following: 
PfuTurbo DNAP, PjuTurbo DNAP buffer, pQR711  DNA, and dNTPs in pure 
water.  An  aliquot  of  the  purified  0.7mM  Mn2+  fepPCR  reaction  (B0.7) 
replaced  the  usual  mutagenic  primers.  The  QuikChange  reaction  was 
submitted  to  a  program of temperature cycling and  then digested  with the 
restriction  enzyme  Dpn  I  to  remove  the  methylated  parental  DNA.  The 
remaining  plasmid  library  (pQR711BH-S  where  "S"  stands  for  SDM)  was 
transformed  into  competent  E.  coli  XLIO-Gold  cells  by  heat-shock.  The 
transformed  cells  were  spread  on  LB  Amp+   agar  and  approximately  4900 
colonies  were  obtained.  Plasmid  DNA  was  prepared  from  10  colonies
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Step  1
Mutant Strand Synthesis (Thermal Cycling)
Thermal Cycles
♦
Step 2
Dpn I Digestion of Template DNA
Me Me
+ +
Me
Mb M e '
(Predominant product
from  Step 1)
Step 3
Transformation
t
Perform  thermal cycling to:
1) Denature input DNA
2) Anneal mutagenic prim ers
(all prim ers bind to same strand)
3) Extend prim ers and ligate nicks 
with the QuikChange M ulti 
enzyme blend
Digest methylated and 
hemimethylated DNA 
with Dpn I
Transform   mutated  ssDNA 
into XL10-Gold 
Ultracompetent Cells
Figure 5.6.  Overview of the QuikChange MSDM method.  (Reproduced from 
Stratagene Ltd., 2003b.)
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(pQR711 B^-SlA1  to  S1A10  [plate  1,  wells  A1  to  A10])  and  sequenced  with 
primer TKN (Figure 5.7).
Five  sequences  were  found  to  contain  single  point  mutations 
(pQR711 Bp-S1 A2,  S1A4,  S1A6,  S1A7,  and  S1A10).  The  five  remaining 
sequences  were  wild-type  (pQR711BP-SlAl,  S1A3,  S1A5,  S1A8,  and  S1A9). 
These  data  are  illustrated  as  a  pie  chart  in  Figure  5.8.  Three  of  the  10 
sequences (30%) had mutations in the BstE II recognition site.
53.2.2  QuikChange MSDM
A variation of the QuikChange MSDM protocol (Stratagene Ltd., 2003b) was 
used (Section 5.2.2.2).  A PCR reaction was made up containing the following: 
QuikChange  Multi  enzyme  blend,  QuikChange  Multi  reaction  buffer, 
QuikSolution,  pQR711  DNA,  and  dNTPs  in  pure  water.  An aliquot of the 
purified  0.7mM  Mn2+  fepPCR  reaction  (B0.7)  replaced  the  usual  mutagenic 
primers.  The  QuikChange  reaction  was  submitted  to  a  program  of 
temperature cycling and then digested with the restriction enzyme Dpn I to 
remove  the  methylated  parental  DNA.  The  remaining  plasmid  library 
(pQR711B^-M where "M" stands for MSDM) was transformed into competent 
E. coli XLIO-Gold cells by heat-shock.  The transformed cells were spread on 
LB  Amp+   agar  and  approximately  6400  colonies  were  obtained.  Plasmid 
DNA  was  prepared  from  20  colonies  (pQR711B^-MlAl  to  M1A20)  and 
sequenced with primer TKN (Figure 5.9).
Four  sequences  were  found  to  contain  single  point  mutations
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p£R711
P(3R711Bm-S1A1 
p(3R711B|j-Sl AE 
P(3R711Bm-S1A3 
P<2R711B|J-S1A4 
P(3R711Bm-S1A5 
p(3R711Bp-Sl At 
p(2R711Bp-SlA7 
pflR711Bp-SlAfi 
p<3R711Bp-Sl AT
p£3R711Bp-SlAlD  E7E
E7E  GTCAGCTGCACTCTAAAACTCC GAAGTGGGTTACACCGCTGGT  3E4
..........................................................  324
..........................................................  324
..........................................................  324
..........................................................  324
..........................................................  324
..........................................................  324
..........................................................  324
..........................................................  324
..........................................................  324
..........................................................  324
Figure  5.7.  Nucleotide sequences of the target B regions in 10 E.  coli XL10- 
Gold  pQR711B^-S  colonies  generated  by  QuikChange  SDM.  Target  B  (tkt 
nucleotides  +295  to  +303)  is shaded  blue and the  BstE  II  recognition site  is 
shaded black.
Single mutation (50%) No mutation (50%)
Figure 5.8.  A pie chart illustrating the proportion of pQR711Bv-S sequences 
with single point mutations in target B.  Target B is 9 nucleotides in length.
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p<3R711  E7E  GTCAGCTGCACTCTAAAACTCC
pC3R711Bp-f11 A1  E7E  ................................................
p(2R711Bp-f11 AS  E7E  ................................................
p(3R711Bp-F11 A3  E7E  ................................................
p<2R71]»Bp-f11A4  E7S  ................................................
p(3R711Bp-niAS  E7E  ................................................
pt3R711Bp-rilAb  E7E  ................................................
p(2R711Bp-MlA7  E7E  ................................................
p(3R711Bp-ni Afi  S7E  ................................................
p(3R711Bp-PllAc l  E7E  ................................................
p(3R?llBp-niAlD  E7S  ................................................
p(2R711Bp-niAll  E7E  ................................................
p(2R711Bp-P11AlE  E7E  ................................................
p<2R711Bp-n:LA])3  E7S  ...............................................
p(3R711Bn-niA14  E7E  ................................................
p(3R711Bp-niAlS  E7E  ................................................
p(2R711BM-niAlb  E7E  ................................................
p(3R711Bp-niA17  E7E  ................................................
p(3R711Bp-niAlfi  E7E  ...............................................
pi3R711BM-niAn  E7E  ...............................................
pi3R711BM-niASa  E7E  ............................................A
SGAAGTGGGTTACACCGCTGGT 3S4
3E3
3S4
353 
3E4 
3E4 
3E4 
3E4 
3E4 
3E3 
3E4
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3E4 
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3 4 * 3
Figure 5.9.  Nucleotide sequences of the target B regions in 20 E.  coli XL10- 
Gold pQR711BP-M colonies generated by QuikChange MSDM.  Target B (tkt 
nucleotides  +295  to  +303)  is shaded  blue and the  BstE  II  recognition site is 
shaded  black.  pQR711 B^-MlAl,  M1A3,  and  M1A9  have  single  deletions. 
pQR711B^-MlA20  has  a  25  nucleotide  addition  at  the  0  symbol 
(S'-GCCAGCTGCACTCTAAAACTCCGGATT).
(65%)
Figure  5.10.  A  pie  chart  illustrating  the  proportions  of  pQR711BH-M 
sequences with single and double point mutations in target B.  Target B is 9 
nucleotides  in  length.  "No  mutation  (65%)"  includes  sequences  that  were 
frame-shifted.
Double mutation (15%)
Single mutation (20%)
No mutation
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(PQR711BMV11A1,  M1A14,  M1A16,  and  M1A17)  and  three  were  found  to 
contain  double  point  mutations  (pQR711BP-MlA3,  M1A5,  and  M1A11) 
(Figure 5.10).  Of these sequences, two were frame-shifted (pQR711BMvllAl 
and  M1A3).  Two  other  sequences  were  frame-shifted  without  any  point 
mutations (pQR711Bt1 -MlA9 and M1A20).  The 11 remaining sequences were 
wild-type  (pQR711B^-MlA2,  M1A4,  M1A6,  M1A7,  M1A8,  M1A10,  M1A12, 
M1A13,  M1A15,  M1A18,  and  M1A19).  Six  of  the  20  sequences  (30%)  had 
mutations in the BstE II recognition site.
5.4 Discussion
5.4.1  FepPCR amplification of target B
Agarose  gel  electrophoresis  revealed  that fepPCR  amplification  of  target B 
was possible when the concentration of Mn2+ was ^0.7mM (reactions BO.O to 
B0.7)  (Section 5.3.1.1).  Mn2+  concentrations  >0.7mM  (reactions B0.8 to B1.0) 
prevented fepPCR and detectable amounts of product were not produced.
The presence of a BstE II recognition site (six nucleotides) in target B 
(nine nucleotides) (Figure 5.1b) allowed the mutation density in each reaction 
product to be gauged.  It was reasoned that if mutations occurred in the BstE 
II  recognition  site,  cleavage  by  the  restriction  enzyme  BstE  II  would  be 
precluded.  The proportion of undigested product would, therefore, increase 
with mutation density.
Aliquots of the reactions were incubated with BstE II for two hours (to 
permit  complete  digestion)  and  then  analysed  by  polyacrylamide  gel
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electrophoresis (Section 5.3.1.2).  The following results were obtained: (a) the 
proportion of fepPCR product with mutations in the BstE II recognition site 
(U) was nil for Mn2+  concentrations ^0.2mM; and  (b)  above 0.2mM Mn2+  U 
increased in a non-linear fashion with Mn2+ concentration to a maximum of 
40.0% at 0.7mM.
In 1985 Beckman and co-workers demonstrated that there were three 
mechanisms by which Mn2+ cations disrupt the fidelity of E. coli DNAP I: (a) 
by  interacting  with  the  DNA  template;  (b)  by  binding  to  single-stranded 
regions of the DNA template; and (c) by binding to weak accessory sites on 
the DNAP.  Beckman observed phenomenon (a) at low concentrations of Mn2+ 
(^O.lmM)  and  the  more  significant  phenomena  (b)  and  (c)  at  higher 
concentrations  (0.5-1.5mM).  These  findings  may  be  used  to  explain  the 
fepPCR results: (i) the products of reactions BO.O to B0.2 were ostensibly free 
of mutation because the Mn2+ concentrations were too low (<0.2mM) for any 
phenomenon other than (a) to occur; and (ii) the products of reactions B0.3 to 
B0.7 were increasingly mutated because the greater Mn2+ concentrations (0.3- 
0.7mM)  brought  about  phenomena  (b)  and  (c).  Further  experimentation 
would, of course, be necessary to prove or disprove this hypothesis.
The  relationship  between  the  proportion  of  fepPCR  product  with 
mutations in the BstE II recognition site (U) and the average point mutation 
density of the product (B) is:
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U*l-(R/L)B
Where R  =  length of the recognition site  (6 nucleotides  for  BstEU)  and  L  = 
length of the target (9 nucleotides for target B).  Or, after rearranging:
(R/L)B  *1 -U
B « log(R/L)(l —  U)
(Note  that  this  relationship  is  approximate  because  addition  and  deletion 
mutations  also  contribute  to  Li.)  This  formula  was  used  to  calculate  the 
average point mutation densities of the target B fepPCR products from their B 
values  (Table  5.7).  The  product  of  reaction  B0.7  had  the  highest  point 
mutation density: 1.26pmpv.  This figure was slightly higher than the target 
density  for  the  target  B  library  (lpmpv,  refer  to  Section  4.3.3)  and  was 
consequently chosen for the construction of the pQR711BP libraries.14
5.4.2  Generation of E.  coli XLIO-Gold pQR711Bn colonies by two different 
methods
QuikChange  SDM  and  QuikChange  MSDM  were  developed  by  Stratagene 
Ltd. to replace the labour-intensive cloning techniques typically used in SDM. 
Both  of these  methods  were  used  to  generate  pQR711Bi*  libraries  from  the 
product  of  fepPCR  reaction  BO.7;  using  this  product  instead  of  the  usual 
mutagenic  primers  meant  that  libraries  were  generated,  rather  than  single 
variants  of SDM.  The  quality  of  the  pQR711Bn  library  generated  by  each 
method was determined by sequencing.
14 It was anticipated that some loss of point mutation density would occur during the cloning 
step.
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Mn2+ conc. 
(mM)
U
(%)
Point mutation 
density
0.0 0.0 0.00
0.1 0.0 0.00
0.2 0.0 0.00
0.3 16.5 0.45
0.4 25.3 0.72
0.5 33.3 1.00
0.6 37.7 1.17
0.7 40.0 1.26
Table 5.7.  The relationship between average point mutation density in target 
B  and  the  Mn2+  concentration  in  target  B  fepPCR  products.  U  is  the 
proportion of undigested product in each reaction following treatment with 
the restriction enzyme BstE II.
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50%  of the  pQR711Bn-S plasmids created  by QuikChange SDM were 
found  to  have  single  point mutations  in target  B  (lpmpv)  (Section 5.3.2.1). 
The  remainder  were  completely  wild-type.  In  comparison,  20%  of  the 
pQR711B^-M  plasmids  generated  by  QuikChange  MSDM  had  single  point 
mutations in target B (lpmpv) and 15% had double point mutations (2pmpv) 
(Section  5.3.2.2).  Both  methods  were,  therefore,  successful  at  cloning  the 
mutated fepPCR product into whole pQR711 plasmids.
QuikChange MSDM generated some plasmids (20%) that were frame- 
shifted due to additions or deletions, but this phenomenon was absent from 
the pQR711Bi1 -S plasmids.  Frame-shifted proteins are drastically mutated or 
truncated, so one fifth of the pQR711Bvi-M library was, therefore, useless.  It 
should be stated, however, that this phenomenon has been observed in other 
experiments  using  QuikChange  SDM,  so  its  apparent  absence  from  the 
pQR711B^-S library was probably a function of the small sample size (only 10 
sequences).
40.0%  of the fepPCR product had mutations in the BstE II recognition 
site of target B (refer to section 5.4.1), while only 30% of the pQR711B^-S and 
pQR711B^-M sequences had them (in both cases).  This reduction in mutation 
density  was  probably  caused  by  one  (or  more)  of  the  following:  (a)  a 
preference of the QuikChange mechanism for less-mutated primer sequences 
(fepPCR  product);  (b)  wild-type  plasmids  being  reconstructed  from  trace 
amounts of the fepPCR primers tktBF and tktBR (instead of fepPCR product); 
or  (c)  incomplete  elimination  of  wild-type  template  (pQR711)  by  Dpn  I
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digestion prior to transformation.
Transforming  small  amounts  of  the  QuikChange  reactions  into 
competent E. coli XLIO-Gold cells resulted in large numbers of colonies being 
generated: 4900 from lpl of the QuikChange SDM reaction (total volume: 50pl) 
and 6400 from lpl of the QuikChange MSDM reaction (total volume:  25pl). 
These figures were used to calculate the total numbers of colonies available 
from the entire reactions: -2.45 x 105 colonies of E. coli XLIO-Gold PQR711BP-S 
(4900 x -^ = 2.45 x 105) and -1.60 x 105 colonies of E. coli XLIO-Gold pQR711B^- 
M  (6400x^ = 1.60 xlO5).  Such numbers were  more  than sufficient for  any 
screening operation.
5.4.3  Application of the fepPCR-QuikChange method
5.4.S.1  This project
FepPCR  successfully  generated  highly-mutated  copies  of  a  short,  defined 
region in the tkt gene (target B).  The point mutation rate in the product was 
observed to increase with Mn2+  concentration, reaching a maximum of 0.14 
per  nucleotide  at  0.7mM  (a  -1270-fold  reduction  in  the  fidelity  of  Taq 
polymerase [Tindall and Kunkel, 1988]).
QuikChange SDM and QuikChange MSDM both proved to be effective 
at  cloning  this  fepPCR  product  into  whole  plasmids.  Firstly,  the  point 
mutation rate of the fepPCR product was well preserved in library pQR711B^- 
S and library pQR711B-HM.  Secondly, the point mutations were limited to the 
targeted  site  (tkt  nucleotides  +295  to  +303)  in  all  cases  (bar  sequence
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pQR711B^-MAll).  Thirdly,  large  numbers  of  E.  coli  XLIO-Gold  pQR711B^ 
colonies were obtained from each transformation.
The  lpmpv  sublibrary  component  of  library  E.  coli  XLIO-Gold 
pQR711B^-S  (50%)  was  found  to  be  greater  than  that  of library  XLIO-Gold 
pQR711B^-M  (20%).  To  achieve  90%  coverage  of  this  sublibrary  would, 
therefore,  require  the  following  numbers  of  colonies:  84  colonies  of  E.  coli 
XLIO-Gold pQR711BH-S (^x42 = 84, refer to Section 4.3.3.2) or 220 colonies
of XLIO-Gold PQR711BH-M ( ^  x 42 = 210).  In order that processing time was 
kept  to  a  minimum  the  pQR711BP-S  library  was  chosen  for  screening  and 
QuikChange  SDM  was  selected  to  generate  the  libraries  pQR711An  and 
pQRTllO.
QuikChange  SDM  was  rejected  as  the  cloning  method  for  the 
construction  of  library  PQR711AB01   as  it  would  have  involved  sequential 
mutagenesis of targets A, B, and C.  QuikChange MSDM was selected instead 
as  it  permitted  simultaneous  mutagenesis  of  the  targets  (Stratagene  Ltd., 
2003b): a swifter and more efficient approach.
5.4.3.2  Other projects
The  implementation  of  the  fepPCR-QuikChange  protocol  in  a  directed 
evolution project is summarised in Figures 5.11 and 5.12.  QuikChange SDM 
(Figure 5.11) is used for cloning when there is a single target for mutagenesis 
and QuikChange MSDM (Figure 5.12) is used when there are multiple targets. 
The strengths of fepPCR-QuikChange as a mutagenesis method are: (a)
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I
(3)
I
(4)
Figure 5.11.  Implementation of fepPCR-QuikChange SDM in the construction 
of a plasmid library with a single mutagenesis target.  (1) fepPCR of the target 
site is performed (point mutations are shown as red dots).  (2) The resulting 
array  of  mutant  dsDNA  fragments  is  purified  by  a  QIAquick  nucleotide 
removal kit (one fragment,  coloured  blue,  is shown here).  (3)  QuikChange 
SDM: the purified mutant fragments are extended into whole plasmids using 
wild-type plasmid DNA as the template (the template is coloured black and 
the  new  DNA  is  coloured  green).  (4)  The  methylated  parental  DNA  is 
removed by digestion with the restriction enzyme Dpn I, leaving a library of 
plasmids with different mutations in the  target site.  Of the three plasmids 
shown here two are members of the lpmpv sublibrary and one is wild-type.
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CO
Target A  Target B  Target C
I  1   I -------1   I -------1
^   ^...........
  nrm-m    ^
(2)
1 1 1
(3) \   I  /
(4)
I
Figure  5.12.  Implementation  of  fepPCR-QuikChange  MSDM  in  the 
construction  of  a  plasmid  library  with  multiple  mutagenesis  targets.  The 
process is identical to that of fepPCR-QuikChange SDM (Figure 5.11) except 
that:  (a)  multiple  target  sites  (coloured  blue,  magenta,  and  yellow)  are 
amplified by fepPCR in parallel reactions (step 1) and purified (step 2); and (b) 
the mutant fragments from all fepPCR reactions are incorporated into whole 
plasmids  simultaneously  by  QuikChange  MSDM  (step  3).  Of  the  three 
plasmids shown here (step 4) one is a member of the 3pmpv sublibrary, one is 
a  member  of  the  2pmpv  sublibrary,  and  one  is  a  member  of  the  lpmpv 
sublibrary.
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one  or more  short,  defined  regions  of a  gene  may  be  subjected  to  extreme 
mutagenesis  (^0.14  point mutations  per  nucleotide);  (b)  the  point mutation 
density in the plasmid library may be varied through modulation of the Mn2+ 
concentration  in  the  fepPCR  step;  (c)  the  QuikChange  cloning  step  is 
extremely simple and rapid (compared to ligation); and (d) large numbers of 
colonies (variants) may be generated from a single cloning reaction (^105).
5.4.4  Novelty of the fepPCR-QuikChange method
Prior to 2002 there were no reports in the literature of QuikChange being used 
to  construct  plasmid  libraries  from  epPCR  products.  This  changed  when 
Miyazaki  and  Takenouchi  (2002)  described  "megaprimer  PCR  of  whole 
plasmid"  (MEG  A  WHOP).  As  MEG  A  WHOP generates plasmid libraries by 
QuikChange  of  epPCR  products,  the  publication  of  this  article  had  some 
impact on the novelty of fepPCR-QuikChange.  The priming fragments used 
in MEGAWHOP are, however, considerably larger (~lkb) than those used in 
fepPCR-QuikChange (~50bp).
The fepPCR process that generates the priming fragments in the first 
instance currently remains a novel variation of epPCR.
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6.1 Introduction
The  results  of  the  previous  chapter  demonstrated  the  need  to  choose  the 
appropriate  QuikChange  protocol  for  creating  a  library  by  fepPCR- 
QuikChange.  As libraries pQR711AH, pQR711BP, and pQR7110* had single 
targets  for  mutagenesis,  QuikChange  SDM  was  selected  as  the  cloning 
method  in  these  cases.  In  contrast,  the  multiple  targets  of  library 
pQR711 ABO1  required that QuikChange MSDM be used for its construction.
E. coli XLIO-Gold pQR711Bn-S colonies had been created by this point 
so  this  chapter  describes  generation  of XLIO-Gold  pQR711A^-S,  XLIO-Gold 
pQR71101 -S,  and  XLIO-Gold  pQR711ABO-M  colonies.  The  screening 
procedure developed in Chapter 3 (summarised in Figure 3.15) was then used 
to test the transketolase variants in all four libraries for the desired activity: 
the conversion of pyruvate and glycolaldehyde to  (S)-3,4-dihydroxybutan-2- 
one  (and  carbon  dioxide)  (Figure  1.14).  The  desired  levels  of  sublibrary 
coverage were: (a) 90% coverage the single target lpmpv sublibraries; and (b) 
90% coverage of the pQR711 ABO12pmpv sublibrary.
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6.2 Methods
6.2.1 Preparation of E. coli XLIO-Gold pQR711AH-S, XLIO-Gold pQRTllO-S, 
and XLIO-Gold pQR711ABO-M libraries
6.2.1.1 FepPCR amplification of targets A and C
FepPCR amplification of target A was performed by repeating Section 5.2.1.1 
with  tktAF  (5,-ATGGACGCAGTACAGAAAGCCAAA-3/)  (Cruachem  Ltd.) 
and tktAR (5'-CCC  ATAGGGGCCCCCGG-3')  (Cruachem Ltd.)  replacing the 
primers  tktBF  and  tktBR,  repectively.  A  smaller  range  of  MnCh  (Mn2+) 
concentrations was used in these reactions: 0,0.7, 0.8,0.9, and l.OmM.
FepPCR amplification of target C was performed by repeating Section
5.2.1.1  with  tktCF  (5,-ACTCCATCGGTCTGGGCGAA-3,)  (Cruachem  Ltd.) 
and  tktCR  (5,-CGACCTGCTCAACCGGCTG-3/)  (Cruachem  Ltd.)  replacing 
the  primers  tktBF  and  tktBR,  repectively.  The  range  of  MnCh  (Mn2+) 
concentrations used in the reactions was identical to that used in the fepPCR 
amplification of target A.
6.2.1.2 Generation of E. coli XLIO-Gold pQRJllAv-S and XLIO-Gold pQR711(y-S 
colonies by QuikChange SDM
The purified 0.7mM Mn2+ fepPCR products of targets A (A0.7) and C (C0.7) 
were used in QuikChange SDM (refer to Section 5.2.2.1) to generate colonies 
of E. coli XLIO-Gold pQR711 A^-S and XLIO-Gold pQR711C^-S, respectively.
Plasmid  DNA  was  prepared  (Section  2.3.6)  from  overnight  cultures 
(Section 2.3.2)  of 10  E.  coli XLIO-Gold  pQR711A^-S colonies  and  sequenced 
with primer TKN (Section 2.3.13).  Plasmid DNA was prepared (Section 2.3.6)
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from  overnight  cultures  (Section  2.3.2)  of  10  E.  coli  XLIO-Gold  pQR7110 
colonies and sequenced with primer TKC (Section 2.3.13).
6.2.1.3  Generation of E.  coli XLIO-Gold pQR711ABO*-M colonies by QuikChange 
MSDM
The purified 0.7mM Mn2+ fepPCR products of targets A (AO.7), B (B0.7), and C 
(CO.7) were used in QuikChange MSDM (Section 5.2.2.2) to generate colonies 
of E. coli XLIO-Gold pQR711AB01 -M.  lOOng of each purified fepPCR product 
were  included  in the  reaction.  Plasmid  DNA  was  prepared  (Section 2.3.6) 
from  overnight  cultures  (Section  2.3.2)  of  20  colonies  and  sequenced  with 
primer TKN and primer TKC (in separate reactions) (Section 2.3.13).
6.2.2  Screening  of  libraries  pQRTllAn-S,  pQRTllBn-S,  pQRTllCn-S,  and 
pQRTllABCn-M for the desired activity
6.2.2.1  Microwell culture
A Qpix2 robot (Genetix Ltd.) was used to pick 147 colonies of E.  coli XLIO- 
Gold pQR711An-S into 147 wells of a single 384-well micro  well culture plate 
(refer  to  Section  3.2.2).  Four  wells  were  inoculated  with  E.  coli XLIO-Gold 
pQR711 to provide controls.  The plate was incubated at 37°C and agitated at 
a rate of 1600rpm for 16 hours.
84 colonies of E. coli XLIO-Gold pQR711BP-S, 230 colonies of XLIO-Gold 
pQR711CH-S, and 2388 colonies of XLIO-Gold pQR711ABO*-M were cultured 
using the same procedure.  Four wells in every plate were set aside for E. coli 
XLIO-Gold pQR711 controls.
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6.22.2  Incubation with target substrates and HPLC analysis
Every microwell culture plate was screened using the procedure described in 
Figure  3.15.  HPLC  chromatograms  were  collected  for  all  of  the  screening 
reactions  following  four  hours  of  incubation  at  25°C.  The  pyruvate  peak 
heights in each library's chromatograms were consolidated into a single text 
file using a small Java program.
6.3  Results
6.3.1 Preparation of E. coli XLIO-Gold pQR711AP-S, XLIO-Gold pQRTllO-S, 
and XLIO-Gold pQR711ABCH-M colonies
6.3.1.1 FepPCR amplification of targets A and C
FepPCR  amplifications  of  targets  A  and  C  were  carried  out  using  the 
following pairs of primers: (a) tktAF and tktAR for target A; and (b) tktCF and 
tktCR  for  target  C  (Section  6.2.1.1).  The  following  range  of  Mn2+  
concentrations was utilised in both cases: 0,0.7,0.8,0.9, and l.OmM.
Agarose  gel  electrophoresis  revealed  that  the  50bp  target  A  product 
had been amplified in reactions AO.O to A0.8 (Figure 6.1).  Mn2+ concentrations 
higher than 0.8mM prevented fepPCR.
A  separate  gel  revealed  that  the  54bp  target  C  product  had  been 
amplified in reactions CO.O to C0.9 (Figure 6.2).  Mn2+ concentrations higher 
than 0.9mM prevented fepPCR.
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M  AO.O  A0.6  AO.7  A0.8  A0.9  A1.0  AC  M
2kbp  ------
1.5kbp  ------
lkbp  —  
750bp  —
500bp  ------
300bp  ------
150bp  —  
50bp  ------ Target A product (50bp)
Figure  6.1.  2.0%  agarose  gel  electrophoresis  of  target  A  fepPCR  reactions. 
Sample lanes "A0.0"  to "A1.0"  contain the corresponding fepPCR reactions. 
Lane  "AC"  contains  the  control  reaction  (no  Taq  DNAP).  Both  "M"  lanes 
contain marker DNA (50-2000bp).  The 50bp band in lanes "AO.O"  to "A0.8" 
corresponds to the fepPCR product of target A.
Target C product (54bp)
Figure  6.2.  2.0%  agarose  gel  electrophoresis  of  target  C  fepPCR  reactions. 
Sample lanes "C0.0"  to  "C1.0"  contain the corresponding fepPCR reactions. 
Lane  "CC"  contains  the  control  reaction  (no  Taq  DNAP).  Both  "M"  lanes 
contain marker DNA (50-2000bp).  The 54bp band in lanes "C0.0"  to "C0.9" 
corresponds to the fepPCR product of target C.
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6.3.1.2  Generation of E. coli XLIO-Gold pQR711Ai4 -S and XLIO-Gold pQR711Ci*-S 
colonies by QuikChange SDM
The purified 0.7mM Mn2+ fepPCR products of targets A (A0.7) and C (C0.7) 
were  used  in  QuikChange  SDM  to  generate  colonies  of  E.  coli  XLIO-Gold 
pQR711AH-S  and  XLIO-Gold  pQR71101 -S/  respectively  (Section  6.2.1.2). 
Approximately  6100  colonies  of  E.  coli  XLIO-Gold  pQR711A^  and  5500 
colonies of XLIO-Gold pQR711C^ were obtained.  Plasmid DNA was prepared 
from 10 colonies of E. coli XLIO-Gold pQR711A^-S (pQR711Avl-SlAl to S1A10) 
and each was sequenced with primer TKN (Figure 6.3).  Plasmid DNA was 
prepared from 10 colonies of E. coli XLIO-Gold pQR71101 -S (pQR71101 -SlAl 
to S1A10) and each was sequenced with primer TKC (Figure 6.4).
Of the pQR711A^-S sequences, two were found to contain single point 
mutations (pQR711 A^-Sl A2 and S1A7).  A single sequence was frame-shifted 
(pQR711 A^-Sl A1).  The  seven  remaining  sequences  were  wild-type 
(pQR711 AH-S1A3, SI A4, S1A5, S1A6, SI A8, SI A9, and S1A10).
Of the PQR71101  sequences, three were found to contain single point 
mutations  (pQR71101 -SlAl, S1A4,  and S1A7).  Two sequences were frame- 
shifted  (pQR711CP-SlA5  and  S1A6).  The  five  remaining  sequences  were 
wild-type (pQR71101 -Sl A2, SI A3, S1A8, S1A9, and S1A10).
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pflR?ll  4b  ATGGACGCAGTACAGAAAGCCAAA 
d<2R711Au-S1A1  4b  .......................................- .........................
TCCGGTCACCCGGGGGCCCCTATGGG  T5
...............................................  = 1 5
d<2R711Au-S1A2  Mb  ................................................................... . . Q........... ...............................................  = 1 5
d(3R711Au-S1A3  Mb  .................................................................... ...............................................  = 1 5
d(3R711Au-S1A4  M b  ................................................................... ..............................................  = 1 5
d(3R711Au-S1AS  M b  ................................................................... ...................................  = 1 5
D(2R711Au-SlAb  M b  ................................................................... ...................................  = 1 5
d(3R711Au-S1A7  Mb  ................................................................... ............. £. ...............................................  = 1 5
nOR711Au-SlAA  M b  ................................................................... ..............................................  = 1 5
n(3R711Aij-SlAc l  M b  ................................................................... ..............................................  = 1 5
p<2R711An-SlA10  Mb  ................................................................... ...................................  TS
Figure 6.3.  Nucleotide sequences of the target A regions in 10  E.  coli XLIO- 
Gold  pQR711 Ap-S  colonies  generated  by  QuikChange  SDM.  Target  A 
(nucleotides +70 to +78) is shaded red.  pQR711 A^-Sl A1 has a single deletion.
p<2R?ll  13A5
P(3R711Cm-S1A1  13AS 
p£3R711Cp-SlA2  13AM 
p(2R711Cp-SlA3  13AS 
p(3R711Cp-Sl  A4  13AS 
p(3R711C|j-Sl  AS  13AS 
p(3R711Cp-Sl  A t j   13A5 
pflR711Cp-SlA7  13AS 
p(2R711Cp-SlAA  13AS 
p<3R711Cp-SlAT  13AS 
P(3R711Cm-S1A10 136S
ACTCCATCGGTCTGGGCGAAGA CGGCCCGACTCACCA
......... Q ...................
GCCGGTTGAGCAGGTCG
...................... C...
........................................4  .
.  .  .   J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
143A
143A
1437
143A
143A
143A
143A
143A
143A
143A
143T
Figure 6.4.  Nucleotide sequences of the target C regions in 10 E. coli XLIO- 
Gold  pQR711Cn-S  colonies  generated  by  QuikChange  SDM.  Target  C 
(nucleotides +1405 to +1419) is shaded magenta.  PQR7110-S1A5 has a single 
deletion.  pQR71101 -SlA6  has  a  38  nucleotide  addition  at  the  0  symbol 
(S'-CTCCATCGGTCTGGGCGAACTCCATCGGTCTGGGCGAA-S').
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6.3.1.S Generation of E.  coli XLIO-Gold pQRJllABCv-M colonies by QuikChange 
MSDM
The purified 0.7mM Mn2+ fepPCR products of targets A (A0.7), B (B0.7), and C 
(C0.7) were used in QuikChange MSDM to generate colonies of E. coli XL10- 
Gold  pQR711 ABC^-M  (Section  6.2.1.3).  lOOng  of  each  purified  fepPCR 
product were  included  in the  reaction.  Approximately  4400  colonies  were 
obtained.  Plasmid DNA was prepared from 20 colonies (pQR711 ABO-Ml A1 
to  M1A20)  and  each  was  sequenced  with  primer  TKN  and  primer  TKC 
(Figures 6.5 to 6.7).
Six  sequences  were  found  to  contain  single  point  mutations 
(pQR711 ABO-Ml A5, M1A8, M1A9, M1A12, M1A19, and M1A20), four were 
found  to  contain  double  point  mutations  (pQR711 ABC^-Ml A2,  M1A10, 
M1A11,  and  M1A17),  two  were  found  to  contain  triple  point  mutations 
(pQR711ABG1 -MlA4 and M1A6), and one was found to contain a quadruple 
point mutation  (pQR711AB01 -MlA13)  (Table 6.1  and  Figure 6.8).  Of these 
sequences,  three  were  frame-shifted  (pQR711ABOJ-MlA2,  M1A10,  and 
M1A12).  Two  other  sequences  were  frame-shifted  without  any  point 
mutations (pQR711 ABC^-Ml A14 and M1A15).  The five remaining sequences 
were wild-type (pQR711 ABCp-MI Al, Ml A3, Ml A7, Ml A16, and Ml A18).
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p<3R711  M b
p(3R711ABC|j-niAl  M b 
pflR711ABCp-niA2  M b  
p(2R711ABCp-HlA3  M b 
p(3R711ABCp-niAM  M b 
pflR711ABCp-niA5  M b 
pflR711ABCp-HlAb  M b 
P(3R?11ABCm-H1A7  M b 
p(3R711ABCp-niAfl  M b 
p(3R711ABCM-niAT  M b 
pflR711ABCp-niA10  M b  
p(3R711ABCp-niAll  M b  
p(3R711ABCp-rilA15  M b 
p(3R711ABCp-niA13  M b  
p(3R711ABCp-niAlM  M b  
p<2R711ABCp-niA15  M b  
p(3R711ABCp-niAlb  M b  
p(3R711ABCp-niA17  M b 
p(3R711ABCp-niAlfi  M b  
p(3R711ABCM-niAn  M b  
pflR711ABCp-niAB0  M b
ATGGACGCAGTACAGAAAGCCAAATCCGGTCACCCGGGGGCCCCTATGGG
...........x.......................
c ...................
........x....................
.. x ..............
..............g. .
...........x....................
...........x....................
...................................................T  . . .
...........A  . . .
...........A.............................
■=15
TS
IS
TS
TS
TS
T5
T S
T S
T S
T S
TS
TS
TS
T S
T S
T S
TS
TS
TS
Figure  6.5.  Nucleotide sequences of the target A regions in 20 £. coli XL10- 
Gold pQR711ABCP-M colonies generated by QuikChange MSDM.  Target A 
(nucleotides +70 to +78) is shaded red.
p<2R711
p(3R711ABCp-
pflR711ABCp-
p(2R?ll ABCp-
p(2R711ABCp-
p(3R711ABCp-
p<2R711ABCp-
p<2R711ABCp-
p<2R711 ABCp-
p(2R711 ABCp-
p<2R711ABCp-
p<2R?llABCp-
p<2R711ABCp-
p<2R711ABCp-
pflR711ABCp-
p(3R711ABCp-
pflR711ABCp-
p<2R711ABCp-
p(2R711ABCp-
pflR711ABCp-
p<2R711ABCp-
P11A1
PI1A2
PI1A3
PI1AM
niAS
niAb
niA?
niAfi
PI1AT
272
272
272
272
272
272
272
272
272
PI1A1D  272 
H lA ll  272 
P11A12  272 
H1A13  272 
PI1A1M  272 
P11A1S  272 
PllAlb  272 
H1A17  272 
PIlAlfi  272 
n iA n   272 
PI1A2Q  272
GTCAGCTGCACTCTAAAACTCCG GGTCACCCGGAAGTGGGTTACACCGCTGGT
....... -X
.   ...  X  ...  •
................... x.
.......................A
.   .   Q.................
x........
32M
32M
323
32M
32M
32M
32M
32M
32M
32M
32M
32M
32M
32M
323
323
32M
32M
32M
32M
32M
Figure  6.6.  Nucleotide  sequences  of  the  target  B  regions  in  pQR711ABO*- 
MA1  to  MA20.  Target  B  (nucleotides  +295  to  +303)  is  shaded  blue. 
pQR711 ABO-M1A2, Ml A14, and Ml A15 have single deletions.
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Sequence Number of target site mutations Frame-
shifted? A B c Total
PQR711ABCP-M1A1 0 0 0 0 No
pQR711 ABC^-Ml A2 1 1 0 2 Yes
pQR711 ABC^-Ml A3 0 0 0 0 No
pQR711 ABCf-MI A4 1 0 2 3 No
pQR711 ABO*-Ml A5 0 1 0 1 No
pQR711   ABCv-Ml A6 1 0 2 3 No
pQR711 ABCh -M1 A7 0 0 0 0 No
pQR711ABO»-MlA8 0 0 1 1 No
pQR711AB01 -MlA9 0 1 0 1 No
pQR711 ABC^-Ml A10 0 0 2 2 Yes
pQR711ABO>-MlAll 0 1 1 2 No
pQR711ABCv-MlA12 0 0 1 1 Yes
PQR711ABCP-M1A13 0 1 3 4 No
pQR711 ABC^-Ml A14 0 0 0 0 Yes
PQR711ABO-M1A15 0 0 0 0 Yes
pQR711ABC^-MlA16 0 0 0 0 No
PQR711ABCH-M1A17 1 0 1 2 No
pQR711 ABC^-Ml A18 0 0 0 0 No
pQR711 ABC^-Ml A19 0 1 0 1 No
pQR711ABC^MlA20 0 0 1 1 No
Table 6.1.  Summary of the numbers of point mutations occurring in targets 
sites A, B, and C of pQR711ABCMvllAl to M1A20.  Sequences which contain 
deletions or additions are identified in the final column of the table.
Quadruple mutation (5%)
Triple mutation (10%)
No mutation (35%)
Double mutation (20%)
Single mutation (30%)
Figure  6.8.  A  pie  chart  illustrating  the  proportions  of  pQR711ABO-M 
sequences with single,  double,  triple, and  quadruple point mutations in the 
overall target.  The combined length of targets A, B, and C is 33 nucleotides. 
"No mutation (35%)" includes sequences that were frame-shifted.
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6.3.2  Screening  of  libraries  pQR711AH-S,  pQRTllBH-S,  pQR7110-S,  and 
pQR711ABO-M for the desired activity
The  following  numbers  of  variants  were  successfully  screened  using  the 
procedure  described  in  Figure  3.15:  (1)  147  colonies  of  E.  coli  XLIO-Gold 
PQR711AP-S; then (2) 84 colonies of E. coli XL10-Gold pQR711Bi1 -S (generated 
in  Chapter  5);  then  (3)  230  colonies  of  E.  coli XLIO-Gold  pQR711C>1 -S;  and 
finally (4) 2388 colonies of E. coli XLIO-Gold pQR711 ABC^-M (Section 6.2.2). 
The PeakNet 5.1  HPLC-management software did not identify a peak at (or 
around)  0.72  minutes  (the  anticipated  retention  time  of  ([S]-3,4- 
dihydroxybutan-2-one)  in  any  of  the  chromatograms.  This  finding  was 
confirmed by ranking the chromatograms from each library in order of final 
pyruvate concentration (Figures 6.9 to 6.12) and examining the lowest 10% in 
each case by eye.
6.4  Discussion
6.4.1  Preparation of E. coli XLIO-Gold pQR711A^-S, XLIO-Gold pQRTHC^-S, 
and XLIO-Gold pQR711ABOI-M colonies
FepPCR amplification of target A was successful with Mn2+ concentrations of 
^0.8mM,  while  fepPCR  amplification  of target C  was  successful  with  Mn2+  
concentrations of £0.9mM (Section 6.3.1.1).  The purified 0.7mM Mn2+ fepPCR 
products  (A0.7  and  CO.7)  were  chosen  to  generate  libraries  pQR711An  and 
PQR71101  so that the mutation rates in these libraries would be equal to that 
of library pQR711B^.  The QuikChange SDM method was selected to create 
these  libraries  so  that  the  lpmpv  sublibrary  component  of  each
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30  -|
0  20  40  60  80  100  120  140
Pyruvate concentration (mM)
Figure 6.9.  Histogram of the final pyruvate concentrations in the screening 
reactions  of library  E.  coli XLIO-Gold  pQR711 Ap-S.  A  total  of 147 variants 
were screened.
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16  n
0  20  40  60  80  100  120  140
Pyruvate concentration (mM)
Figure 6.10.  Histogram of the final pyruvate concentrations in the screening 
reactions of library E. coli XLIO-Gold pQR711BP-S.  A total of 84 variants were 
screened.  The  chromatogram  for  variant  pQR711Bn-S2B20  revealed  a 
dramatically  reduced  donor  substrate  (pyruvate)  peak  (final  concentration: 
6.75mM), but no associated product ([S]-3,4-dihydroxybutan-2-one) peak.
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80  n
60  -
bo
40  -
20  -
0  20  40  60  80  100  120  140
Pyruvate concentration (mM)
Figure 6.11.  Histogram of the final pyruvate concentrations in the screening 
reactions  of  library  E.  coli  XLIO-Gold  pQR7110-S.  A  total  of 230  variants 
were screened.
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400  -|
Pyruvate concentration (mM)
Figure 6.12.  Histogram of the final pyruvate concentrations in the screening 
reactions  of  library  E.  coli  XLIO-Gold  pQR711ABO-M.  A  total  of  2388 
variants were screened.
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was maximised (refer to Section 5.4.2).
Sequencing revealed that 20% of the pQR711A^-S plasmids and 30% of 
the  pQR7110-S  plasmids  created  by  QuikChange  SDM  had  single  point 
mutations in the relevant target site (lpmpv) (Section 6.3.1.2).  The following 
numbers  of  colonies  were,  therefore,  required  for  90%  coverage  of  each 
lpmpv sublibrary (refer to Sections 4.3.3.2 and 4.4):  (a) target A: at least 210 
colonies of E. coli XLIO-Gold pQR711A^-S ( ^  x 42 = 210); and (b) target C: at
least  230  colonies  of  E.  coli  XLIO-Gold  pQR711G1 -S  (^x69 = 230).  The 
apparently low lpmpv contents of these libraries (compared to pQR711Bi1 -S) 
may have been due to one or more of the following:  (a) random variation in 
the  sample  sets;  (b)  Taq  DNAP  having  a  variable  misincorporation  rate  in 
0.7mM  Mn2+,  depending  on  the  target  sequence;  or  (c)  the  cloning  step 
(QuikChange) being of variable efficiency, depending on the target sequence. 
The small size of the sample sets means that factor (a) almost certainly made a 
contribution; further deductions based upon these data would, therefore, be 
unreliable.  Additional experiments that could be used to gauge the influences 
of factors (b) and (c) in the absence of factor (a) are described later.
The purified 0.7mM Mn2+ fepPCR products of targets A (A0.7), B (B0.7), 
and C (C0.7) were used in QuikChange MSDM to generate colonies of E. coli 
XLIO-Gold  pQRTllABG1 .  QuikChange MSDM was chosen for this task for 
two reasons: (a) it had been successful at generating a plasmid library from a 
fepPCR  product  (pQR711Bv>-M);  and  (b)  it  was  theoretically  capable  of 
incorporating the fepPCR products of targets A, B, and C into whole pQR711
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plasmids simultaneously (Stratagene Ltd., 2003b).  If QuikChange SDM had 
been chosen for  this  role  instead,  library  pQR711ABCP  would  have  had  to 
have  been  generated  by  sequential  mutagenesis  of  the  three  targets 
(pQR711AH, then pQR711AB^, and finally PQR711AB01 ).  This process would 
have  been  much  slower  than  QuikChange  MSDM  and  introduced 
significantly more variables.
30%  of  the  pQR711 ABC^-M  plasmids  generated  by  QuikChange 
MSDM had single point mutations (lpmpv) in the overall target (targets A, B, 
and  C),  20%  had  double  point  mutations  (2pmpv),  10%  had  triple  point 
mutations (3pmpv), and 5%  had quadruple point mutations (Section 6.3.1.3). 
The following numbers of colonies were, therefore, required for 90% coverage 
of the two sublibraries of interest (refer to Sections 4.3.3.2 and 4.4): (a) lpmpv: 
at least 507 colonies of E. coli XLIO-Gold pQR711ABG1 -M (^ x  152 = 507); and 
(b)  2pmpv:  at  least  22680  colonies  of  E.  coli  XLIO-Gold  pQR711ABO-M 
( q *2 x 4536 = 22680).  In the 20 plasmids sequenced the overall distribution of 
point mutations was:  four in target A, six in target B, and 14 in target C (a 
total of 24).  In theory, an even point mutation density (point mutations per 
base-pair)  across  the  three  targets  would  have  resulted  in  the  following 
distribution:  6.5  in  target  A,  6.5  in  target  B,  and  11  in  target  C.  As  with 
libraries pQR711 Ah-S and pQR711GI-S the small size of the data set precludes 
any meaningful discussion of variations between these two distributions.
The random variation that almost certainly impacted on the sequence 
analyses  of  libraries  pQR711A^-S,  pQR7HOI-S,  and  pQR711ABO-M  (this
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Chapter) and pQRZllB^-S (refer to Chapter 5) calls into question the accuracy 
of the  subsequent calculations for library  coverage  numbers.  The levels of 
library  coverage  that  are  stated  as  being  achieved  in  this  project  (refer  to 
Section  6.4.2)  are,  therefore,  only  approximate.  In  future  applications  of 
fepPCR-QuikChange accuracy could be improved either by sequencing more 
library members or doing the following: (a) ensuring that all of the target sites 
contain a restriction enzyme recognition site (targets A and C did not); and (b) 
measuring  the  mutation  density  of  each  target  site  in  the  plasmid  library 
(post-QuikChange)  by  PCR  amplification  (using  the  fepPCR  primers)  and 
subsequent restriction analysis (see Section 5.4.1).  There are two advantages 
of this approach over extra sequencing: (a) it would be far less expensive; and 
(b)  it would  allow  accurate  determination  of the  mutation  densities  in  the 
target sites at each stage of the process (post-fepPCR and post-QuikChange). 
Sequencing of library members would, however,  still be required to ensure 
that mutation had been effectively focused to the target sites.
6.4.2  Screening  of  libraries  pQR711AH-S,  pQR711Bn-S,  pQRTllCH-S,  and 
pQRTllABCn-M for the desired activity
The  following  (approximate)  levels  of  sublibrary  coverage  were  achieved 
during the screening phase of this project: (a) -81% of the pQR711A^ lpmpv 
sublibrary; (b) -90% of the pQR711Bn lpmpv sublibrary; and (c) -90% of the 
PQR7110  lpmpv  sublibrary  (Section  6.3.2).  Not  a  single  HPLC 
chromatogram exhibited a product ([S]-3,4-dihydroxybutan-2-one) peak.  One
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variant (pQR711B^-S2B20) did exhibit an appreciable drop in donor substrate 
(pyruvate)  concentration,  but  attempts  to  repeat this  observation with new 
cultures failed.  These findings suggested that a single point mutation in the 
target sites was  unlikely  to  yield  a variant of  E.  coli transketolase  with the 
desired activity (Figure 1.14).
Next,  the  2pmpv  sublibrary  of  pQR711ABO  was  screened.  2388 
colonies of E. coli XLIO-Gold pQR711ABO-M provided -22% coverage of the 
pQR711ABO  2pmpv  sublibrary.15  Unfortunately,  not  a  single  HPLC 
chromatogram  exhibited  a  product  peak  or  an  appreciable  drop  in  donor 
substrate concentration.
If  it  is  assumed  that  the  screening  system  did  not  suffer  from  a 
fundamental  flaw,  then  the  following  may  be  deduced:  (a)  a  variant  of 
transketolase  with the  desired  activity  was  not among the  members  of the 
four libraries that were screened; (b) it is extremely unlikely that any single 
point  mutation  in  the  codons  of  residues  Ser24-His26,  Gly99-Prol01,  or 
Asp469-His473 of E. coli transketolase would yield a variant with the desired 
activity; and (c) at least 22%  of variants with double point mutations do not 
have the desired activity.  As the screening system has successfully revealed 
transketolase  activity  with  only  one  modification  (P-HPA  as  the  donor 
substrate),  the  only  conceivable  flaw  with  it  is  that  the  product  (S)-3,4- 
dihydroxybutan-2-one  does  not  yield  a  peak  at  (or  around)  0.72  minutes, 
perhaps due to a low exctinction coefficient at 210nm wavelength or unusual
15 The target of 22680 colonies (90% coverage) was not achieved owing to equipment failures 
and time constraints.
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behaviour in the HPLC column.  As it is almost identical in structure to L- 
erythrulose these possibilities seem unlikely, but the acquisition of a sample 
of this compound is absolutely essential for the HPLC method to be validated 
and the conclusions of this chapter to be confirmed.
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7.1  Overall summary of this project
Transketolase has significant potential as an industrial biocatalyst.  It transfers 
a C2 (1,2-dihydroxyethyl) moiety from a donor substrate to a wide range of 
acceptor substrates in a stereospecific manner.  It is, therefore, suited to the 
production of pharmaceuticals and other compounds where optical-purity is 
required.  However,  its  application is  limited  by  the  expense  of the  donor 
substrate  that is typically  used  to force the  reaction to completion:  p-HPA. 
The aim of this project was to modify the donor substrate-specificity of E. coli 
transketolase so that it would accept pyruvate as a donor substrate.  Pyruvate 
is vastly cheaper than p-HPA but is chemically similar and would still render 
the reaction irreversible.
E.  coli  transketolase  required  two  modifications  for  it  to  be  able  to 
catalyse  the  desired  reaction  (Figure 1.14):  (a)  the addition of the  ability  to 
synthesise  1-hydroxyethyl  ThDP  from  pyruvate  and  ThDP;  and  (b)  the 
elimination of the  activity  that splits  this compound  into  acetaldehyde  and 
ThDP.  It was hoped that these modifications could be brought about by the 
directed  evolution  of  three  stretches  of  residues  that  lie  close  to  the  C2- 
hydroxyl  group  of  the  standard  reaction  intermediate  (1,2-dihydroxyethyl 
ThDP).  It  is  this  hydroxyl  group  that  is  absent  from  pyruvate  and  its 
(potential) reaction intermediate.
The  three  stretches  of residues  chosen for  mutagenesis  were:  Ser24- 
His26  (target  A),  Gly99-Prol01  (target  B),  and  Asp469-His473  (target  C)
187Chapter 7 - General discussion
(Chapter  4).  Primers  were  designed  to  flank  these  targets  and  they  were 
amplified by PCR in the presence of 0.7mM Mn2+ (fepPCR) (Chapters 5 and 6). 
Restriction  analysis  of the  target  B  product revealed  that these  cations  had 
lowered the fidelity of Taq DNAP approximately 1270-fold:  its frequency of 
misincorporation was 0.14 per nucleotide (Chapter 5).  The fepPCR products 
of targets A, B, and C were simultaneously incorporated into whole pQR711 
plasmids using QuikChange MSDM, thus creating the library pQR711ABCn 
(Chapter 6).  Three  additional  libraries  were  prepared  from the  individual 
fepPCR products: libraries pQR711A^, pQR711B>1 , and PQR71101  (Chapters 5 
and 6).  As only single products were being cloned, QuikChange SDM was 
chosen to generate these libraries.
A high-throughput screen for the desired activity was developed at the 
same  time  as  the  libraries  were  constructed.  The  screen has  the following 
steps:  (1)  transformation  of  the  plasmid  library  into  £.  coli  XLIO-Gold 
competent cells;  (2)  microwell culture of individual colonies;  (3)  lysis of the 
cultures; (4) incubation of the lysates with cofactors and the target substrates 
(pyruvate  and  glycolaldehyde);  and  finally  (5)  high-throughput  HPLC 
analysis measuring donor substrate (pyruvate) depletion.  The first four steps 
were  optimised  to  ensure  the  highest  possible  concentration  of 
holotransketolase in each screening reaction (Chapter 3).
The  sublibrary  compositions  of  the  libraries  were  determined  by 
sequencing and the numbers of colonies required for 90% coverage of certain 
sublibraries were calculated: (a) 210 for the PQR711AJ1  lpmpv sublibrary; (b)
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84  for  the  PQR711B11   lpmpv  sublibrary;  (c)  230  for  the  pQR7110  lpmpv 
sublibrary; and (d) 22680 for the pQR711ABO 2pmpv sublibrary (Chapters 5 
and 6).  It was anticipated that the single-target lpmpv sublibraries would be 
screened first to see whether the desired activity could be obtained through a 
single  point  mutation  in  either  target  A,  target  B,  or  target C.  The  larger 
pQR711ABO* 2pmpv sublibrary - with potential synergistic alliances between 
mutated residues - would be screened afterwards.
The  following  levels  of  coverage  were  actually  obtained  during  the 
screening step: (a) ~81% of the pQR711A^ lpmpv sublibrary; (b) -90% of the 
PQR711B11  lpm pv  sublibrary;  (c)  -90%  of the PQR71101  lpmpv  sublibrary; 
and  (d)  -22%  coverage  of the  PQR711AB01  2pmpv  sublibrary  (Chapter 6). 
Unfortunately, not a single variant was identified that possessed the desired 
activity.  The  ramifications  of  this  finding  and  possible  extensions  to  this 
project are described below.
7.2  Overall conclusions
The following conclusions were reached during the development of the high- 
throughput screen for the desired activity (Figure 1.14):
a)  Of  the  E.  coli  strains  tested,  XLIO-Gold  was  the  best  host  for  the 
pQR711  plasmid.  After adjusting for culture  turbidity,  E.  coli  XLIO- 
Gold  pQR711  sonicate  was  found  to  have  a  transketolase  activity 
approximately  double  that  of  JM107  pQR711  sonicate  (the  original 
strain used for transketolase-mediated condensations at UCL).  E. coli
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XLIO-Gold was, therefore, chosen to host the libraries.
b)  E.  coli  XLIO-Gold  pQR711  cultures  were  grown  to  substantial 
turbidities in 96- and 384-well plates.  A mean final OD600 of 3.410DU 
was  achieved  in 60pl  cultures  agitated  at 1400rpm for  16 hours in a 
37°C incubator.16
c)  Of the lytic methods tested, sonication proved to be the most effective 
at  releasing  transketolase  from  E.  coli  XLIO-Gold  pQR711  culture. 
However, a single cycle of freezing at -80°C and thawing was judged to 
be  the  most  efficient  way  of  lysing  microwell  cultures  in  a  high- 
throughput manner.
d)  A spectrophotometric assay for transketolase activity, based on the pH 
change that accompanies transketolase-mediated condensation, proved 
to  be  unreliable.  Further  work  may  allow  the  potential  of  this 
approach to be realised.
e)  An accurate, high-throughput HPLC assay for the desired activity was 
developed.  Based on a 50mm guard column, it is capable of processing 
one sample in 1.2 minutes.
The following conclusions were reached during the development of fepPCR- 
QuikChange and the construction of transketolase libraries:
a)  The  residues  most  likely  to  perform  the  role  of  p-HPA/pyruvate 
discrimination in E. coli transketolase are His26, HislOO, Asp469, and
16 Researchers at UCL are currently developing new methods of microwell culture that are 
better characterised and more effective than the method described here.
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His473.  These residues lie within 5.6lA of the C2-hydroxyl group of 
the  1,2-dihydroxyethyl  ThDP  reaction  intermediate  in  the  highly- 
homologous S. cerevisiae transketolase.
b)  The  best  targets  for  mutagenesis  were  reasoned  to  be  Ser24-His26, 
Gly99-Prol01,  and  Asp469-His473.  These  targets  incorporated  the 
four residues of primary importance, plus residues either side to allow 
flexibility or side-chain repacking.
c)  FepPCR  of  each  of  the  three  target  sites  was  possible  in  Mn2+  
concentrations of up to 0.7-0.9mM with higher concentrations causing 
more point mutations.  The misincorporation rate of Taq polymerase in 
0.7mM Mn2+ was estimated to be 0.14 per nucleotide.
d)  Overall,  the fepPCR-QuikChange technique proved  to be effective at 
creating plasmid libraries with mutation focused to specific sites.  Not 
only were mutations limited to the target stretches, but it was possible 
to derive large numbers of colonies from each cloning reaction:  more 
than  1  x  105  in  every  case.  QuikChange  MSDM  was  successful  at 
assimilating  the  fepPCR  products  of  multiple  targets  into  whole 
plasmids simultaneously.
The following conclusions were reached during the screening step:
a)  The  first  phase  did  not  reveal  the  desired  activity  in  the  following 
sublibraries: (i) -81% of the pQR711An lpmpv sublibrary; (ii) -90% of 
the  pQR711B^  lpmpv  sublibrary;  and  (iii)  -90%  of  the  pQR711CH
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lpmpv sublibrary.  This suggested that a single point mutation in any 
of the target sites was unlikely to yield an active variant.
b)  The  second  phase  of  screening  (library  pQR711ABO)  provided 
complete  (-100%)  coverage  of  the  lpmpv  sublibrary.  This  extra 
coverage failed to yield an active variant so it was concluded that no 
single point mutation in any of the target sites was capable of yielding 
the desired activity.
c)  The  second  phase  of  screening  also  provided  -22%  coverage  of the 
pQR711ABO 2pmpv sublibrary.  As no active variants were identified 
it was  concluded  that  one  fifth  of  all  possible  pQR711ABO  double 
point mutation variants do not possess the desired activity.
The failure of this project to identify a single variant of transketolase with the 
desired activity (Figure 1.14) was extremely disappointing.  It is possible that 
the limited sensitivity of the HPLC assay meant that variants with very low 
levels of the desired activity were screened but not identified.  If it is assumed 
that  the  formation  of  lOmM  (S)-3,4-dihydroxybutan-2-one  in  a  screening 
reaction would have been detected, then a variant yielding less product than 
this  would  have  had  an  activity  of  <0.102mkat.nr3  in  a  0.25ODU  culture 
sonicate:  126-fold  less  than  the  activity  of  a  wild-type  E.  coli  XLIO-Gold 
pQR711 sonicate with p-HPA.  Such a variant would have been of little use as 
a biocatalyst,  although it may have been suitable for further fine tuning by 
directed evolution.
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It  is  also  possible  that  a  useful  variant  existed  in  the  portion  of the 
2pmpv  sublibrary  that was  not screened.  However,  the  absence  of even a 
low-activity  variant  amongst  those  that were  screened  does  not  encourage 
optimism.
A  possible  explanation  for  the  dearth  of  variants  with  detectable 
activities is that the  project goal was too ambitious for the sublibraries that 
were  screened.  The  project  goal  was  ambitious  for  two  reasons:  (a)  two 
significant modifications to the enzyme functionality were required; and (b) 
the enzyme did not exhibit the desired activity to any extent to begin with.
7.3  Future work
Possible extensions  to this project that might enable the achievement of the 
project goal (Figure 1.14) are:
a)  Screening  a  pQR711ABO  sublibrary  with  a  higher  point  mutation 
density, such as 3pmpv, or
b)  Increasing the number of target sites or expanding the existing ones, or
c)  Using  random  oligonucleotide  mutagenesis,  rather  than  fepPCR,  to 
create a library that accesses all twenty amino acids at the four primary 
residues  (His26,  HislOO,  Asp469,  and  His473).  The  total  number  of 
unique protein sequences in such a library would be 1.6 x 105 (204 = 1.6 
xl05).
The latter three of these extensions would require a screening system that was
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capable of handling larger numbers of screening reactions than the existing 
one.  Possible improvements to the system are:
a)  Using  the  spectrophotometric  assay  for  transketolase  activity.  This 
would require  a massive improvement in the reliability of the assay, 
but  it  would  allow  multiple  384-well  plates  to  be  screened 
simultaneously.
b)  Culturing library members in 1536-well plates.  Good turbidities may 
be  achieved  if  a  high  shake  speed  is  used  (>1400rpm);  one  way  of 
attaining  such  a  speed  would  be  through  the  use  of  a  pneumatic 
shaker.17
c)  Pooling cultures before screening.  If 1536-well plates were used with, 
for example, four cultures per screening reaction, it would allow 6144 
variants to be screened per plate.
Alternatively, the ambitiousness of the goal could be reduced.  There are two 
ostensible ways to achieve this.  The first approach is to replace the starting 
point  of  the  directed  evolution  process  -  wild-type  transketolase  -  with  a 
mutant that exhibits a small amount of the desired activity (Figure 1.14).  It 
may  be  possible  to  generate  such  a  mutant  through  rational  protein 
engineering  using  the  active  sites  of  pyruvate-accepting  ThDP-dependent 
enzymes  as  templates  (see  Section 4.1).  The  second  approach  is  to  target 
acceptor substrate-specificity instead.  Such a goal would be "softer" because
17 Techelan LLC  manufactures  microwell plate shakers  that are capable of shake speeds in 
excess of lOOOOrpm.
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a substrate with some initial (wild-type) activity could be used.
Whether  a  more  complex  library  is  screened  for  the  desired  activity 
(Figure 1.14), the ambitiousness of the project goal is reduced, or an entirely 
new enzyme selected for direct evolution, it would be extremely interesting to 
see whether fepPCR-QuikChange can deliver the step enhancements  that it 
promises.
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